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Abstract 
Luminescent complexes of europium and terbium, incorporating new sensitizing 
chromophore moieties containing carboxylic acid functional groups, have been 
synthesised. It has been shown that the new tetraazatriphenylene chromophore leads 
to highly emissive complexes. A thiaxanthone chromophore, despite sensitizing 
lanthanide emission, results in complexes with lower quantum yields and is only 
practically useful for europium. 
Modification of the azaxanthone chromophore by formation of its N-oxide was 
investigated as a possibility of extending its longest wavelength absorption 
maximum beyond 340 nm. 
Phosphinate pendant arms were introduced into complexes containing the 
azaxanthone chromophore and resulted in highly emissive complexes 
Complexes of the new chromophores were investigated, together with numerous 
further examples, in terms of their susceptibility to quenching by electron rich 
species (iodide, ascorbate, urate). These experiments enhanced the mechanistic 
understanding of this process. 
Complexes using an azaxanthone chromophore with a carboxylic function and 
phenyl amide arms were used in coupling reactions. The coupling reactions involved 
isolation of the NHS ester of the complex. Cellular uptake and cytotoxicity 
experiments were carried out with several of these conjugate complexes. The 
possibility to observe these complexes using two photon excitation fluorescence 
microscopy was demonstrated. 
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CHAPTER] Introduction 
1 Introduction 
The importance of the phenomenon of fluorescence, first described by Sir George 
Gabriel Stokes in 1852, has grown from a simple and intriguing observation into a 
very widely used technique. Fluorescence based techniques are now amongst the 
principal tools used in biological research, especially in the fields of microscopy and 
cell imaging The high intrinsic sensitivity and modality of fluorescence had 
predestined it for this role, and its realisation comes through endless amounts of 
research and development.''^'^ 
The development has two principal aspects: instrumental development on the 
one hand and new fluorescent probes on the other. Confocal and multiphoton 
microscopy procedures are just some of the major advancements in instrumental 
development over recent years, each of which is being refined and improved 
constantly.'* 
Many fluorophore molecules have been developed and are being used for 
more specific and intriguing observations. The vast selection of small organic 
fluorophores' is accompanied by several other types of fluorescent label. The group 
of fluorescent proteins probably constitutes the major one. Isolation and cloning of 
the Green Fluorescent Protein from the jellyfish Aequorea Victoria initiated the 
development of this field. Since then, many new variants of the protein have been 
developed with improved photophysical, stability and functionality properties.^ 
Recent years have also seen a boom in the use of quantum dots. This advance is 
much more recent and hence not so well developed.' 
Receiving less attention from the biological community are luminescent 
metal complexes, whether based on a transition metal or a lanthanide (III) ion. These 
possess unique properties, which make'them particularly attractive for cellular 
imaging. Namely, their long luminescent lifetimes making time gated experiments 
possible and large Stokes' shifts, especially useful in FRET based experiments. 
Lanthanide emission fiirther offers a sharp, line-like spectrum, which can even 
exhibit ratiometric sensitivity to its environment.* 
The development of highly specific probes, capable of directed localization 
and reporting on cell status and activity, is happening for each class of fluorophore. 
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In vivo imaging in small animals is slowly being made possible by the development 
of NIR probes and multiphoton excitation techniques, as the problems associated 
with light propagation in tissue are decreased in these cases.^''° 
1.1 Development of Imaging Instrumentation 
Whilst this thesis deals with the development of new fluorescent probes, it is fitting 
to mention some of the current technological advances in the field of fluorescence 
microscopy, as these have implication for the design and structure of the new 
fluorophores. 
Inslniment Key application Advantage Disadvantage 
Scanning confocal 
Scanning disk confocal 
Multi-photon 
Wide-field 
Core confocal microscope 
suitable for most applications 
including imaging of fixed 
and living specimens. Can be 
used for many techniques 
including FRAP and FLIP. 
Add-ons enable FLIM and 
multiphoton. 
Live cell imaging confocal. 
Imaging thicker tissue 
specimens. 
General 'work horse' in 
imaging that is available in 
most departments. 
Highly flexible core Expensive. Notwell suited to 
technology, widely available longer-term live cell 
in many institutions imaging. Generally slow 
scanning except of the less 
flexible fast-scanning 
variations (e.g. resonant 
scanners). 
Less photobleaching, faster 
acquisition rates. 
Can be used to image deep 
inside tissues and model 
organisms. 
Fast, flexible data 
acquisition, with high spatial 
and temporal resolution; 
multidimensional data can be 
processed using 
deconvoluticn. 
Not suitable for 
photobleaching, and can 
have lower resolution than 
scanning systems, e.g., less 
amenable to imaging of 
multiple fluorophores, or 
more limited scan 
orientations during 
acquisition. 
Expensive. Requires 
specialised equipment and 
maintenance. Axial 
resolution inferior to 
scanning confocals. 
Not confocal so z-
information really requires 
deconvolution which is a 
complex issue. 
Photobleaching techniques 
require laser coupling. 
Table 1.1 - Instrumentation of fluorescence microscopy 
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1.1.1 Confocal Microscopy 
The aim of obtaining images with the best possible resolution and contrast is 
omnipresent in any imaging technique. One of the reasons for loss of these in normal 
(Epi-illumination, widefield) fluorescence microscopy set ups, is the fact that light 
emitted out of focus reaches the detector as well as light that is in focus. Confocal 
microscopy offers significant improvement to the image contrast and resolution, as 
only light coming from the plane of focus is allowed to reach the detector." 
^ ^ = Detector aperture 
Dichroic 
nunror 
Illumination sojrce 
lumination aperture 
Objective lens 
— Focal carte 
Specimen 
Figure 1.1 - Schematic representation of a confocal microscope" 
This is achieved by placing a pinhole between the specimen and the detector, which 
allows only the in-focus light (solid line. Figure 1.1) to reach the detector, rejecting 
the out-of-focus light (dashed line, Figure 1.1). This, however, creates new problems 
as spectral acquisition is much slower. Hence, more extended illumination of the 
sample is needed, leading to the danger of photobleaching and photodamage. These 
disadvantages are effectively removed by the use of spinning disk confocal 
microscopy, where a disc with multiple pinholes is used instead of a single one. Thus, 
a confocal image of the field of view can be generated in a much shorter time, 
furthermore a camera can be used instead of a photomultiplier tube. Recent advances 
include the use of high senshivity cameras, which leads to a decrease in the 
excitation intensity needed and a lessening of induced photodamage. 
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1.1.2 Multiphoton microscopy 
An alternative way of reducing the amount of light coming from planes out of focus 
is to reduce the amount of specimen being excited. Two-photon excitation 
procedures, using a pulsed laser as a light source offer one possible solution. Under 
these conditions, the excitation of the fluorophore is achieved by the concomitant 
absorption of two "low energy" (IR) photons (Figure 1.2). 
LD 
Exciled state lifetime 
Figure 1.2 - Energy diagram describing two photon excitation in fluorescence spectroscopy" 
The reduced number of excited fluorophore molecules results from the fact that it is 
the square of the intensity of the light that determines the probability of excitation. 
So, the number of excited fluorophores falls non-linearly as a function of the distance 
from the plane of focus. Thus, not only light generated from out of focus 
fluorophores is diminished, but also photobleaching and photodamage are 
significantly reduced. Moreover, the long wavelength (NIR) excitation wavelength 
suffers less scattering in the biological sample, leading to the possibility to collect 
information from within a tissue. The long wavelength, however, brings decreased 
spatial resolution. 
1.1.3 4Pi and I^ M mlcroscopy^^ 
The 4Pi microscopy is a modification of confocal microscopy experiment, which 
improves its axial (z-axis) resolution. The sample is however illuminated by light 
focused onto it from two opposing objectives. The fluorescence light is also collected 
using these two objectives (Figure 1.3). This is in principle equivalent to increasing 
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the numerical aperture value of the system, thus making the focal spot 3-4 times 
narrower than that of a single objective. 
The I^M microscopy set up replaces the laser excitation with a spatially coherent 
source such as an arc lamp. Once agaui the sample is illuminated through two 
objectives but Kohler illumination should preferably be used (Figure 1.3). An 
interference pattern is created and its modulation rapidly falls of f to constant 
intensity outside the common focal plane of the lenses. The signal collection is 
similar to that of the 4Pi experiment. 
a 
o 
CD 
r 
CL 
LU 
D-
e 
M 01 02 M 
^ 2-photon exc C det d eff 
• — -
z 
1 urn 
•\ A I lamp 
M Ol 02 M 
Figure 1.3 - 4Pi and I*M microscopy set ups and excitation light patterns" 
Both techniques thus achieve narrowing of the central excitation spot to 
approximately 100 nm. Further developments are needed however, for more 
practicable application of these principles. 
1.2 Developments of Imaging Techniques 
Developments are bemg made not only in the instrumentation for fluorescence 
microscopy, but also with new experimental techniques. 
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Technique Key application Advantage Disadvantage 
Fluorescence Recovery After 
Photobleaching (FRAP) 
Fluorescence Loss In 
Photobleaching (FLIP) 
Photoactivation 
Fluorescence Resonance 
Energy Transfer (FRET) 
Fluorescence 
Imaging 
Lifetime 
Total Internal Reflection 
Fluorescence Microscopy 
(TIR-FM) 
Fluorescence Correlation 
Spectroscopy (FCS) 
Monitoring diffusion rates of 
fluorescent species in cells. 
Monitoring diffusion rates of 
fluorescent species in cells. 
Selective illumination of a 
fraction of cell/organelle. 
Similar in many ways to a 
pulse-chase experiment. 
Monitoring protein-protein 
(or protein-lipid) interactions 
in live and fixed cells. 
A key technology for FRET 
measurement as it is 
concentration independent. 
Monitoring fluorophore 
mobility close to the 
covers! ip-sample interface. 
Monitoring diffusion 
dynamics in solution and in 
cells by measuring small 
changes in fluorescence 
caused by changes in 
microenvironmem. 
Simple. Implemented in 
most confocal microscopes 
very easily. 
More appropriate for longer 
time frames than FRAP. 
Very useful validation of 
FRAP kinetics and 
additionally indicates 
connectivity of fluorophore 
pools. 
Simple, allows selective 
imaging of subpopulation of 
structures/proteins. 
Multiple methods can be 
used to verify experiments. 
Can be implemented on both 
confocal and wide-field 
systems. 
Concentration-independent 
FRET measurements. Can 
also give useful data on the 
microenvironmeil of a 
fluorescent probe. Can be 
used for separation of closely 
related fluorophores. 
Excellent for monitoring 
dynamics of exo- and 
endocytosis, and plasma 
membrane events. 
Applicable to the analysis of 
size distributions (e.g., 
ligand hinging, complex 
formation). 
Data analysis can be 
complex. 
Continual illumination 
required can lead to more 
photodamage. 
Only applicable to a limited 
number of photoactivatable 
fluorophores and 
nonstandard lasers. 
Data analysis can be 
complex, careful correction 
for bleed-through and/or 
cross-talk required. 
Absolutely dependent on the 
orientation as well as 
proximity of fluorophores. 
Technically demanding, 
complex data analysis, 
difficult to apply to living 
cells. 
Requires careful alignment 
of illumination using 
specialise quipment. Can 
only by used for events 50-
200 nm from the coverslip. 
Complex mathematical 
analyses required. 
Table 1.2 - Experimental techniques for fluorescence microscopy'* 
Some of the more common protocols for fluorescence microscopy are described in 
Table 1.2. 14 
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1.2.1 Total Internal Reflection Fluorescence Microscopy 
(Evanescent Wave Microscopy) 
The principle of this teclinique arises from the formation of a standing (evanescent) 
wave during total internal reflection of light. Total internal reflection happens when 
light reaches an interface of high (glass) and low (water) refractive index media, in 
the medium with high refractive index, above a critical angle. The intensity of the 
new field ('evanescent wave'), which is formed in the medium of low refractive 
index, decreases exponentially with distance from the interface. 
f 
V % . 
10 urn 
Illumination for confocal and 
epifluorescence imaging 
Illumination for T IRF imaging 
Figure 1.4 - Differences in confocal and total internal reflection illumination and images 
obtained 12 
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Thus, only fluorophores close to the interface are excited. The depth of excitation can 
be varied with the angle of incidence and can range from 50 nm to 150 nm (Figure 
1.4). Once again the exposure of the cell to the excitation beam is significantly 
reduced, minimizing photobleaching and photodamage. 
1.2.2 Fluorescence Correlation Spectroscopy 
Fluorescence correlation spectroscopy (FCS) is a more specialised technique based 
on the observation and measurement of the fluorescence intensity fluctuation in a 
small volume (10''^ 1), arising from the diffusion of fluorophores in and out of the 
illuminated region as well as changes in their emission spectra. Its main use is in the 
study of events at cell membranes, where the diffusion is much slower than in the 
cytoplasm and, within the cellular compartments. Better resolution of this technique 
can be achieved with two photon excitation or by using total internal reflection 
fluorescence microscopy (TIRFM). 
1.2.3 Fluorescence (Forster) Resonance Energy Transfer (FRET) 
FRET is a process whereby energy of an excited chromophore (donor) is non-
radiatively transferred to another chromophore (acceptor) that is in close proximity 
(Figure 1.5). The transfer process involves a long range dipole-dipole coupling. The 
acceptor chromophore may subsequently emit the gained energy as fluorescence. The 
efficiency of this process is inversely proportional to the 6"^  power of the distance 
between the donor and the acceptor. Thus, observation of FRET implies that these 
two chromophores are within the range of 1-10 nm. Ranges of this order of 
magnitude are common in many biomolecules, their domains, complexes and 
conformational transitions and are far below the diffraction limits of optical 
microscopy. Further parameters, determining the efficiency of FRET are; spectral 
overlap of donor emission and acceptor absorpfion spectra, the relative-orientations 
of the donor absorption and acceptor transidon moments and the refractive index.''' 
16, 17 
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Excitation 
So 
FRET" 
V . . . A, : , : . i | ; . t . : . i 
Eni ic ; i : .h: 'n 
Donor 
Excitation 
Internal Conversion 
Donor Emission 
Acceptor 
So 
Non-radiative Process 
Energy Transfer Process 
Acceptor Emission 
Figure 1.5 - Schematic energy diagram representing Fluorescence Resonance Energy Transfer 
( F R E T ) " 15 
Therefore, it comes as no surprise that FRET based experiments have been widely 
used in many fluorescence microscopy experiments. Schematic examples of two 
ideas using FRET principles are shovra in Figure 1.6. 
B 
Step 1 step 2 
Kinase 
FRET reporter (direct) 
Binding of a ligand (triangle) (1) 
leads to a conformational change 
(2) In a receptor (gray) and alters 
FRET from CFP to FIAsH (green dot) 
FRET sensor (Indirect] 
A substrate undergoes modification 
(1) (e.g. pfiosptTorylation. orange 
dot), causing a conformational 
cfiarge (2) and altering FRET from 
CFP to YFP 
Figure 1.6 - Use of F R E T between a fluorescent protein and an organic dye or two fluorescent 
proteins to observe a conformational change in a peptide chain'* 
Metal complexes and quantum dots can also be part of FRET pairs. Work by Mathis 
et. al, for example, uses a europium cryptate complex as a donor for Alexa Fluor 
647, in experiments aimed at cell surface detection of membrane protein 
interactions. 
1 0 
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1.2.4 Fluorescence Lifetime Imaging Microscopy 
Fluorescence Lifetime Imaging Microscopy (FLIM) is based on the observation and 
determination of fluorescent lifetimes of probes in cellular media, instead of 
measuring emission intensity. The major advantage of measuring the fluorescent 
lifetime instead of the intensity is the fact that this measurement is independent of the 
probe's concentration and the light path length. Thus, a direct measurement of 
excited-state dynamics and reaction kinetics can be obtained, in suitable cases.'^ '^ '^ ' 
(a) Time domain (b) Frequency domain 
Exctaton Sample Fluorescence Escitatoi Samole FIjoresceroe 
l i l t 
0 37 Fc 
\ ''^ ' 
V V V V 
M = = ,Ec..FcE, 
I ft I 
. ^ ^ V — r - - -7-
11= 
Figure 1.7 - Two ways of measuring fluorescence lifetime; a) in the time domain and b) in the 
frequency domain^" 
The measurement of the lifetime can be undertaken using two different procedures 
(Figure 1.7). One is the time domain measurement and the second is a frequency 
domain measurement. It is the exponential decay after a single pulse excitation of the 
fluorescence intensity that is recorded and used for the lifetime calculation in the 
time domain experiment. In the frequency domain experiment, it is the modulation of 
the fluorescence signal from the probe, as a response to time modulated excitation, 
which forms the basis of the lifetime measurement. 
11 
CHAPTERl Introduction 
1.2.5 Fluorescence Recovery After Photobleaching (FRAP) and 
Fluorescence Loss in Photobleaching (FLIP) 
Fluorescence recovery afl;er photobleaching is a technique used to investigate the 
mobility of fluorescent probes in cellular media. It is based on the photobleaching of 
a defined space within the studied region and subsequent observation of the recovery 
of the signal, arising from new (unbleached) fluorophores diffusing into the bleached 
region (Figure 1.8).^ ^ 
Phojrib ejci-
Recovery 
Photobieach 
11, 
Immobllj Fraction 
"t|,-2 Mobile Fraction 
Time 
Figure 1.8 - Schematic representation of Fluorescence Recovery After Photobleaching 22 
Fluorescence loss in photobleaching is a complementary method, in which a specific 
region is photobleached repeatedly and the effect on the overall emission intensity 
from the given cell is observed. The decrease of the overall emission intensity is 
interpreted as evidence of free interchange of fluorophores between different regions 
of the cell. The failure to photobleach the entire population of chromophores in the 
given cell indicates isolation of different sub-populations and restricted exchange 
between them (Figure L9). 
B Initial ptiotobleacti 
Bleach 1 Bleach 2 Bleacn 3 Bleach 4 
Time 
Figure 1.9 - Schematic representation of Fluorescence Loss In Photobleaching^^ 
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1.2.6 Stimulated Emission Depletion (STED)^^ 
Stimulated emission depletion microscopy is based on a forced relaxation of the 
excited fluorophore back to the ground state by a means of a second light pulse. A 
photon of energy correspondmg to the depleting beam is emitted. This deactivation is, 
however, carried out with a pulse having a "doughnut-shaped" intensity profile. Thus, 
only molecules in the periphery of the excitation focal spot are deactivated and a 
very sharp excitation is achieved (Figure 1.10). 
(A) 
S T E D principle 
(B) 
S T E D microscope 
244 nm 
Bhaseplale 
Excitalion^STED Saturated 
spot spot * deptelion 
STED 
i 
104 nm 
Figure 1.10- Principle and experimental set up of Stimulated Emission Depletion Microscopy^^ 
1.2.7 Fluorescence Speckle Microscopy^*' 
Fluorescence speckle microscopy is a method to analyse the movement, assembly 
and disassembly dynamics of macromolecular structures. It was established during 
the study of cytoskeleton, for which it is very well suited. It uses covalently labelled 
macromolecules, which appear to be "speckled" when observed by flurorescence 
microscopy. The dynamics of the each macromolecule can then be deduced from the 
changes in the speckle patterns (Figure 1.11). 
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270 nm 
Figure 1.11 - Images demonstrating the principles of Fluorescence Speckle Microscopy" 
1.3 Classes of Fluorophore 
As mentioned earlier, the fluorophores used for cellular imaging may be divided into 
fovir distinct classes. The two more established ones are small organic dyes and 
fluorescent proteins, whereas the less common ones are quantum dots and 
luminescent metal complexes. 
1.3.1 Small Organic Dyes 
The list of small organic dyes that have found application in cellular imaging is very 
long. Fluorescein, DAPI, ethidium bromide, Hoechst 33342 or rhodamines are just a 
few of the classical examples of these.^  
The most powerful demonstration of the level of development in this field can almost 
certainly be obtained from Invitrogen's Handbook of Fluorescent Probes (The 
Handbook-A Guide to Fluorescent Probes and Labeling Technologies; 
http://probes.invitrogen.com/handbook/).^ It describes about 3000 fluorescent probes, 
designed and developed for use in cellular imaging. 
The major strength of small organic dyes is that they can be engineered and adapted 
for a particular purpose. Hence, series such as the ' Alexa''^^ or 'Cyanine''^^ (Figure 1. 
12) dyes have been developed where the excitation/emission wavelength is 
systematically changed by the changes in the structure of the fluorophore , thus 
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covering large parts of the visible and near infra-red regions of the spectrum (Figure 
1.13). Inclusion of reactive functional groups which enable conjugation of these 
probes to biologically relevant macromolecules is an integral part of the development 
in this field. 
HO3S, 
C y 2 Cy 5 
o^ 
H O 3 S 
Alexa 350 
COOH 
ONa' 
Alexa 546 
Figure 1.12 - Examples of small organic fluorescent molecules used in cellular imaging; the 
'Cyanine Cy' and 'Alexa Fluor' series''^* " 
s ^ 
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Figure 1.13 - Absorption (A) and emission spectra (B) of selected dyes from the 'Alexa Fluor' 
series^* 
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The emergence of new series of dyes, such as the DyLight, BODIPY and Nile blue 
derived dyes suggests that developments in this field are still ongoing.^^ 
The main drive at the moment is the development of probes emitting in the red and 
near infra-red end of the spectrum. These can be used for in-vivo imaging, as well as 
fluorescence microscopy at the cellular level. 
Short luminescence lifetimes (typically 1-10 ns), of the same order as endogenous 
fluorophores, and poor spectral separation of the excitation and emission bands (e.g. 
<50 nm) are the most common disadvantages of the low MW organic fluorophores. 
1.3.2 Fluorescent Proteins^®-
The use of fluorescent proteins in cellular imaging was initiated by the discovery of 
Green Fluorescent Protein from the jellyfish, Aequorea Victoria. 
Tyt5a Oly67 
Figure 1.14 - Image of the barrel structure protecting the G F P florophore and the structure of 
the fluorophore indicating the amino acids it has formed from' 
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It was the observation that the protein expressed outside of the original organism 
remains fluorescent, which led to the realisation that the fluorophore (Figure 1.14) 
assembles in an autocatalytic reaction of the polypeptide chain. 
The possibility to fluorescently tag proteins of choice by the hybridization of the 
native genome with the gene for FP production thus became apparent and has been 
exploited in many experiments 31,32, 33 
i GlyS7 
Uu64 
S t 
GFP W DsRed 
Figure 1.15 - Structure of the fluorophore of GFP and its mutated variant DsRed^'' 
Phe64 
The fluorescent proteins have been further developed by mutation. The primary aim 
was creafion of proteins with different excitation/emission profiles to the original 
GFP (Figure 1.15). Thus, proteins emitting from the blue to the far red are now 
available (Figure 1.16). 
Absorption sp«ctra of selected fluorescent 
proteins 
Emission spectra of selected fluorescent proteins 
Sapphire 
m Orange 
— mChehy 
•TiPltirri 
300 400 500 600 
Wavelength (nm) 
400 500 600 
Wavelength (nm) 
700 800 
Figure 1.16 - Absorption and mission spectra of selected fluorescent proteins (FPs)^' 
Further developments have been aimed at removing the tendency of FPs to 
oligomerise, optimizing the folding efficiency at 37 °C and increasing their 
photostability and optical brightness. These developments are expected to extend the 
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usefulness of FPs in cellular imaging even ftirther (Table 1.3). Nevertheless, the 
problem of labelling proteins with an allegedly "non-invasive" label of the same 
order of molecular volume and molecular weight, wil l always be present. 
Class Protein 
Source laboratory 
(references) 
Epilation' 
(ran) 
Emisjion^ 
(nm) 
Brighiness' Photastability* pKa Oligomerizatlon 
Far-red inFlum" Tilen (5) S9U 649 4 1 53 <4.5 Mciipiiier 
Red mClierrv« Tsleii I ' l l 587 filU 16 96 <4.5 Mcdcuer 
lilTcinjtCii Tslen 14) 5S4 581 95 98 4.7 Tande'1 dlmer 
inStr3wbeiTy« Tsleri 14) 574 596 26 15 '4.5 Mcii?fner 
J-Red' Evrogen 684 61U 8 8 ' 13 5. J Dlmer 
DsRed-inonoiner'' Clpntech 55ti 586 3.5 16 4 5 Mciioner 
Orange mOranges Ttlen (4) 648 562 49 9.0 6.5 Monomer 
mH) MBL Intl. (10) 548 559 31" 122 5.0 Uonaiier 
viellavf-greeii mCliriire' Tsien (16,23) 5t6 529 59 49 5.7 Monomer 
Venus Mlyav;akl (1) sts 528 53' 15 6.J Weak dimerl 
YPet« Dauglierly (2) 517 530 80' 49 5.6 Weak dlmer^  
EYfP InvltiDgen (18) 514 527 51 6'J 6.9 Weak dlmer^  
Breen Enteral d9 Invltnigen (18) 487 5l]9 39 0.69* 6.0 Weak dimerl 
E6FP Ctontech' 488 597 34 174 6.0 Weakdlmeii 
Cyan CyPet Daugheny (2) 435 477 18' 59 5.0 Weak dimeri 
tnCFPm™ Tslen (23) 433 475 13 64 4.7 Mononter 
Cerulean^ Piston (3) 433 475 27' 36 4.7 Weak dimerl 
T-Sapphit?" Qrieibtcklg] 399 511 2f i ' 25 t 9 le ikdln ier i 
Table 1.3 - Classification of the most useful fluorescent proteins 30 
1.3.3 Quantum Dots^ ® 
Quantum dots constitute the most recent addition to the range of fluorescent probes 
suitable for cellular imaging. They started off as a curiosity in materials science little 
more than two decades ago and have developed into a useful tool for biological 
science, particularly for cell labelling studies. 
The photochemical basis comes from the luminescence observed from colloidal 
suspension of monocrystals of semiconductors such as CdSe or CdTe. They typically 
consist of a protective ZnS shell. The surface layer may be coated to provide water 
solubility and fiinctionality for conjugation or interaction with biological systems. 
(Figure 1.18) 
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Figure 1.18 - Characteristics of quantum dots; A) dependence of emission wavelength on 
material and size; B) excitation and emission spectra; C) size comparison to other fluorescent 
probes or proteins^ 
The interesting properties of quantum dots relate to the possibility of obtaining 
different emission/excitation wavelengths based on the size of the semiconductor 
core which, in turn, can be tuned by the conditions of its synthesis. Furthermore, 
quantum dots have 10 to 100 times higher extinction coefficients, compared to 
simple organic fluorophores and fluorescent proteins, as well as very high 
photostabilities. Quantum dots also possess luminescent lifetimes longer than 10 ns, 
which makes them suitable for time-resolved microscopy, where the fluorescence of 
endogenous fluorophores is eliminated from the signal observed. Their size however 
does make it difficult for them to cross the cellular membrane. Thus, they can be 
used mainly for membrane staining or in fixed or permeabilised cells. On the other 
hand, their size and electron density makes them suitable for use in correlated 
electron microscopy.^ 
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1.3.4 Metal Complexes 
Luminescent metal complexes offer an alternative to entirely organic fluorophores. 
There are two major categories of luminescent metal complexes (Figure 1.19); 
luminescent transition metal complexes (e.g. Ru, Re, Os) and luminescent lanthanide 
complexes (Tb, Eu, Sm, Nd, Er, Yb).^' 
'•i^t>t'-'^..._ 
NM 
Figure 1.19 - Examples of emissive transition metal and lanthanide complexes 
The two common features that give these compounds advantages as fluorescent dyes 
for biological applications are their large Stokes' shifts and long lifetimes of 
luminescence (up to microseconds for transidon metal complexes and up to several 
milliseconds for lanthanide comlexes). The large Stokes' shifts ensure sufficient 
separation of excitation and emission spectra, which is most useful in FRET 
measurements. The long lifetimes of luminescence, on the other hand, enable time 
gated experiments that remove the background fluorescence from the signal observed. 
The nature of the excited state is what distinguishes these two types of metal 
complexes from the photophysical perspective. The transition metal complexes 
generally emit from an MLCT based excited state, whereas the lanthanide (III) ions 
all emit from a metal based excited state. The luminescence observed can be 
modulated by the design of the ligand structures in each case. 
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1.4 Applications of Fluorescent Probes 
The cellular medium is a very complex system, divided into numerous compartments 
(organelles), with an enormous number of events (chemical reactions, transport of 
compounds across membranes and supramolecular interactions) happening at any 
given time. Fluorescent compounds used in cellular imaging are expected to convey 
information about the condition of the biological system into which they are 
introduced. Therefore, further requirements are placed upon fluorophore molecules 
apart from the ability to enter the biological system and maintaining their 
fluorescence in a cellular medium. 
Hence, another way of classifying fluorescent probes is by their intended use and the 
information they should deliver. Some of the tasks that fluorescent molecules in 
cellular imaging are expected to perform are: selective staining of a particular 
cellular compartment, reporting on the concentration of ions (Ca^ "^ , H"^ ) and 
molecules, measuring enzyme activity or monitoring the synthesis transfer and 
interactions of biological macromolecules, such as proteins and nucleic acids. 
1.4.1 Compartment Staining 
Cells, especially eukaryotic ones, are divided into many different compartments. 
Being able to visualize these selectively is of interest to the biologist, as 
morphologies of different organelles can be indicative of the state of the cell. 
The compartments of greatest interest for observation are nucleus, mitochondria, 
Golgi complex, endoplastic reticulum, endosomes/lysosomes and cellular 
membranes (Figure 1.20)."'*'''^  Structures of the cytoskeleton such as tubulin and 
actin are also common targets for visualisation using fluorescent probes. 
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Figure 1.20 - Image of an animal cell showing its different compartments^ 
The staining of organelles is currently dominated by low MW organic dyes. With 
traditional, empirically identified dyes being replaced by dyes made for specific 
purposes. 
1.4.1.1 Nuclear Probes 
The cell nucleus (Figure 1.21) is an organelle of paramount importance, storing, 
reproducing and bringing into life the genetic information of the cell. Hence, 
visualisation of the nucleus, its substructures and dynamics is highly desirable. 
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Figure 1.21 - Micrograph of the cell nucleus 
Ethidium bromide, DAPI, Acridine orange, Hoechst dyes (Figure 1.22) and their 
derivatives are the classical examples of fluorescent dyes that interact with DNA. 
They are also capable of traversing the cellular and the nuclear membrane, hence 
staining the regions where most of the DNA resides. 
23 
CHAPTER] Introduction 
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CHjCHj 
Ethidium Bromide 
NH,* 
DAPI 
CHjNH* 
N(CH3)j 
Acridine Orange Hoechst 
Figure 1.22 - Examples of traditional fluorophores that stain the nucleus 2,5 
Ethidium bromide itself does not cross cellular membranes; only structurally related 
compounds such as Hexidium Iodide and Dihydroethidum are able to do that.' 
(CH,)5CH 
Hexidium Iodide 
CHjCH 
Dihydroethidium 
Figure 1.23- Cell permeable derivatives of Ethidium bromide' 
Dihydroethidium (Figure 1.23) fluoresces in the blue and stains the cytosol. In many 
viable cells, however, it gets oxidised to ethidium, which gives a red fluorescence 
only after intercalating into DNA."*" Hexidium iodide (Figure 1.23), which upon 
DNA binding has a shorter wavelength of emission compared to ethidium, stains the 
nuclei and cytosol of eukaryotic cells and it has been observed to stain mitochondria 
and nucleoli in certain instances. 
Both DAPI and Hoechst dyes exhibit blue fluorescence upon binding into the minor 
groove of DNA. DAPI shows selectivity for AT base pairs'" and possesses a higher 
photostability but lower brightness. The selectivity of DAPI for DNA binding over 
RNA binding is more pronounced than for Ethidium bromide and related probes. 
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Acridine orange is another intercalating DNA stain, which undergoes emission 
wavelength changes from 525 nm to 650 nm, upon binding. 
Another long wavelength emitting, cell permanent dye that targets the nucleus is 
LDS 751 (Figure 1.24). It undergoes fluorescence intensity enhancement upon DNA 
binding. It can be used to discriminate between intact nucleated, damaged nucleated 
and non-nucleated cells."*^ 
(HjCjzN 
N(CH3)2 
CH2CH3 
LDS 751 
Figure 1.24 - Structure nuclear probe LDS 751 
Further fluorescent probes for the nucleus have been developed by Invitrogen in their 
SYTO® range (Figure 1.25). 
Figure 1.25 - Overlay of brigiitfield and fluorescence images of human neutrophil nuclei stained 
with SYTO® dyes^ 
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Most of the SYTO dyes stain both DNA and RNA. The SYTO™RNASelect dye is 
claimed to stain RNA selectively.'*^ The usefulness of this series has yet to be fully 
tested. 
Chang et. al. have recently published the synthesis and cellular localisation of a 
library of styryl based fluorescent probes (Fig 1.26).'*'* 
Hjcq 
E36 F22 
Figure 1.26- Structures of styryl based fluorescent nuclear probes'*^  
These fluorophores show an increase of emission quantum yield as well as a red shift 
of excitation wavelength, upon binding to RNA and DNA (Figure 1.27). The 
increase in the emission intensity is larger in the case of RNA binding. 
P ion 
E36 E144 
to IS 
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Figure 1.27 - Titration curves for the styryl dyes with RNA (blue) and DNA (yellow)'''' 
The probes show strong nucleolus staining in cell labelling experiments, which is 
interpreted in terms of their selectivity for RNA. The authors claim better results in 
the live cell experiments (Figure 1.28) than with the commercially available 
SYTORNA^^Select dyes. 
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Figure 1.28 - Fluorescence images obtained with the styryl dyes in dilTerent cell types'*'' 
GFP and its variants are also used in nuclear staining. The motive is, however, to 
determine the localisation of a protein to which the GFP is fused. Thus, a GFP fused 
to DNA binding proteins was used to visualise structures such as centromers and 
histones in live cells (Figure 1.29).'''''*^ 
MSI 
Figure 1.29 - Fluorescence images obtained with GFP expressing together with a nuclear 
localizing protein in HeLa cells in different cell cycle phases'*' 
Nuclear localisation was observed in Durham with cyclen based complexes of 
terbium and europium, in experiments with live NIH 3T3 and CHO cells. 
Complexes containing a tetraazatriphenylene moiety were observed to reversibly 
stain the nucleus i f a high concentration gradient was maintained (0.2 to 1 mM 
complex in growth medium. Figure 1.30).''^  
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tJH. 
Figure 1.30 - Lanthanide complex and the fluorescence image obtained in NIH 3T3 cells 47 
A similar complex, bearing an azathioxanthone moiety, was shown to localise in the 
nucleolus by co-stainmg with SYTO-RNA dye (Figure 1.31)."* 
m 
o 
EtOzC 
Figure 1.31 - The fluorescence image showing the staining of NIH 3T3 cells with the Europium 
complex (red), SYTO-RNA dye (green) and a merged image"** 
1.4.1.2 Mitochondrial Probes 
Mitochondria are vitally important organelles of eukaryotic cells (Figure 1.32). 
Their key function is performing the energy transforming/producing reactions based 
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on oxidative phosphorylation and lipid oxidation. Further functions of the 
mitochondria involve urea, heme and non-heme iron production, steroid biogenesis 
and intracellular Ca^ "^  homeostasis. Mitochondria also play a key role in cell 
apoptosis. The morphology of mitochondria is highly variable across cell types and 
during the cell cycle. 
Figure 1.32- Electron micrograph of a mitochondrion 
The traditional fluorophores that stain mitochondria in live cells are Rhodamine 123 
and Tetramethyl rosamine (Figure 1.33). 
CO2CH3 
Rhodamine 123 Tetramethylrosamine 
Figure 1.33 - Structures of classical fluorescence probes for mitochondria^ 
Derived from the tetramethylrosamine and X-rosamine structures are the 
commercially available mictochondrial probes MitoTracker Orange and MitoTracker 
Red (Figure 1.34). They incorporate choromethyl groups that are assimied to react 
with thiol groups to link the probe covalently to proteins in the mitochondria.^ '*^  
This improves the retention of the probe for the work with fixed cells. However, 
subjecting cells to alkylating reagents can lead to damage and mutations. 
Phototoxichy of the MitoTracker dyes has been observed as well 50 
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MitoTracker*"' Orange 
CHjCI 
MitoTracker^"' Red 
Figure 1.34 - Structures of Mitotracker® probes' 
In addition, partially reduced forms of these fluorescent probes are available as well 
(Figure 1.35). They are non-fluorescent and become fluorescent only upon oxidation 
inside normally respiring cells. 
CH2C1 
MitoTracl(er<''' Orange-Hj 
Figure 1.35 - Structures of reduced mitochondrial probes* 
CHjCI 
MltoTrackei*"' Red-Hj 
Also available are the MitoTacker® Green and MitoFluor^"^ Green mitochondrial 
probes (Figure 1.36).^' Their major advantage is the fact that they are non-
fluorescent in aqueous media and only become fluorescent upon being taken into the 
less polar 'lipid'-like environment of the mitochondria. This practically eliminates 
background luminescence from the probe.^ 
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Figure 1.36- Structures of green fluorescent mitochondrial probes 
Furthermore, probes with a degree of responsiveness have been developed as well. 
Examples of these include RedoxSensor^"^ Red (2,3,4,5,6-
pentafluorotetramethyldihydrorosamine) and the JC-1 probe (5,5',6,6'-tetrachloro-
l,r,3,3'-tetraethylbenzimidazoylcarbocyanine iodide) (Figure 1.37). 
(CH3)jN NCCHafe 
RedoxSensor^" Red 
CHjCHz 
^JI^^J^ ^ C H = C H CH=<^ ^ 
CH2CH3 I 
CHjCHj 
JC-1 
Figure 1.37 - Structures of responsive mitochondrial probes' 
The RedoxSensor^'^ is introduced into the cell in its reduced non-fluorescent form. 
Depending on the reduction potential of the cytosol, it might be oxidised to its 
fluorescent form (excitation/emission 540 nm/600 nm) and then be taken up by 
mitochondria.^^ Alternatively, the reduced form is taken up by lysosomes and 
oxidised to the fluorescent probe there. Co-staining with MitoTracker® Green is 
beneficial for quantitative measurement of this distribution (Figure 1.38). 
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PF-TMRos Lysosomes Mitochondria 
Figure 1.38 - Live cell experiments with the RedoxSensor™ in NRK cells; upper row showing 
cells stained by the RedoxSensor during quinescent time (showing lysosomal localisation) where 
as lower row shows staining with RedoxSensor for proliferating cells. Lysosomes are stained by 
cascade blue conjugated dextran and mitochondria by MitoTracker green. S2 
The JC-1 probe displays concentration and potential (membrane) dependent 
excitation/emission profiles, which are attributed to its monomer (low concentration, 
low potential) and "J-aggregate" (high concentration, high potential). The momomer 
absorption and emission maxima are at 514 and 529 nm respectively. The aggregate 
on the other hand exhibits broad absorption and emission spectra with maxima 
around 590 nm (effective excitation can be achieved between 485 and 585 nm). The 
ratio of the two emissions is claimed to be dependent only upon the membrane 
potential. The spectral overlap of the emission of the monomer and absorption of the 
aggregate can, however, lead to problematic signal deconvolution. 
Carbocyanine dyes (Figure 1.39) with short chains (up to hexyl) stain mitochondria 
as well. 
y CH=CH-CH=>(^ 
R = C, loCe 
3,3'-dialkylcarbocyanine Iodide (DIOC f , ) 
Figure 1.39 - Short chain carbocyanine dye staining mitochondria* 
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The pentyl and hexyl derivatives stain the endoplasmic reticulum as well, at higher 
concentrations. 
A new mitochondrial probe MitoSOX red (Figure 1.40), capable of detecting 
superoxide production, has been developed by Invitrogen.'^ 
MitoSOX^" Red 
Figure 1.40 - Novel mitochondrial probe for superoxide detection 53 
Mukhopadhyay et. al. have used this fluorescent dye to monitor superoxide 
production in rat cardic-derived H9c2 myocytes and in human coronary artery 
endothelial cells (Figure 1.41). Antimycin A, Paraquat, Doxorubicin or high glucose 
were used as triggering compounds. The response was observed using confocal 
fluorescence microscopy as well as flow cytometry.''* 
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Figure 1.41 - Change in fluorescence of the MitoSOX^ probe upon addition of Doxorubicin''* 
Taliani et. al. have recently published the synthesis of a new fluorescent probe 
selective for mitochondria. The probe contains a ligand for the peripheral type 
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benzodiazepine receptor (PBR), which is expressed on the outer mitochondrial 
membrane. This receptor is believed to be involved in many of the biological 
frinctions of the mitochondria. Furthemore, its over-expression should mark a 
pathological state of the cells such as variety of tumours or neurodegenerative 
diseases (Huntington's and Alzheimer's disease, as well as muhiple sclerosis). The 
fluorophore in this probe is the 7-nitrobenz-2-oxa-l,3-diazol-4-yl (NBD) moiety 
(Figure 1.42). 55 
Figure 1.42 - Fluorescent probe for the Peripheral Benxodiazepine Receptor expressed on the 
mitochondrial surface 55 
Selective mitochondrial staining was also reported by Koide et. al. with their 
modified rhodamine fluorophore MitoAR (Figure 1.43). The MitoAR probe is 
faintly fluorescent due to the quenching by intramolecular photoinduced electron 
transfer. The fluorescence is "switched on" by the reaction of the probe with highly 
reactive oxygen species (hROS) such as hypochlorite or hydroxy 1 radical, which are 
formed in cellulo under oxidative stress conditions. The strongly fluorescent 
HMTMR (Figure 1.43) fluorophore is formed in this reaction 56 
MitoAR 
Almost nonfluorescent 
HMTMR 
Strongly fluorescent 
Figure 1.43 - Modified rhodamines as mitochondrial probes^ 
34 
CHAPTERl Introduction 
The localisation of the MitoAR was shown to be equivalent to that of the 
commercially available MitroTracker in a co-localisation experiment, despite the low 
emission intensity of MitoAR (Figure 1.44). 
(a) (b; 
1 
Figure 1.44 - Fluorescence microscopy images for MitoAR probes'* 
An increase in the emission intensity of the complex taken into HL-60 cells was 
observed, following addition of H2O2 (100 ^M) to the growth medium (Figure 1.45). 
Figure 1.45 - Response of MitoAR probe to H2O2 oxidative stress** 
In recent work, deriving from the work on cell penetrating peptides, two examples of 
mitochondria selective stains, based on guanidinium vectors, have been reported. 
Mendoza et. al. have syntheised a tetraguanidium, non-peptidic vector and labelled it 
with fluorescein (Figure 1.46).^ ^ 
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Figure 1.46 - Tetraguanidinum vector labelled with fluorescein^^ 
In cellular experiments, with HeLa cells, mitochondrial localisation was observed 
and confirmed by colocalisation with MitoTracker dye (Figure 1.47). 
i i 
Figure 1.47 - HeLa cells fluorescently labelled with the guanidinium probe (green), 
MitoTracker (red) and a merged image" 
Matiti et. al. have based their probe on sorbitol, once again using fluorescein as the 
label and guanidinium groups for targeting (Figure 1.48)." 
-R , 
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- O H 
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R2 = 0H 
Figure 1.48 - Sorbitol based polyguanidium fluorescent probe** 
Cellular experiments, involving colocalisation with MitoTracker probe, in HeLa cells 
were consistent with mitochondrial localisafion (Figure 1.49). 
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Figure 1.49 - HeLa cells imagined with the sorbitol based probe (gree), MitoTracker (red) and a 
merged image** 
Tsien et. al. have made an interesting GFP based probe for the mitochondrial redox 
potential. They have obtained a GFP (roGFP) variant containing two cysteines in 
close proximity, on the surface of the barrel structure incorporating the fluorophore 
(Figure LSO).^ *^  
B 
CysA147 
Cys/^ 204 
Reduced 
10A 
Figure 1.50 - Structures of RoGFP*' 
The formation and cleavage of the corresponding disulfide bridge induces changes in 
the emission intensity of the protein. 
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Figure 1.51 - Redox response of roGFP*' 
Furthermore, as the excitation spectra show an isosbestic point, a ratiometric 
measurement is possible with this probe (Figure 1.51). 
The cellular localisation of the roGFP was achieved by its expression with the El a 
subunit of pyruvate dehydrogenase, which is located in the mitochondrial matrix 
(Figure 1.52). 
Figure 1.52 - Fluorescence microscopy image obtained with roGFP*' 
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1.4.1.3 Probes for the Endoplasmic Reticulum and Golgi apparatus 
The endoplasmic reticulum and Golgi apparatus (Figure 1.53) are two closely linked 
organelles. They are the key biosynthetic compartments of the cell. Proteins are 
synthesised in the translation process in the ribosomes associated with the rough 
endoplasmic reticulum. Lipid biosyntheis also takes place here. The Golgi apparatus 
continues the biosynthesis by further transformations of these biological 
macromolecules and their packaging before being dispatched to other parts of the 
cell to ftilfil their roles.^ *'^ ^ 
The principal component of Endoplasmic reticulum and Golgi apparatus is a lipid 
membrane. Thus, the majority of the probes are highly lipophilic or lipid based. 
Others are molecules that affect protein movement, as this interferes with the 
function of these organelles. 
39 Figure 1.53 - An electron micrograph of the Colgi apparatus 
Some of the carbocyanine dyes, such as DiOC6, stain the endoplasmic reticulum as 
well as mitochondria, as mentioned in the previous section. The ER-Tracker^'^ Blue-
White DPX dye is claimed to be exclusively selective for endoplasmic reticulum 
(Figure 1.54).^° 
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ER-Tracker™ Blue-White DPX 
Figure 1.54 - Structure of ER-Tracker™ probe' 
This dye possesses several interesting properties, such as a large Stokes' shift, high 
extinction coefficient and solvatochromic dependence of emission wavelength and 
quantum yield. The emission wavelengths maximum exhibits a red shift with 
increasing solvent polarity in the range fi-om 430 to 640 nm. The emission quantum 
yield decreases with increasing solvent polarity. Furthermore, two-photon 
fluorescence microscopy has been perftjrmed with this dye (Figure 1.55).^ ' 
Figure 1.55 - Fluorescence microscopy image obtained with ER-Tracker probe in bovine 
pulmonary artery endothelial cells' 
The commercially available probes fox the Golgi apparatus are based on two 
fluorophores NBD and BODIPY and their conjugates with ceramide and 
sphingomyelin (Figure 1.56). They are usually used in solution with bovine serum 
albumin, which helps to dissolve these highly lipophilic molecules. 
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Figure 1.56- Fluorophore and lipid constituents of E R probes^ 
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Figure 1.57 - Fluorescence microscopy images showing the location of the Golgi apparatus in 
relation to other organelles'^ 
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Such a probe (NBD Ce-ceraminde) has been used in a study, together with Mito-
Tracker deep red (mitochondria staining) and BODIPY Texas Red thapsigargin 
(endoplasmic reticulum staining), investigating the juxtaposition of these organelles 
in pancreatic acinar cells and their responses to acetocholine-induced signals using 
Ca^ ^ ions (Figure 1.57)." 
Fluorescently labelled derivatives of Brefeldin A, which is a fungal metabolite, are 
also available for staining the Endoplasmic reticulum and Golgi apparatus. 
An interesting result in staining the Endoplasmic reticulum and Golgi apparatus has 
recently been reported by Villa et. al. They have published the preparation of NBD 
labelled choline (Figure 1.58) and described its use for fluorescence microscopy, in 
a study using commercially available Ce-NBD-phosphatidylcholine as well.^'' 
N O , 
NBD-choline 
Figure 1.58 - NBD-clioline" 
These dyes have shown differential localisation profiles in three related cell lines; 
drug sensitive carcinoma MCF-7 cells, multidrug resistant carcinoma MCF-7/DX 
cells and normal immortalized MCFIOA cells. 
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Figure 1.59 - NBD-choline fluorescence images in different cell types a) drug sensitive MCF-7 
cells, b) multidrug resistant MCF-7/DX cells, c) normal immortalised MCFIOA cells" 
Both probes localised in the Endoplasmic reticulum of the drug sensitive MCF-7 
cells. Predominant staining of the Golgi apparatus was observed with the two probes 
for the resistant MCF-7/DX cells, with partial ER staining especially with the Ce-
NBD-phosphatidylcholine probe. Virtually no staining was observed in the normal 
MCFIOA cells with NBD-choline, but a diffuse signal from the cytosol was observed 
for Ce-NBD-phosphatidyl choline (Figure 1.59).^ ^ 
R' 
N H H N 
Figure 1.60 - Squaraine rotaxane fluorescent probe and a fluorescence microscopy image 
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An interesting result has been reported by Smith et.al. using squaraine rotaxanes as 
fluorescent probes (Figure 1.60). They have prepared a rotaxane with the squaraine 
anion, as the fluorophore in the thread being protected by the macrocyclic ring to 
improve the chemical stability of the fluorophore. Different cellular profiles are 
observed with this fluorophore in different cell lines, with endoplasmic reticulum 
staining being observed in CHO cells (Figure 1.60). 
A europium complex with an acridone moiety has been observed to have cytosolic as 
well as ER localisafion in experiments carried out in Durham (Figure 1.61).^ ^ 
EtOjC" 
Figure 1.61 - Sturcture of europium complex exhibiting E R localisation^^ 
The cell experiments were carried out in NIH 3T3 cells and the localisation was 
confirmed by costaining with labelled Brefeldin A (Figure 1.62). 
Figure 1.62 - Fluorescence images of NIH 3T3 cells stained with the europium complex (red), 
labelled Brefeldin A (green) and the colocalisation image^ ^ 
A GFP that localises in the endoplasmic reticulimi has been used by Irvine et. al. in a 
study of ER and mitochondrial motility. The study was performed with HEK-293 
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cells and the authors observed the effect of Ca^ ^ and ATP on the motility of the 
organelles (Figure 1.63).^ ^ 
Figure 1.63 - Fluorescence image for an E R localising GFP** 
The GFP technique was recently used by Garstka et. al. in a study on the post 
translational processes and packing of the 'Major Histocompatibility Complex Class 
r molecules in the endoplasmic reticulum and Golgi of wild-type lymphocytes 
(Figure 1.64).^ ^ 
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Figure 1.64 - Fluorescence images of H-2D-GFP in Vero and C H O cells showing the 
translocation of the protein from E R to Golgi in the absence and presence of a peptide that 
disturbs this cycling*^ 
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1.4.1.4 Probes for Lysosomes 
Lysosomes are the digestive compartments of cells, involved in the processing of 
material taken up by cells in autophagy and endocytosis. They contain over 50 
different hydrolases (e.g. nucleases, proteases, glycosidases, lipases, phosphatases 
and sulphatases) that operate in acidic conditions. Therefore, the pH of lysosomes is 
keptatS.^^'^^ 
The lower pH of lysosomes is also used as a means for their labelling with some 
fluorescent dyes. This, for example is the case for the LysoTracker®^^ dyes from 
Invitrogen, where a weakly basic amine is linked to the fluorophore. Only a small 
portion of the probe is thus jV-protonated at the neutral pH of most of the cell 
compartments. The amine group gets substantially protonated in the acidic organelles, 
such as the lysosomes, switching off the photoinduced electron transfer process that 
quenches the singlet excited state.^  
Also available are the LysoSensor^'^ dyes, which show pH dependent changes in 
their emission spectra. The fluorophore in these probes is quenched by the amino 
group side chain. This quenching is effectively removed by the protonation of the 
amino group in weakly acidic compartments. Dyes with different emission maxima 
and pKa values are available (Table 1.4). 
Dye hbs (nm) (nm) pKa 
LysoSensor Blue DND-167 373 425 5.1 
LysoSensor Green DND-189 443 505 5.2 
LysoSensor Green DND-153 442 505 7.5 
LysoSensor Yellow/Blue DND-160 384 540' 3.9 
329 440'' 
LysoSensor Yellow/Blue 10000 MW Dextran 381 540' 4.2 
335 440'' 
Table 1.4 - Properties of different LysoSensor dyes (a: pH 3; b: pH 7)' 
46 
CHAPTER] Introduction 
The 2,3,4,5,6-pentafluorotetramethyldihydrorosamine, mentioned in the section on 
mitochondrial staining, can also stain lysosomes. The compartmental selectivity 
appears to be dependent on cytosolic redox potential, as mentioned above. Also the 
(2-aminoethyl)sulphonamide derivative of Dapoxyl® (Figure 1.65) shows 
accumulation in acidic organelles. 
Dapoxyl'"' (2-aminoinethyl)sulfonamide 
Figure 1.65 — Dapoxyl lysosomal fluorescence probe 
Lysosomal staining has been observed for compounds synthesised as Cathepsin K 
inhibitors (Figure 1.66) containing the piperazine-thiazol-phenyl fluorophore. 
Figure 1.66- Fluorescent Cathepsin K inhibitors exhibiting lysosomal localisation^ 
Figure 1.67 - Two photon fluorescence microscopy images of HepG2 cells loaded with 
Cathepsin K inhibitors showing lysosomal localisation 
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An analogous Eu complex to that mentioned in the section on endoplasmic reticulum, 
indeed its constitutional isomer, has been found to localise in lysosomes (Figure 
1.68). 
EtCbC > 
EtOjC" 
Figure 1.68- Europium complex localising in lysosomes 8,65 
The localisation was confirmed in NIH 3T3 cells by co-staining experiments with 
Lysotracker green (Figure 1.69). 
Figure 1.69 - Images of NIH 3T3 cells labelled with the europium complex (red), LysoTracker 
(green) and the merged image** *' 
Further lanthanide complexes were seen to be cell permeant in the work in Durham, 
and late endosomal or lysosomal localisation is suspected. This has yet to be verified 
in co-localisation studies.^'' 
1.4.1.5 Probes for cellular membranes 
Biological membranes are not organelles, as such, but are of paramount importance 
to the living system. They define the boundaries of cells and organelles, separating 
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their contents from the surroundings. Their structure does not permit free diffusion of 
matter from one side to the other. Their basic lipid bilayer structure is enhanced by 
incorporation of many membrane peptides. These are involved in reactions at the 
membrane, transport of chemical substances across the membrane or the receipt of 
chemical information from the surroundings."'^ ' 
The lipid constituents of biological membranes can be sorted into several groups. 
The major structural theme is their amphiphilicity, meaning that they contain a polar 
head group and a non-polar (hydrocarbon) tail. There are three major classes of 
molecules of membrane lipids: phospholipids, sphingolipids and cholesterol and its 
derivatives.''*'^^ Many experiments carried out to enhance the understanding of 
biological membranes are carried out using models such as vesicles, which range 
immensely in size and composition.^'' 
Many available fluorescent probes, localising into biological membranes, are derived 
from lipid molecules by the incorporation of fluorophores into the lipid structures. 
The fluorophores can be incorporated both into the long chain acid tails, as well as 
the head-groups for phospholipids. 
N(CH3); 
C,-BODIPY 500/510 C,2 
1-Pyrenedodecanoic add 
11 -((5-dimethylaininonaphlhalene-1 -sulfonyl)amino)undecanoic acid (DAUDA) 
p 
OH 
cis-parinaric add 
Figure 1.70 - Fluorescently labelled fatty acids 
Fluorescently labelled fatty acids (Figure 1.70) are available, even though their main 
use is for incorporation into fluorescent lipid molecules. They are also used directly 
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as probes for membranes and liposomes as well as in live cell experiments, 
conceming their metabolic fate. 
Phospholipid molecules, fluorescently labelled in the fatty acid part of the molecule 
(Figure 1.71), usually contain the probe in one chain of the acid, acylating position 
two of glycerol. The most common fluorophores are BODIPY and pyrene molecules. 
Diphenyl hexatrienyl and NBD fluorophores are used as well. It is, however, 
suspected that the NBD fluorophore is too polar, and therefore it localises in the head 
group region rather than deep in the phospholipid bilayer. 
2-(4.4-dinuoro-5-methyl-4-bora-3a,4a-diaza-s-jndacene-3*dodecanoyl) 
-1-hexadecanoyl-3n-glycero-3-posphocholine 
2-(6(7-nilrobenz-2-oxa-1.3-diazol-'l-yl)amino)hexanoyl-
1-hexadecanoyl-sn-glycero-3-phosphocho|jne 
C,5H3, 
1 -hexadecanoyl-2-(1 -pyrenedecanoyl)-sn-glycero-phosphocholine 2-(3-(diphenylhexatrienyl)propanoyl)-
1-hexadecanoyl-sn-glycero-3-phosphocholinB 
Figure 1.71 - Phospholipids with fluorescent label in fatty acid residues 
Both fatty acid residues of the phospholipid molecules may be labelled as well. 
NBD labelled phosphatydyl inositol was used in a study of cellular delivery of 
fluorescently labelled inositol derivatives by polyamine shuttles (Figure 1.72) 74 
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Figure 1.72 - Fluorescent staining by NBD labelled phophatidyl inositol in different cell lines; a) 
C H O cells, b) 3T3-L1 preadipocyte cells, c) M D C K cells, d) E. Coli cells, e) S. cerevisiae cells, 0 
A, Thaliana root tip cells and g) C Parvum cells^ '* 
Head group labelling needs to be carried out with more polar fluorophores such as 
Marina Blue®, NBD, Fluorescein or Rhodamine (Figure 1.73).^ ^ 
C15H31 o 
C15H31 
(CHjCHzjaNH* 
N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-1,2-dihexadecanoyl-sn-
glycero-3-phosphoethanole amine 
triethylammonium salt 
Marina Blue'"' 1,2-dihexadecanoyl-sn-
glycero-3-phosphoethanolamine 
COOH 
(CHsCHjjjNH* 
N-(fluorescein-5-thiocarbamoyl)-1,2-dlhexadecanoyl-sn-
glycero-3-phosphoethanolamine 
triethylammonium salt 
(CHjCHzjaNH* 
Lissamine rtiodamine B 1,2-dihexadecanoyl-sn-
glycero-3-phosphoethanolamine 
triethylammonium salt 
Figure 1.73 - Head group labelled phospholipids^ 
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Sphingolipids are important components of biological membranes, especially for 
eukaryotes. Both sphingomyelin and glycosylsphingolipids, that contain fluorophores 
are therefore available (Figure 1.74). The BODIPY fluorophore is the most common 
label in these probes. 
9l3^27 HO^ 
C,3H: 
N-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-dia2a-s 
indacene-3-penlanoyl) 
sphingosyl phosphocholine 
N-(4.4-difluoro-5,7-dimethyl-4-bora-3a.4a-diaza-s-
indacene-3-dodecanoyl) 
sphigosyM-b-glucopyranoside 
Figure 1.74- Fluorescently labelled sphingolipids^ 
Sphingolipids labelled with an NBD fluorophore, such as NBD Ce-ceramide, were 
extensively used, prior to the development of the BODIPY chromophore. 
Cholesteryl esters, where the 3p-hydroxyl group of cholesterol is acylated with a 
fatty acid incorporating a fluorescent probe, can be used to smdy the transport of 
cholesterol in cells or the receptor-mediated endocytosis of lipoproteins. The 
BODIPY labelled cholesteryl ester is available commercially (Figure 1.75). 
Fluorescent cholesterol derivatives as membrane probes have recently been reviewed 
by Wustner. 76 
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Cholesteryl 4,4-dmuoro-5,7-dimethyl-4-bora-3a,4a^iiaza-s-indacene-3-dodecanoatB 
Figure 1.75 - Fluorescently labelled cholesteryl ester' 
Probes for biological membranes that are not structurally related to their lipid 
components are available as well. Examples of these are long chain 
dialkylcarbocyanines, lipophilic coumarines (fluoresceins, rhodamines), diphenyl 
hexatrienyls, Nile red, prodan, laurdan and anilinonapthalene sulfonates (Figure 
1.76).' 
CIO.-
1.r-didodecyl-3,3.3',3'-letramBlhyl-indocartJocyanine 
perchlorate 
Ci7H3f 
4-heptadBcyl-7-hydroxycumarin 
r 
C,6H37 
Octadecyl rhodamine B chloride 
O 
1,6-diphenyl-1,3,5-hexalriene Nile red 6-dodecanoyl-2-dimethylaminonapthanele 
(laurdan) 
NH SO3H 
1 -anilinonalhalene-8-sulphonic acid 
Figure 1.76 - Non-lipid probes for cellular membranes^ 
A range of these probes as well as GFP labelled a-synuclein have been used in the 
studies of membrane interactions of amyloid fibril forming proteins. These are 
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summarised in a review by Munishkina and Fink^' ' A further review by Johnson 
discusses the studies of protein conformations and interactions at membranesJ^ 
Traffic o f hpid molecules has also been observed by Pagano et al, using BODIPY 
labelled sphinogmyelin (N-[5-(5,7-dimethyl boron dipyrromethene dif luoride)- l-
pentanoyl)]-D-eryr/2ro-sphingosylphosphorylcholine). They have observed the 
intemalisation o f the probe f rom the cellular membrane into endosomes, through 
endocytosis, and later incorporation into the Golgi apparatus (Figure 1.77). 
E 
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Figure 1.77 - Fluorescent images of normal and Nieman-Pick, Type A human flbroplasts with 
iysosomes stained by blue fluorescent dextran. The fluorescent probes exhibit concentration 
dependent emission proflles, emitting in red at high concentration and in green in low 
concentration" 
Labelling on the outer side o f cellular membranes can be achieved by non-permeant 
dyes, which can associate wi th transmembrane proteins. Such an approach was used 
by Tsien and Hauser, to label the stromal interaction molecule S T I M 1 co-expressed 
with a hexahistidine tag (Figure 1.78).^° 
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Figure 1.78 - Fluorescence images of cell surface of HEK293T cells coming from the association 
of the fluorescein probe with the hexahistidine tag by Zn^^ complexation^" 
They have achieved labeUing of the cellular membrane o f HEK293T cells, 
expressing the given peptide, using the aff ini ty o f Zn^^ ion for the hexahistidine 
moiety and a suitably modified fluorescein derivative (Figure 1.78). 
1.4.1.6 Probes for the cytoskeleton 
The cytoskeleton is composed o f fibres o f cytoskeletal proteins, such as actin and 
tubulin, which form a network throughout the cytoplasm. Cytoskeletal proteins ftilfil 
many important functions, such as maintaining the shape o f the cell, the spatial 
organisation o f organelles and the movement o f vesicles within the cell. 
Most commercially available probes for the cytoskeleton are based on proteins and 
antibodies and thus are not usable for live cell imaging. The fluorescent derivatives 
o f Paclitaxel (anticancer drug Taxol) (Figure 1.79) and vinblastine (Figure 1.80) are 
some of the excepfions. Oreon Green dye is used for labelling o f Paclitaxel and a 
BODIPY fluorophore for both Paclitaxel and vinblastine.^' -
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Oregon GreenW-Paclitaxel, Flutax-2 
Figure 1.79 - Oregon Green® labelled Taxol (Flutax-2) and a fluorescent image of microtubules 
of HeLa cells* '' 
""CH2CH3 
BODIPYlRI FL - Vinblastine 
Figure 1.80 - BODIPY® F L labelled Vinblastine and images obtained with Vinblastine-
Fluorescein conjugate*'*^ 
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The technique o f Fluorescent Speckle Microscopy has been used in the analysis of 
cytoskeleton dynamics as has been discussed in section 1.2.7. 
1.4.2 Targeted imaging 
Following analysis o f the fluorescent molecules, fluorescent proteins apart, 
mentioned in the preceding brief overview of probes for cellular organelles, it 
becomes apparent that another classification is possible. Two fluorophore. groups can 
be identified. The first group are molecules where the fluorophore itself is also the 
moiety determining the fate of the probe in cellulo (e.g. Ethidium, Hoechst or 
MitoTracker). The other group is comprised o f probes, where a clear breakdown of 
the structure to a fluorophore and a localising vector is possible (e.g. lipid based 
membrane probes, guanidinium mitochondrial probe or fluorescently labelled Taxol 
and Vinblastine). 
The idea of making targeted or specific fluorescent probes by combining a 
fluorophore and a targeting vector w i l l be discussed further. Preparation of targeted 
fluorescent probes was one o f the major aims o f the work presented in this thesis, 
using luminescent lanthanide complexes as the lumophore. 
1.4.2.1 Organelle Targeting 
Several conclusions for organelle targeting can be inferred f rom preceding sections. 
These should however be treated as guidelines rather than 'hard' rules. 
Nuclear localisation can be expected for molecules including 
flat aromatic moieties, as these tend to intercalate the DNA 
and RNA. 
High positive charge favours mitochondrial localisation due to 
the highly negative potential of the mitochondrial membrane. 
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Incorporating the fluorophore into a lipid like structure can 
enhance localisation into endoplasmic reticulum and Golgi 
apparatus as they are highly membraneous oranelles. 
Incorporation o f weakly basic amino groups into the probe 
structure should enhance localisation into acidic organelles 
such as lysosomes 
Further developments o f targeting vectors, especially of those with low molecular 
weights, are however needed, to achieve a state where a "toolbox" o f such agents 
would be available. 
One possible base for development could be the cell penetrating peptides (CPPs). 
The permeation and localisation o f small molecules and macromolecules alike can be 
enhanced by conjugation to certain oligopeptide sequences. The seminal work in the 
field was carried out with the /ra«5-activating transcriptional activator (TAT) from 
H I V - 1 . Many more CPPs have been identified to date. '^^ ' 
Despite having been developed mainly to enhance cellular penetration, they can 
impart effects on localisation as well. Some o f the T A T sequences can impart nuclear 
localisation.^^ Some of the arginine rich sequences can target mitochondria due to 
their high positive charge. 
The success o f the CPPs has been a starting point for the development o f new 
localisation vectors, such as the oligoarginine vector developed by de Mendoza et. 
al..^^ The aim was to maintain the localisation profile due to the high positive charge 
imparted by the guanidinium groups, but to remove deficiencies such as the danger 
o f hydrolysis imminent for the peptide chains. 
Targeting by means o f complex molecules such as taxol or vinblastine as the 
targeting vectors is also possible.*^ It , however, is a case to case approach rather than 
on 
a general tool, as targeting based on guests for specific receptors. 
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1.4.2.2 Macromolecular targeting 
Targeting and fluorescently labelling any given macromolecule of choice in the 
living system can be seen as one o f ultimate goals for fluorescent imaging. The most 
obvious example o f coming very close to this aim are the fluorescent proteins, which 
can be tagged by co-expression to many endogenous peptides.^* This, however, is not 
without problems. The major issue is that fluorescent protein probe is the same size 
as the protein it is reporting. Thus, the localisation and function o f the protein 
monitored may be altered significantly. The development o f specific labelling o f 
macromolecules with low molecular weight fluorescent probes is thus necessary, and 
the goal is still far f rom being achieved. 
A way of labelling the macromolecule in question by the probe needs to be 
established. Several bioorthogonal reactions have been identified for this purpose. 
These include formation o f hydrazides, the Staudinger ligation and reaction of azides 
with alkynes.^^ The benefit of these reactions is that they do not need the biological 
machinery of the cell to make them happen. They still have their drawbacks. To 
achieve labelling, the cells have to be fed unnatural monomers of macromolecules 
bearing one o f the reactants (eg. azide). In the simplest scenario, these would then be 
nonspecifically incorporated into the biological macromolecule, which would 
become labelled reacting with the probe incorporating the other reactant (e.g. 
triphenyl phosphine) (Figure 1,81).^" This approach is however non-specific, as 
different macromolecules can be labelled. Incorporation o f a larger number of 
unnnatural residues can also compromise the structure and function o f the 
macromolecule in question. A more specific way o f labelling w i l l need to be carried 
out by interference with the biochemical machinery. 
This is most easily realised with peptides where sequences can be added by genetic 
modification. By modifying the tRNA and the aminoacyl-tRNA synthtase, the above 
described methodology can be used for specific labelling o f protein of choice by an 
unnatural amino acid (Figure 1 . 8 1 ) . ^ ' ' A most general approach, however, is to 
incorporate a small oligopeptide chain at the end o f the protein o f interest, which can 
then be recognised and used for labelling. 
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reporter tags 
Figure 1. 81 - Some ideas of selective peptide labelling' 88 
Such an oligopeptide could be the tetra-cysteine mot i f used in the formation o f 
FlAsH and ReAsH fluorescent tags.^^ Oligohistidine sequences have also been used 
for targeting fluorescent probes to a specific protein. Other short peptides can 
undergo changes during post translational modifications, which can either modify the 
amino acid residues so that they can be labelled by bioorthogonal reactions (Figure 
1.80).^ "^ '^ ^ Alternatively, the oligopeptide tag can be labelled directly by an enzymatic 
reaction such as the reaction o f Co A conjugates wi th the phosphopantetheinyl 
transferase.^^ Also, an entire enzyme can be tagged to the protein o f interest, even 
though the same problems as for fluorescent proteins w i l l apply, and cause labelling 
by its action, as in the case o f O^-alkylguanine-DNA alkyltransferase. This enzyme 
irreversibly transfers an alkyl group f rom O^-alkylguanine onto its cysteine residue. 
Thus, a fluorescent label can be introduced to a protein o f interest co-expressed with 
this enzyme. 
A l l o f these techniques still need to be developed for practicable use in targeted 
fluorescent labelling, but they are a promising starting point for further development. 
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1.5 Introduction to lanthanide lumniescence 
The aim o f the work presented in this thesis was the synthesis o f luminescent 
lanthanide complexes as cellular probes. Hence, it is fitting to describe the principles 
governing lanthanide luminescence at this point. 
1.5.1.1 The forbidden nature of#transitions^*' '"^  '"^^ 
The predominant oxidation state o f lanthanides in solution is +3 and the 
corresponding 4 f electron configurations apply. The 4f electrons are strongly 
shielded fi-om surroundings by 5^ and 5p outer shells resulting in a weak splitting o f 
the Jf transitions (-100 cm"'). This results in very sharp absorption and emission 
bands o f lanthanides, in comparison with dd bands o f transition metals, which are 
strongly split by ligand fields. Despite this general rule the relative intensities and 
fine structure o f the bands can carry a substantial amount o f information (especially 
for Eu^*). 
The ff transitions in Ln^^ ions are Laporte forbidden with increased intensities for 
systems without a centre o f symmetry or those where the centre o f symmetry is 
removed by coupling the electronic transition with a vibrational state. Low molar 
extinction coefficients (<10 M ' ' cm' ') are one practical result o f the Jf transition 
being forbidden. Long luminescence liftetimes is the second outcome. Whereas the 
first implication o f the forbidden nature o f ff transition creates an obstacle in the 
design o f lanthanide luminescent complexes, the second is highly favourable, since 
long luminescence lifetimes are beneficial for cellular imaging purposes. 
Lanthanide ions can emit both in the visible range (Tb'^*, Eu"''*^ ) as well as in the near 
infrared region (Nd^*, Er^ "*^  and Yb^^) part o f the spectrum. Only complexes o f Tb^^ 
and Eu"'^ have been synthesised in the presented work. 
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1.5.2 Sensitised emission 
Sensitised excitation of the lanthanide ions is used to bypass the problem of their low 
extinction coefficients. A suitable organic chromophore is used to absorb the light. 
Thus, the chromophore is excited to one o f its singlet excited states S\. An 
intersystem crossing to its triplet excited state T i follows after vibrational relaxation 
to the lowest Si level. Chromophore fluorescence is a competition process, hence fast 
intersystem crossing is necessary for efficient sensitisation. The lanthanide ion is 
excited by energy transfer from the chromophore Ti state (Figure 1,83). Sufficient 
separation of the Ti and lanthanide emissive states is necessary (>1700 cm' ') to 
prevent thermally activated back energy transfer, which would lead to the reduction 
of the emission intensity and lifetime. The emissive energy levels lie at 17 240 cm' ' 
(^Do, Eu "^^ ) and 20 400 cm' ' (^D4, Tb'''^), and intramolecular energy transfer to these 
levels therefore requires that the sensitising triplet possesses an energy in excess of 
22 500 cm 
Absorption 
ISC 
Sensitiser 
fluorescence 
Energy 
transfer 
Sensitiser 
phosphorescence 
Emissive state 
Lanthanide 
fluorescence 
Ground state 
Sensitiser Ln 3+ 
Figure 1.82 - Simplified Jablonski diagram for sensitised emission of lanthanide (III) ions 8, 99 
This involvement o f several excited states leads also to large Stokes' shifts for 
lanthanide emission, which is a further advantage for their use as cellular probes. 
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1.5.3 Basic features of europium and terbium (III) emission 
spectra 
Emission spectra o f lanthanide ions consist o f several well defined bands. The ratio 
of intensities and fine structure of these bands can provide information about the 
coordination sphere o f the lanthanide, especially in the case o f europium. 
The emissive state o f Eu(III) complexes is ^Do and the strongest emission comes 
f rom the transitions to the ^Fi and states at 590 and 612 nm respectively (Figure 
1.83). The transition to the ^Fi state (AJ = 1) has magnefic dipole character and is not 
very sensitive to the structure of the coordination sphere. However, the transition to 
'F2 (AJ = 2) state is electric dipole in character wi th high sensitivity to the nature and 
symmetry o f the coordination sphere. Symmetry determines the number o f bands in 
the AJ = 1 region giving two bands for complexes with C4 symmetry and at least 
three bands for less symmetric ones. The last relatively intense transifion is to the ^¥4 
state, which is predominantly electric dipole in character and thus sensitive to the 
ligand field. There are more small intensity transitions in the Eu spectrum. The 
transition to ^Fq at 580 nm is one of them. Its energy is sensitive to ligand 
environment and it may therefore be used to probe the homogeneity o f the europium 
speciation. Thus, the number o f bands in this transition depends on the number o f 
chemically distinct environments o f Eu(IlI) ion. 
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Figure 1.83 - Schematic diagram showing transitions corresponding to different bands in 
emission spectra of Eu^* and Tb'"^* '' 
The Tb(III ) emission spectrum offers less structural information. Its emissive level is 
^D4 and the major band comes f rom the transition to the ^Fs state (zy = I ) at 545 nm 
(Figure 1.83). It is hypersensitive, but not as sensitive as the transition to ''F2 state in 
Eu(III). Even analysis o f the fine structure o f the spectrum does not give much 
information on the coordination sphere o f the ion because o f the large number o f 
unresolved transitions in the bands. 
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1.5.4 Energy dissipation pathways^"'*' 
The pathway o f sensitised emission o f lanthanide ions contains three excited states 
(Figure 1.84). These are: (i) the chromophore singlet excited state (S|), ( i i) the 
chromophore triplet excited state (Ti ) and ( i i i ) the lanthanide excitated state. Energy 
can either be passed on through the system from Si state to the light emission from 
lanthanide centre or it can be dissipated by a number o f competing processes. 
,. , l a n t h a n i d e 
ligand fluorescence luminescence 
4 
hv 
sens—Ln 
hv' 4 
energy 
•^m transfer "^ em hv" 
kisc Ket 
sens—Ln ^sens—Ln «- ^ sens—Ln — sens—Ln* 
ksET absorption 
kq[Q] kq[02] kq"[XH 
Figure 1.84 - A kinetic scheme of energy transfer processes in the lanthanide ion sensitisation 
pathway*'*' 
The singlet state o f the chromophore can release its energy by the desired inter 
system crossing to the triplet state, fluorescence or be quenched by energy or 
electron transfer. Fast intersystem crossing therefore increases the overall efficiency 
o f the sensitisation pathway. 
Molecular oxygen is a classical quencher o f triplet states, which yields singlet 
oxygen and the ground state o f the chromophore. Chromophore phosphorescence and 
back intersystem crossing are the other common competing pathways to the desired 
energy transfer to the lanthanide ion. 
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Lanthanide excited state deactivation, apart f rom the desired emission o f a photon, 
can proceed by several pathways. It was previously mentioned that a small enough 
energy gap between the lanthanide excited state and chromophore triplet state can 
result in back energy transfer. Energy then can be dissipated by competing procesess 
at the triplet state. 
It has been experimentally established that OH, N H and CH oscillators can 
deactivate the lanthanide emissive state. This takes place by vibrational energy 
transfer to bound solvent molecules or the ligand (Figure 1.85). Both emission 
intensity and lifetime decrease in this case. 
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Figure 1.85- Lanthanide excited state deactivation by vibrational relaxation 
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It is amine N H groups o f the ligand and the OH oscillators in bound water molecules 
that are the most efficient quenchers. The energy gap o f 12 000 cm' ' for Eu^ "^  as 
opposed to 15 000'' for Tb "^^  makes Eu(IIl) more sensitive to this type of quenching. 
This is because in the case o f Eu"'"^  the energy is best matched with the third 
vibrational overtone o f OH vibration compared to the fourth overtone in the case 
Tb^" .^ The Franck-Condon overlap factor is less favourable for Tb^" .^ The OD 
oscillators have a lower frequency and matching is therefore possible only with 
higher vibrational states, which leads to significantly lower levels o f quenching in 
D2O. Significant quenching by amide N H and CH vibrations is observed for Eu^ "^  but 
is much less pronounced for Tb^" .^ 
A further quenching mechanism of the lanthanide excited states by electron transfer 
from electron rich species w i l l discussed in detail in Chapter 3 o f this thesis. 
The presence o f the deactivation pathways described above implies that the 
structures of the ligands for the luminescent lanthanide complexes need to be 
designed carefully to obtain highly emissive complexes. Some of the complexes 
suitable for cellular imaging were mentioned in earlier sections of this chapter and 
the knowledge gained in their synthesis and administration in cellular imaging 
experiments was used as the basis for the work presented herein. 
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2 New Chromophores and their Integration into 
Lanthanide (III) Complexes 
Luminescent complexes of Tb''"^  and Eu''" ,^ based on the cyclen (1,4,7,10-
tetraazacyclododecane) macrocycle, containing suitable sensitizing chromophores 
and various pendant arms have been synthesized. The ability to stain live and fixed 
cells with these complexes has been observed.' Issues with the ease of crossing the 
cell membrane and sensitivity to quenching of the Ln^ "^  excited states have been 
identified and tentatively related to certain structural features of these complexes. 
The synthesis and photophysical investigation of two new chromophores 
incorporating carboxylic acid groups to allow conjugation, and the synthesis and 
characterisation of their D03A complexes are discussed in this chapter. 
2.1 Sensitizer structures 
The core structures of the new chromophores are based on sensitizers previously 
used in luminescent complexes to stain cells for fluorescence microscopy 
experiments; namely 7-methyl-dipyrido[3,2-f 2',3'-h]quinoxaline, 1, and 2-
methylazathioxanthone, 2 (Figure 2.1). 
Figure 2.1 - Parent structures of desired chromophores 
These sensitisers have previously been integrated into emissive systems, such as 
[TbL']^^ and [EuLY^ (Figure 2.2).^ '^  
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NH 340 ran 
H;0 - j tu; ' 
EtOjC 
"Mui 385 nm 
9% (dtrale adduct) 
Figure 2.2 - Emissive complexes incorporating tetraazatriphenylene and azathioxanthone 
chromophores 
The structures (1, 2) were amended by incorporating carboxylic acid groups into tiie 
ring structure. Two carboxylic groups were attached to the tetraazatriphenylene 
chromophore into positions 2 and 3. One carboxylic group, in position 7, was 
attached to the azathioxanthone structure. Thus, the following chromophore core 
structures were obtained; dipyrido[3,2-f;2',3'-h]quinoxaline-2,3-dicarboxylic acid, 3, 
and 7-carboxyazathioxanthone, 4 (Figure 2.3). 
Figure 2.3 - Target sensitizer structures containing carboxylic acid groups 
The carboxylate ftinctional group was introduced into the chromophore structure to 
serve as a possible linking group for conjugation of the desired lanthanide (III) 
complexes. An additional aspect was to study their effect on the sensitivity of the 
complexes to quenching by electron rich species such as iodide, ascorbate or urate. It 
was postulated that the negative charge of the deprotonated carboxylic acid group (as 
the quenching experiments are to be performed at physiological pH) would render 
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the complexes less sensitive to this type of quenching, by virtue of Coulombic 
repulsion to encounter. 
2.2 Chomophore Synthesis 
2.2.1 Synthesis of the Tetraazatriphenylene Chromophore 
Being derived from the dipyrido[3,2-f:2',3'-h]quinoxaline (dpq) chromophore, the 
new carboxyhc acid functionalised tetraazatriphenylene chromophore, 3, was 
expected to retain its attractive properties for sensitisation of lanthanide 
luminescence. These may be listed as follows: high molar extinction coefficient at 
wavelengths above 340 nm; an absence of chromophore fluorescence; fast 
intersystem crossing to the triplet energy state that is sufficiently high in energy to 
avoid back energy transfer from the Tb '^^ excited state.'* 
The synthetic steps were expected to follow established methodology, used for the 
synthesis of related 'dpq' and 'dpqc' chromophores, changing only the diamine 
reactant to introduce the carboxylate functionality. 
1 MeLi 
2) MnOz/ 
N MgSO 
Scheme 2.1 - Synthesis of 2-methyl-l,10-phenanthroline-5,6-dione 
The synthesis starts by methylation of 1,10-phenanthToline, 5, in position 2, creating 
a site for attachment into the ligand structure. The methylation is achieved by 
reaction with MeLi in dry THF, which leads to the formation of a dihydro species 
that is subsequently re-aromatised by reaction with Mn02, to yield the desired 2-
methyl-l,10-phenanthroline, 6 (Scheme 2.1). This was then oxidised to the 
corresponding 5,6-quinone, 7, using KBr, H2SO4 and HNO3. This reaction involves 
generation of molecular bromine in situ. The quinone can then be used in a 
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cyclisation reaction, with a chosen diamine, to form the extended heteroaromatic 
structure with appropriate functionality. 
N C v ^ ^ N H j O 
1)THF 
2) DMF 
EI3N N C ^ ^ N ' > ^ - N 
Scheme 2.2 - Attempts to obtain the desired heterocyclic structure by cyclisation with 2,3-
diamino-maleinonitrile 
Initial attempts at the synthesis of dipyrido[3,2-f:2',3'-h]quinoxaline, with the 
desired functionality were carried out according to a published procedure, based on 
the reaction of 2,3-diamino-maleinonitrile, 8, with the dione, 7 (Scheme 2.2). The 
reaction, however, yielded an insoluble black, tar-like, material, from which only 
very small amounts of the desired product, 9, could be recovered. Hence, a different 
diamine precursor had to be identified. 2,3-Diamino-succinic acid, 10, was chosen as 
a suitable candidate. It was esterified to give the diethyl ester, 11, using dry HCl gas 
in dry EtOH (Scheme 2.3). 
ElOH/HCI 
NHjHCI O; 
NHjHCI O 
10 11 
2) Mn02 
1) EtOH 
ElOOC-
Scheme 2.3 - Synthesis of the desired tetraazatriphenylene chromophore as its diethyl ester 
The cyclisation reaction between 11 and 9 was, however, not followed by a 
spontaneous air-promoted aromatisation to the desired product, 12, as was the case 
for other diamines. The diethyl-7-methyl-dipyrido[3,2-f:2',3'-h]quinoxaline-2,3-
dicarboxylate, 12, was obtained from the dihydro precursor by the action of Mn02 
(Scheme 2.3). An aqueous EDTA extraction had to be used during the work-up 
procedure, to remove traces of manganese (II) salts from the product. 
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Having obtained the desired chromophore structure, containing the carboxylate 
functionality, the methyl group needed to be transformed into a haloalkyl group, so 
that it could be used in an Sn2 alkylation reaction with a cyclen ring nitrogen. 
Previous experience showed that direct bromination using N-bromosuccinimide was 
not possible, and an alternative reaction sequence had to be adopted (Scheme 2.4). 
E t O O C ^ 
S e O , 
E t O O C ^ , N 
EtOOC N 
E l O O C ' 
NaBHjCN 
C H Q j / E I O H 
48% (2 steps) 
15 14 
Scheme 2.4 - Functionalisation of the chromophore methyl group for cyclen alkylation 
The methyl group was first transformed into the corresponding carboxaldehyde 13 
using selenium dioxide in dioxane. The aldehyde was reduced to the alcohol, 14, by 
sodium cyanoborohydride. This reagent gave better results than sodium borohydride, 
used in the synthesis of analogues of this chromophore. Finally, the alcohol 14 was 
converted to the desired chloromethyl compound 15 using P C I 3 . The overall yield of 
the reaction sequence was rather low, but sufficient material was obtained for the 
further steps of the ligand synthesis. 
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2.2.2 Synthesis of the azathioxanthone chromophore 
The synthesis of azaxanthones and azathioxanthones is carried out in two key steps. 
The first involves the coupling of a phenol or thiophenol of choice with a suitably 
functionalised 2-chloronicotinic acid. The heteroaromatic ring system is 
subsequently formed by an electrophilic cyclisation reaction in hot polyphosphoric 
acid (PPA).^ 
2-Chloro-6-methylnicotinic acid, 26, and methyl-4-thiobenzoate, 25, were considered 
the reactants of choice for the coupling reaction. The latter was not commercially 
available and had to be prepared from a suitable precursor. 
^OH 
MeOH 1)NaOH 225°C 
Scheme 2.5 - Synthetic route to 4-thio-benzoic acid 
In preliminary work, the synthesis was based on 4-hydroxybenzoic acid, 16. This 
was esterified in methanol catalysed in the presence of concentrated H2SO4. The 
esterification was followed by reaction with dimethyl thiocarbamoyl chloride to yield 
the thiocarbamate 19. A high temperature (225°C) rearrangement led to the 
formation of the precursor 20 with sulphur attached to the aromatic ring. The final 
step in the sequence involved aqueous base hydrolysis to yield the 4-thio-benzoic 
acid, 21. The length and modest yields of this reaction sequence led to consideration 
of an alternative sequence, starting from p-anthranilic acid, 22. (Scheme 2.6) 
^ 2) NaOH 
3) HCI 
94% 
24 
Scheme 2.6 - Alternative synthetic route to 4-thio-benzoic acid 
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In this alternative reaction sequence, the amino group was converted into the 
corresponding diazonium salt 23, which was reacted with potassium ethyl xanthate, 
24. The desired 4-thiobenzoic, 21, acid was obtained after base hydrolysis. 
9 o 
MaOH JK^ ^ 
OH iT O ' ^ 
HCI 
100% J 
H S ' HS 
21 25 
Scheme 2.7 - Synthesis of methyl-4-thio-benzoate 
Esterification of the carboxylic acid 21 in methanol catalysed by dry HCI, yielded the 
desired methyl-4-thiobenzoate, 25, quantitatively (Scheme 2.7). 
Q Q 
O H , 
" O ' 
27 Q o 
^ DMF 
OH * 
K2CO3 
CuBr' 
" N ' "CI H S ' 64% O O 
26 25 
28 
Scheme 2.8 - Nucleophilic aromatic coupling reaction 
The methyl-4-thiobenzoate, 25, was subsequently used in the coupling reaction with 
2-chloro-6-methyl nicotinic acid, 26. The reaction was carried out in D M F using 
K2CO3 as base and CuBr as a catalyst. This procedure is different to the one used in 
the synthesis of azaxanthones, where the reaction is carried in molten phenol using 
sodium methoxide deprotonation prior to the reaction. Partial hydrolysis of the 
methyl ester was observed ( ' H N M R analysis) in the isolated product. The mixture of 
the ester 27 and the acid 28 was carried forward for the cyclisation reaction (Scheme 
2.9) 
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1)PPA 
2) H,0 
t )PPA 
2) MeOH 
28 30 
Scheme 2.9 - Chromophore cyclisation 
The cyclisation reaction was carried out by heating the starting material in 
polyphosphoric acid (PPA) for 20 hours (Scheme 2,9). Performing the reaction work 
up in water, as was the case of other azaxanthones and azathioxanthones, led to the 
hydrolysis of the ester. The isolation of the acid product proved to be cumbersome 
and isolated yields were mediocre. Much better results were achieved by working the 
reaction up using methanol. The desired azathioxanthone, 30, was thus obtained in 
good yield. 
30 
C O , 
NBS 
DibenzoyI peroxidQ 
25% 
31 
Scheme 2.10 - Chromophore methyl group bromination 
The functionalisation of the methyl group was performed by benzylic bromination 
with N-bromosuccinimide ( N B S ) (Scheme 2.10), using dibenzoyl peroxide as the 
radical initiator. The bromination does not, however, stop after the formation of the 
desired product 31 and proceeded to the dibrominated compound 32. Hence, the 
reaction needed to be monitored by ' H N M R to determine the optimal conversion, at 
which point the reaction mixture contained the highest proportion of the desired 
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product. The starting material and both products were isolated in the 
chromatographic separation of the reaction mixture. The dibrominated product 32 
was converted into the monobromo species 31 in a reductive reaction using diethyl 
phosphite (Scheme 2.11). 
Diethy phosphite 
N-ettiyl-di-isopropyl amine 
30 
Scheme 2.11 - Debromination reaction 
This reaction proceeds to the completely debrominated azathoxanthone 30 as well as 
the desired monoboromo compound 31. The parent azathioxanthone can thus be 
recycled to increase the overall efficiency of this sequence. 
2.3 Complex Synthesis 
2.3.1 DO3A Alkylation 
l,4,7,10-Tetraazacyclododecane-l,4,7-triacetic acid was chosen as the core ligand 
structure for the first series of complexes incorporating the new chromophores. The 
functionalisation of the cyclen ring was carried out on the tris ^butyl ester of D03A 
(Scheme 2.12). 
Alkylation reactions were carried out in acetonitrile in each case, using K2CO3 and 
CS2CO3 as bases for the tetraazatriphenylene and azathiaxanthone examples, 
respectively. In each case, the A^-alkylated product was purified by column 
chromatography on neutral alumina. 
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0 ^ 
K j C O j 
Kl 
56% 
/ V V 
Aceionitrile ^BuO 
^—omu 
33 15 34 
(BuO 
NH 
^ — - O f B u 
(BuO-— 
Acelonitrite (BuO i S 
C s , C O 
30% 
33 31 35 
Scheme 2.12 - D03A alkylation with chromophores 
2.3.2 Ligand Deprotection and Complexation 
The tetraazatriphenylene containing ligand was deprotected by acid hydrolysis of 
each ester group in hot 6M HCI (Scheme 2.13). 
— ^ N 
^ O H 
34 36 
Scheme 2.13 - Ligand deprotecion 
Thus, the desired ligand containg free carboxylic acid groups, 36, was obtained. 
Direct complexation with a Ln (III) salt was expected to yield the desired complex. 
81 
CHAPTER 2 
New Chromophores and their Integration into Lanthanide (III) Complexes 
Two different deprotection approaches had to be used in the azathioxanthone system, 
as a result of difficulties in subsequent synthetic steps (Scheme 2.14). 
6M HCl 
CF3COOH /CH 
^ N 
Scheme 2.14 - Ligand deprotection 
Aqueous acid hydrolysis of the protected ligand, removing all of the ester groups to 
yield compound, 37, was carried out as well as selective removal of the /-butyl ester 
groups by TFA in CH2CI2, leading to ligand 38. 
UCl3.6H2( 
i \ ~ \ HjO/MeOH 
OH PH5.5 
OH l-n = Tb^', Eu^* 
[Ln.L'] 
O L n a i . 6H ,0 
HaO/MeOH 
pH 5.5 
U =Tb3', Eu^' 
[Ln.L'l 
Scheme 2.15 - Complexation reaction with Ln (III) salts 
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The tetraazatriphenylene containing ligand 36 was complexed with terbium or 
europium chloride in a water/methanol mixture (Scheme 2.15). The pH of the 
complexation reaction mixture was maintained at 5.5 by addition of dilute aqueous 
KOH solution. The crude reaction mixtures were purified by reverse phase HPLC 
chromatography to yield the desired complexes [Tb.L''] and [Eu.L^]. 
Attempts to perform the complexation reaction of the azathioxanthone containing 
ligand 37 in a similar manner to obtain complexes [Ln-L**] were unsuccessful 
(Scheme 2,15). Formation of a precipitate was observed shortly after the addition of 
the lanthanide salt. Tb"'^  and Eu^^ emission profiles were observed from the reaction 
mixtures, but the luminescence lifetimes measured were significantly shorter than 
anticipated from results in similar systems. Furthermore, no Ln emission signal was 
observed after the treatment of the samples at pH 10 (a treatment used for the 
removal of excess Ln salt). This led to the conclusion that the desired complexes 
[Ln.L'*] had not been formed. 
LnClsSHjO 
HjO/MeOH 
pH 5.5 
Ln = Tb^', E u ' -
[Ln.L'] 
NaOH/HjO 
pH 10, 295 K 
Scheme 2.16 -Complexation and ester hydrolysis 
° -Xii'-
[Ln.L'j 
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The proposed explanation of this observation was that the Ln"''*^  ion was loosely 
complexed by the chromophore carboxylate groups, preventing it from being 
properly installed into the ligand cage. This complex would be expected to have a 
reduced luminescence lifetime due to a higher number of coordinated waters, and 
would also be expected to be easily hydrolysed into Ln(0H)3 under basic conditions. 
To avoid this problem, the partially deprotected ligand 38 was prepared (Scheme 
2.14) and the lanthanide (III) complexes [Ln.L^] were synthesised (Scheme 2.16). 
The complexes [Ln.L^] were purified by reverse phase HPLC chromatography. The 
subsequent hydrolysis of the methyl ester was attempted using mild base conditions 
(NaOH, pH 10; Scheme 2.16). The reacUon was slow and a significant degree of 
decomplexation was observed. Small quantities of the desired complexes [Ln.L**] 
were however obtained, after HPLC purification. 
2.4 Azaxanthone chromophore 
In a parallel project, the D03A complexes incorporating azaxanthone chromophore 
analogous to the 7-carboxyazathioxanthone, 4, were synthesised. The chromophore 
core structure was 7-carboxyazaxanthone, 39 (Figure 2.4). 
39 
Figure 2.4 - Azaxanthone chromophore containing a carboxylic acid group 
2.4.1 Chromophore synthesis 
The synthesis of the azaxanthone chromophore 41 and its bromomethyl derivative 42 
was carried out in a similar fashion as for the azathioxanthone chromophore 
(Scheme 2.17). 
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OH 
16 17 
c r N 
26 
1. MoOH/Na 
2. 120°C 
61% 
40 
PPA 
MeOH 
37% 
NBS 
Dibens}yl peroxide 
C C I . 
13.5% 
41 
Scheme 2.17 - Synthesis of the bromomethyl derivative of the desired azaxanthone 
chromophore 
In this sequence, methyl-4-hydroxybenzoate, 17, was coupled to the 2-chloro-6-
methylnicotinic acid in this reaction sequence. The coupling reaction was carried out 
in a different manner, compared to the azathioxanthone synthesis. Excess of the 
phenol, which melted at the reaction temperature, was used as the solvent and the 
deprotonation was carried out with sodium methoxide in methanol, generated in situ. 
The cyclisation and bromination reaction followed the scheme described above. 
Once again, both the desired bromomethyl derivative 42 and the undesired dibromo 
compound 43 were isolated. The reductive debromination, described above (Scheme 
2.8), was employed to improve the overall yield of the desired bromomethyl 
derivative 42. 
2.4.2 D03A complex synthesis 
For initial investigation of this chromophore, the Ln (III) complexes based on 
l,4,7,10-tetraazacyclododecane-l,4,7-triacetic acid (D03A) were synthesised. The 
synthesis was carried out following the previously described route starting from the 
r-butyl ester o fD03A. 
85 
CHAPTER 2 
New Chromophores and their Integration into Lanthanide (HI) Complexes 
BuO ^ 
+ 
^ OIBu 
AcatonilrilB ffiuO 
33 42 44 
6M HCI 
;Ln;' 
[Ln.L^l 
LnClj.BHjO \ / \ - / 
HjO/MeOH 
pH 5.5 
Ln =Tb'*. E u " 
45 
Scheme 2.18 - Synthesis of the D03A complexes incorporating the azaxanthone chromophore 
2.5 Synthesis of complexes incorporating amide arms 
The D03A complexes are suitable for assessing the ability of the chromophores to 
sensitise the luminescence of Ln(III) ions, as well as for further solution experiments. 
Our previous work has, however, shown that they are not particularly suitable for 
cellular experiments because of their intrinsic sensitivity to quenching by 
endogenous reductants such as ascorbate and urate (see Chapter 3). It was the more 
lipophilic 3+ charged complexes such as [TbL']"''^ and [EuL ]^"*"^  that were considered 
more appropriate for preliminary cellular imaging experiments. Hence, the new 
chromophores were incorporated into complexes bearing the (5)-l-
phenylethylacetamide arm, for these cellular imaging experiments (discussed in 
detail in Chapter 4). 
Protective groups need to be employed to achieve selective alkylation of the cyclen 
nitrogens. 
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K 2 C O 3 / K 1 
MoCN 
31 X = S 47X = S 
42X = 0 48X = 0 
TFA/CH2CI2 
MeCN 
52X = S 49X = S 
5 0 X = O 53X = 0 
Scheme 2.19 - Ligand synthesis for the amide arm series of complexes 
The synthesis of the ligands containing amide arms began with the alkylation of the 
unprotected nitrogen of tris 5oc-cyclen, 46, using the bromomethyl derivative of the 
azathioxanthone, 31, or azaxanthone, 42. The protecting Boc groups were then 
removed in a reaction with dry TFA in DCM to give the ligand precursors 49 and 50. 
The ligand synthesis was then accomplished by alkylating the free amino groups of 
the cyclen with (5)-1 -phenylethylchloroacetamide, 51.. 
The prepared ligands 52 and 53 were then used in complexation reactions with the 
Ln(III) salts. The standard procedure of such a reaction, using an appropriate Ln(III) 
triflate salt in dry acetonitrile was used. 
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EufOTOj 
M9CN 
[EuL^]3* 
Ln(0Tn3 
MeCN 
Ln = Eu, Gd. Tb 
V. 
" • • " j ^ - - ' - L n ? ; - - . . ^ 
[LnL«]^ 
Scheme 2.20 - Complexation reactions forming the phenyl amide series of complexes 
The complexes were purified by precipitation onto dry Et20, which was followed by 
an anion exchange reaction to replace the triflate anion with a more water soluble 
chloride counterion. 
2.6 Photophysical Charcterisation of the Chromophores 
An organic chromophore needs to fulf i l several characteristics to be considered 
suitable as a senzitizing moiety for lanthanide luminescence. The most important are: 
high molar extinction coefficient, fast intersystem crossing and suitable energy of the 
triplet excited state. Furthermore, for practical considerations in fluorescence 
microscopy, absorption above 340 run is important for the complexes considered for 
cellular imaging. 
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2.6.1 Azaxanthone and Azathiaxanthone Chromophores 
Aromatic ketones are known to populate effectively their triplet state, hence 
benzophenones and acridones have been used in previous work to sensitize 
lanthanide luminescence.^ Several photophysical studies have suggested that hetero-
atom derivatives of acridones such 1-azaxanthone and 1-azathioxanthone should 
possess suitable properties as sensitizers of lanthanide luminescence. • * • ^  
Furthermore, the replacement of a phenyl group with a pyridyl moiety in the 
chromophore structure, introduces another possible binding atom into the ligand. 
This should decrease the distance between the chomophore and the metal, thus 
increasing the efficiency of energy transfer to the metal centre. 
The carboxymethyl substituted azaxanthone 41 and azathioxanthone 30, were 
synthesised as a part of a small library of chromophores, with the aim of studying the 
effect of substitution of the core structures on their photophysical properties.'" 
Figure 2.5 - Structures of a-methyl azathioxanthone and azaxanthone chromophores 
Structure Xmax/nm (e, M'cm'')" Xen/nm" El/cm'" 
54 371 (6,770) 425 23,700 
30 369 (5,360) 433 23,800 
55 330 (6,900) 405 24,800 
41 328 (5,720) 392 24,900 
Table 2.1 - Photophysical properties of selected azaxanthone and azathioxanthone 
chromophores a: (MeOH, 295 K); b: (Et20-isopentane-ethanol glass, 77 K) 
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The small energy gap of the n;i* and mi excited states led to the expectation that the 
photophysical properties would be sensitive to substitution, as well as to solvent 
effects. 
The data in Table 2.1 show that the introduction of the carboxymethyl group into the 
chromophore structure does lead to small changes in the singlet and triplet excited 
state energies. It needs to be mentioned that a significantly higher amount of 
fluorescence was observed for the 1-azathioxanthone chromophores in comparison to 
the 1-azaxanthone ones. A similar trend was observed with the introduction of an 
alkyl substitutuent, such as a ^butyl group in position 7, 56. 
Figure 2.6 - 7-/Butyl-l-azaxanthone 
More dramatic substituent effects were observed with the introduction of amino or 
methoxy groups. Figure 2.7, in which lone pair conjugation can occur. 
Figure 2.7 - Amino and methoxy derivatives of the azaxanthone chromophore 
Structure ^max/f^f^l (£, M'cm'')° XeJnm" Ej/cm-'" 
57 356 (18,000) 458 21,600 
58 355 (4,845) 453 21,500 
Table 2.2 - Photophysical properties for azaxanthone chromophores with strongly electron 
donating substituents a: (MeOH, 295 K); b: (EtjO-isopentane-ethanol glass, 77 K) 
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These changes are also demonstrated in the following absorption and 
phosphorescence spectra. Figure 2.8, showing the difference between 1-azaxanthone, 
55, and 8-amino-l-azaxanthone, 57. 
300 350 
Wavo<ength / nm 
100 
80 
i 
% 60 
3 
20 
440 490 
Wavelangth /nm 
Figure 2.8 - Absorption and phosphorescence spectra for 1-azaxanthone and 8-amino-l-
azaxanthone 
These results show that structures 57 and 58 are not suitable for sensitisation of 
lanthanide luminescence. The energy of their triplet state (21,600 cm"') is too low for 
efficient Tb"^ "^  sensitization and they possess several hundred fold higher fluorescence, 
which would be expected to significantly decrease the overall Ln"'^ emission quantum 
yield. 
Small changes in absorption maximum for the parent I-azaxanthone, 55, were 
observed in different solvents. The absorption band at lowest energy shifted fi-om 
329 nm in EPA to 330 nm in MeOH and 334 nm in water. This can be explained by 
an increased nn contribution to the predominantly n7i* character of the singlet 
excited state. The extinction coefficient of this peak also shows solvent dependence, 
going from 6,900 M''cm'' in MeOH to 4,500 M"'cm"' in 33% water-MeOH. A blue 
shift and a decrease in fluorescence intensity was observed for the azaxanthones with 
decreasing solvent polarity, with no observable fluorescence in CH2CI2, EtOAc, THF 
and toluene. The effect of solvent on the chromophore fluorescence was even more 
significant for the thioxanthones, where the amount of fluorescence observed varied 
to a greater extent. The veiriation of the fluorescence emission maxima with solvent 
polarity are shown in Figure 2.9, showing a reasonable correlation with Reichardt's 
classical solvent polarity parameter, ET30. 
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Figure 2.9 - Solvatochromic effects on azathioxanthone chromophore fluorescence 
2.6.2 Tetraazatriphenylene chromophores 
It has been shown that the tetraazatriphenylene chromophore is a very good 
sensitizer of lanthanide luminescence. Several tetraazatriphenylene derivatives have 
been assessed for this purpose in recent publications and some (59, 60) have been 
incorporated into well-defined Ln^ "^  complexes used in cellular imaging. 
12 59 60 
Figure 2.10 - Tetraazatriphenylene chromophore structures 
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Structure X,„Jnm (e, M'cm'')" XJmf Ej/cm'' * 
7 2 355 (5,430) Not observed 22,800 
59 340(3,800) Not observed 23,800 
60 347 (6,400) Not observed 23,400 
Table 2.3 - Photophysical properties of tetraazatriphenylene chromophores; a: (295 K, MeOH), 
b: (Et20-isopentane-ethanol glass, 77 K) 
The results show that the new tetraazatriphenylene bearing a di-carboxyethyl 
substitution has maintained the adequate properties for practicable lanthanide 
sensitization. Efficient absorption at wavelengths exceeding 350 nm is still present. 
The lack of chromophore fluorescence is consistent with fast intersystem crossing. 
Also, the triplet energy is sufficient for both Tb^ "^  and Eu'^ "^  sensitization. 
2.7 Characterisation of complexes 
2.7A HPLC separation and analysis 
The purity of the prepared complexes was assessed by reversed phase HPLC. The 
complexes [LnL'']^' and [LnL^] both showed one major peak in the chromatograms 
of the crude complexation mixtures. This was purified by semi preparative HPLC, 
also with the aim of removing the salts contained in the crude samples. The 
purification and analysis of complexes [LnL ]^"'"*' is discussed in Chapter 4. 
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2 3 4 5 6 7 8 9 10 11 12 13 14 IS 10 17 18 19 2D 21 22 Z3 24 2S 26 
Figure 2.11 - Chromatogram of the crude complexation mixture for [LnL^]^' (Method A with 
TFA, Appendix) 
J . 
2 3 A 5 6 7 8 9 10 11 12 13 14 IS 16 17 IB 19 20 21 22 Z3 24 25 26 
Figure 2.12 - Chromatogram of the crude complexation mixture for [LnL ] (Method A no acid, 
Appendix) 
2.7.2 NMR analysis 
The paramagnetism of lanthanide (III) ions, which makes them useful for 
applications such as MRI relaxation and MRS shift agents, has complicating 
implications in the ' H analysis of their complexes. Both shifting and broadening of 
signals is frequently observed, the extent of which is dependent on the lanthanide (III) 
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ion, the distance between the atom and the metal and its orientation in relation to the 
principal axis of the complex. It is the macrocycle ring protons that are the most 
shifted in the cyclen based complexes prepared in this work. Eu^^ and Yb^^ are the 
lanthanide ions of choice for ' H N M R analysis of lanthanide complexes." 
It has been observed that D03A based complexes exist as a mixture of stereoisomers 
in solution at room temperature, which leads to the broadening of the ' H N M R 
signals, decreasing spectral resolution and precluding detailed analysis. Similar 
behaviour was observed for the newly synthesised Eu^^ complexes [Eu.L''] and 
[EuL^]. A well defined ' H N M R spectrum was observed for the triamide complex 
[Eu.L*]^^ (Figure 2.13). 
I i l l 
Figure 2.13 - ' H N M R spectrum of [ E U L ' | ' ^ ( D J O , 295 K , pD 6) 
2.7.3 Photophysical characterisation of complexes 
2.7.3.1 Absorption and emission spectra 
The absorption spectra of the complexes were recorded in water at 295 K. Their 
spectral form did not vary with the lanthanide ion and they closely resembled the 
absorption spectra of the chromophores used. 
95 
CHAPTER 2 
New Chromophores and their Integration into Lanthanide (III) Complexes 
0.7-| 
0.6-
0.5-
U 
n 
0.4-
CQ . 0 
u 
0 
0.3-
< 0.2-
0.1 -
0.0-
220 240 260 280 300 320 340 360 380 
X, /nm 
abs 
Figure 2.14 - Absorption spectrum for the anionic dpq complex, [LnL"*]^ ", (HjO, 295 K) 
Complexes with the tetraazatriphenylene chromophore possessed the longest 
wavelength absorption at 347 nm (Figure 2.14). 
e 
•e 
o 
< 
220 240 260 280 300 320 340 360 380 400 
X ^  /nm 
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Figure 2.15 - Absorption spectrum for the azathioxanthone complex, [LnL'), (H2O, 295 K) 
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Figure 2.16 - Absorption spectrum for the azaxanthone complex, [LnL*] , (H2O, 298 K) 
Figures 2.15 and 2.16 demonstrate the spectral differences between the 
azathioxanthone and azaxanthone chromophores, with the latter absorbing at higher 
energy. 
1.60EH» 
aooE.<]6 
S.OOEHH 
4.00E*O5 
2,DOE*05 
500 550 
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Figure 2.17 - Emission spectra for the anionic tetraazatriphenylene complex, [LnL^]^', Ln = Tb 
(left), Ln = Eu (right), (HjG, 298 K) 
The emission spectra were recorded in water at 298 K. Emission spectra of D03A 
complexes [Ln.L"'] containing the tetraazatriphenylene chromophore, showed strong 
lanthanide emission and an absence of chromophore fluorescence. 
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Figure 2.18 - Emission spectra for the azathioxanthone coniplex,[LnL'], (H2O, 298 K) 
The emission spectra of the azathioxanthone complex, [Ln.L^], showed a significant 
amount of chromophore fluorescence, with a rather weak lanthanide emission. 
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Figure 2.19 - Emission spectra for the azaxanthone complex, |LnL*]^^ (HjO, 298K) 
The emission spectra of the cationic triphenylamide complexes [Ln.L*]^'^ exhibited 
strong lanthanide emission and a very weak chromophore fluorescence could be 
discerned in the case of the europium complex, [Eu.L ] . 
2.7.3.2 Luminescence lifetime measurements and hydration state 
analysis 
Luminescence quantum yields and luminescence lifetimes are highly informative 
about the photophysical properties of the emissive complexes. 
The lanthanide emission quantum yield is indicative of the overall efficiency of the 
process that populates the lanthanide excited state and its emissive relaxation. 
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Complex Lifetime in 
H2O (ms) 
Lifetime in 
D2O (ms) 
9 Quantum yield 
(%) 
[Tb.L^l' 2.26 2.41 0 55 
I E U . l Y " 1.07 1.61 0 17 
[Tb.L"] 1.46 N.d. N.d. 33 
[ E U . L " ] 1.08 N.d. N.d. 18 
[Tb.L^] 0.53 0.62 1.1 2.2 
[Eu.L^j 0.51 1.62 1.3 2.1 
[Tb.L'"] 1.89 2.88 0.64 12 
[ E U . L ' " ] 0.60 2.08 1.1 8 
[Tb.LT^ 1.60 N.d. N.d. 19 
[Eu .LT^ 0.58 N.d. N.d. N.d 
[ T b . L ' r ^ 1.65 2.89 1.00 37 
f E u . L " l ' " 0.54 1.73 0.97 8 
Table 2.4 - Emission lifetimes and quantum yields of selected lanthanide complexes 
The emission lifetime, in turn, gives information about the coordination sphere of the 
metal defined by the corresponding ligand, and the extent to which it protects the 
lanthanide excited state from non-radiative deactivation processes. 
ILn.L'I |Ln.Ll [LnL»l 
(LnL'»l [ U n L ' V [ L n L " I " 
Figure 2.20 - Structures of the complexes used for comparison of emission data 
Thus, it can be seen that the complexes incorporating the new tetraazatriphenylene 
chromophore, [LnL^]^', have maintained the favourable photophysical properties of 
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previous complexes bearing analogous chromophores, such as [LnL^]. Indeed, both 
the luminescence lifetime and the quantum yield are actually increased. 
In the case of the azathioxanthone complexes [LnL"'], the photophysical 
characteristics are not so favourable, with both quantum yields and luminescence 
lifetimes decreased in comparison to analogous azaxanthone complexes [LnL***]. 
Measurement of the luminescence lifetimes in H2O and D2O for the newly 
synthesised complexes allowed an estimation of the hydration state of each complex. 
The tetraaztriphenylene complexes, based on a nonadentate ligand, did not have a 
bound water molecule. The thiaazaxanthone complexes, derived from an octadentate 
ligand, bind one water molecule at the metal centre. The number of bound water 
molecules was calculated according to the following equations'^: 
^Bu =1 -2 • (ICH2O - ko2o - 0-25 - X • (0.075)) (1) 
=5-(^„2o-^D2o-0.06) (2) 
In these equations, ^H20 and ^020 are the radiative decay rate constants in water and 
deuterium oxide respectively; the term 0.25 for Eu (0.06 for Tb) refers to quenching 
due to second sphere water molecules and the 0.075 term refers to amide NH 
quenching for Eu complexes. 
2.7.3.3 C P L measurements for triamide complexes 
Since the triamide complexes [LnL*]^^ are chiral, their photophysical properties can 
be further investigated by chiroptical methods. Circular dichroism measurements, 
which assess the difference in absorption of right and left circularly polarised light 
(ground state investigation), are not easily used for these complexes. This is because 
the measurement of the lanthanide absorption spectrum is necessary and requires 
relatively concentrated solutions, due to the forbidden nature of the f - f transitions. 
Circularly polarised luminescence (excited state investigation), on the other hand. 
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can be used as it measures the differential amounts of right and left circularly 
polarised light emitted by lanthanide ( I I I ) centre. Thus, CPL can provide information 
about the helicity and structure of the complex as well as reporting on the electronic 
and magnetic environment of the lanthanide ( I I I ) ion.'^' 
Eu-S-Phj-AzaCOCHMe (in DjO, 340 nm ex.) 
Total luminescence 
C P L 
Wavelength (nm) 
Figure 2.21 - Emission and C P L spectra of | E U L ' 8,3+ 
A description of the "degree of chirality" sensed by the electronic transition is 
obtained using the dissymmetry factors, gem, equation (3), where IL(R) is the intensity 
of the left (right) circularly polarised component. 
S em (3) 
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Tb-S-Ph,-AzaCOOMe (in D20,340 nm ex.) 
T o t a l l u m i n e s c e n c e 
C P L 
W a v e l e n g t h ( n m ) 
Figure 2.22 - Emission and C P L spectra of [TbL*]'* 
The gem factors were calculated for the [LnL*]"*^ complexes and are compared to 
values for the related tetraphenyl amide complexes (5)-A-[L i iL'^1^ for which the 
absolute configuration has been verified by X-ray crystallography.'^ 
Ph 
NH 
HN 
[LnL' ] ' [LnL" ] ' * 
Figure 2.23 - Comparison of complex (S5'S)-ILnL''p and the parent tetraamide complex 
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Complex 589 
o em o em o em 
(5"5'5)-[EULY^ 
(5)-A-fEuL 'T^ 
+0.009 
+0.09 
-0.077 
-0.09 
+0.011 
+0.08 
Complex 
o em 
544 
o em o em 
(5)-A-[TbL 'T^ 
+0.080 
+0.14 
-0.050 
-0.1 
+0.018 
+0.17 
Table 2.5 - Comparison of g e m values for the (5'5'5)-enantiomers of [ L n L Y * and (iS)-A-[LnL'Y^ 
The sign and sequence of the transitions for the Eu and Tb complexes [LnL*]"'"^ was 
the same as for the (5)-A-[LnL'^]^'^. Hence, a A-helicity can be assigned to these 
complexes. 
2.7.3.4 Two photon excitation 
As has been discussed in the introduction (Section 1.1.2), two photon excitation is 
currently being pursued for certain fluorescent probes in biological imaging, as it 
offers higher resolution and deeper tissue penetration and may cause less 
photodamage. Only a limited number of reports have been published so far dealing 
with two photon excited luminescence of lanthanides. 
Recently, two photon emission spectra were recorded for two europium complexes 
synthesised in Durham, [ E U L ' ^ ] ^ ^ and [ E U L ' Y ^ ' * 
C O , E I 
•X"; - - O H j 
| E u L " | -
Figure 2.24 - Complexes used in initial two photon excitation experiments 
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The two photon excitation was achieved at 758 nm using a cavity dumped mode 
locked Ti-sapphire laser. The experimental set-up did not allow recording of the 
AJ=4 manifold above 680 nm. 
2 0 C O 
C 
3 M 400 450 sac 5SC 600 6f>0 
— I 
/CO 
wavelength [nm] 
Figure 2.25 - Emission spectrum of | E u L ] recorded in D2O using two photon excitation at 
758 nm 
Similarly two photon excitation was achieved for [ E U L ' ] " ^ , with excitation at 770 
nm. 
fk 06/178 
= 370 nm 
exc 
A = 770 nm 
exc 
500-• 
400-^ 
m 250 
9! 
c 200-1 
wavelength (nm) 
8 , 3 + , 
7 0 0 
Figure 2.26 - Emission spectra for | E u L | acquired using single plioton (blue) and two photon 
(red) excitation (H20,298 K) 
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The lower signal to noise ratio for the Eu^* emission is due to the fact that the 
emission spectrum for [ E U L ' ] ^ ^ was measured in H2O, as opposed to D2O for 
The possibility for two photon excitation of the azaxanthone complexes was 
demonstrated with [TbL*]^^ using excitation at 670 nm from a Ti-Sapphire laser. The 
slope of the plot of log(Iobs) versus log (power) was 2.03, consistent with a two 
photon excitation process. 
X (nm) 
• s lope=2.033 ep=0.03 
log (Incident power) 
Figure 2.27 - Two photon emission spectrum of |TbL*j** and the power dependence of the 
emission intensity; 670 nm excitation 
These experiments have demonstrated the possibility of using two photon excitation 
in fluorescence microscopy experiments involving complexes prepared in Durham. 
2.7.4 Further experiments assessing potential for use in high 
throughput assays 
The tetraazatriphenylene complexes (LnL^]^" were tested, by our collaborators in 
CisBio international, for stability in media containing different metal ion salts. HPLC 
and MS analysis was also carried out on the samples submitted for the tests. It should 
be noted that these samples had been kept in solution for over two years under 
ambient laboratory conditions, prior to this analysis. 
Two major peaks were observed by analytical HPLC and were isolated by HPLC, for 
both the Tb^^ and Eu^ "" complexes 3+ 
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29 11 07 T b D 0 3 A d p q C 0 0 H mimpurif Diode Array 
Range 1.083e*2 
0.00 1.00 2.00 
1-07 E u D 0 3 A d p q C 0 0 H mini pucif 
3.0e+1 
2.56+1 
2.0e*1 
1.5e•1^ 
1.0e+1 
5.0J 
0.0 
3.00 4.00 5.00 6.0 
553 
0 55 
5 93 
7.00 8 00 9.00 10 00 11.00 12.00 13.00 
Diode Ariay 
Range 3 588e+1 
0.00 1.00 2 00 3.00 4.00 5.00 6.0O 7.00 8.00 9.00 1o!oO 1l!oO 12^ 00 1300 
Figure 2.28 - H P L C analysis of samples submitted for stability testing to CisBio, performed in 
CisBio by Dr. R. A. Poole 
The MS analysis showed both major peaks (4.92 and 5.33 min) to have the same 
mass, corresponding to the loss of one carboxylate group from the complex 
(complexes [LnL*^] and [LnL**]). The minor peak with retention time of 5.80 min 
was shown to correspond to the dpq complex [LnL*^] without any carboxylic groups. 
This observation was further supported by the UV-Vis absorption spectra where the 
longest wavelength absorption for this peak was 340 nm, corresponding to previous 
results with the dpq chromophore.'^ 
VF^ < ^ ^ // 
[Ln.U«] [Ln.L"] 
Figure 2.29 - Structures of the partially and fully decarboxylated complexes 
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T = 0 
/ / / / / / 
1 I i 2 C CaCI2 • M g C I 2 • M n C E 
EDTA 
R M p i i 
T = overnight 
• M g C C 
• M n C I 2 
B D T A 
Figure 2.30 - Stability test in presence of CaCh (20 mMf), MgCU (20mMf), MnCU (20 mMT), 
E D T A (20mM0, SVNN (New Born Calf Serum, 50 %) , RPMI++ (Roswell Park Memorial 
Institute cell medium, 50 %). (Measured for purified samples of the l " and 2"" major peaks by 
H P L C of the Eu and Tb complexes in H E P E S buffer pH 7, 50 mM + 0.1 % BSA with and 
without K F at 0.4 M. Complex concentration was 1 uM). 
The samples were however highly emissive and so were examined m the stability test 
(Figure 2.30), where the emission intensity was measured in the presence of several 
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salts and in biological media. These conditions correspond to assay conditions used 
in different protocols commercially. 
The results are consistent with a high stability of the complexes with time, with the 
exception of the observed sensitivity to Mn^ "^  ions. 
[EuL" ] ' 
Figure 2.31 - Structure of the reference Eu^* cryptate Krer, used in the stability experiment 
The observation of stepwise decarboxylation for the aged samples is not surprising. 
Decarboxylation of carboxylic acids in the a-position to pyridine, quinoline or 
pyrazine groups is well established in the literatue and is usually associated with a 
thermally activated process for the protonated ligand. 
H — O H 2 
Scheme 2.21 - Possible mechanism of decarboxylation of tetrazatryphenylene complexes [LnL^] 
2.8 Chromophore modification by N-oxide formation 
The longest wavelength absorption maximum in the azaxanthone spectrum, lying just 
below 340 nm, is on the borderline for practicable use in fluorescence microscopy. 
Previous work in Durham has shown that the formation of the A^-oxide on the 
pyridine ring of the azaxanthone chromophore shifts the absorption maximum more 
than 10 nm to the red.^" The DOS A complexes containing this modified azaxanthone 
chomophore were prepared to assess their utility in sensitising lanthanide 
luminescence. 
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2.8.1 Complex synthesis 
The synthesis was carried out along the established route for azaxanthone synthesis, 
preparing the bromomethyl derivative 64 in three steps. This was then used to 
alkylate the tris-terthutyl ester of DOS A, 33. 
61 
P P A 
M e O H 1. M e O N a / M e O H 
2. 1 2 0 ° C 
1 2 % 
ffluO 
— ^ N 
N N 
C S j C O j 'Bu i 
M o C N L 
6 6 % NH ' 
N B S 
D ibenzoyt peroxide 
ecu 
2 7 % 
64 33 63 
Scheme 2.22 - Synthesis of an azaxanthone substituted D03A derivative 
The protected ligand was obtained following alkylation in acetonitrile. The r-butyl 
esters were removed by TFA/DCM at room temperature followed by boiling of the 
crude reaction mixture in H2O2/TFA, to allow the formation of the desired N-oxide. 
* I . T F A / C H j C l j R . T 
" 2 . H j O y T F A reflux 
3 . L n C i y M e O H / H j O 
p H 5.5 
L n = T b . E u 
[LnU=] 
Scheme 2.23 - Synthesis of N-oxide complexes 
The complexes were then formed by reacting with appropriate lanthanide chlorides 
in aqueous methanol mixtures, with the pH kept at 5.5. 
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2.8.2 Photophysical properties of the N-oxide complexes 
The absoption spectrum of [TbL"] recorded in H2O showed that a shift of 10 nm for 
the longest wavelength absorption was achieved, by transforming the pyridine of the 
azaxanthone to its N-oxide. 
0.8 
0.6 
a 
o 
< 
0.2 
O.O-L. 
2 5 0 
MeCN 
3 0 0 3 5 0 4 0 0 
Wavelength (nm) 
4 5 0 
Figure 2.32 — Absorption spectra for the N-oxide complex | T b L " | recorded in H2O and MeCN 
(298 K ) 
The emission spectrum recorded in water, however, showed no lanthanide emission. 
Only a broad fluorescence at 500 was observed. Lanthanide emission was only 
observable in a dry aprotic solvent (e.g. MeCN). 
I 6 00E-HD5 
3ry MeCN 
500 550 
VtovBtength (nm) 
-Dry MeCN 
-MeCNffi%V*tBf I 
V\feve!enoth (nm) 
Figure 2.33 - Emission spectra of complexes [ L n L " | recorded in dry MeCN and water 
(MeCN/HjO) 
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Even a small amount (5% v/v) of water added to the dry acetonitrile solution of the 
N-oxide complex led to nearly complete removal of the lanthanide luminescence. 
This could be the result of weak binding of the chromophore N-oxide to the metal 
ion as a result of strain in the bite angle. Thus, the chromophore is easily displaced 
by competitive coordination of water molecules. These results showed that the N-
oxide complexes were not suitable for cellular imaging by fluorescence microscopy 
and were not developed further. 
2.9 Phosptiinate complexes 
Previous work in Durham has shown that tetrakis phosphinate complexes, [LnL^"]", 
possess long luminescence lifetimes (nearly 4 ms of Tb^ "^  complex), and high overall 
emission quantum yields, up to 44% in HaO. '^ 
[LnL^"]-
Figure 2.34 - Tetrakis phospinate comlexes 
This observation, together with the possibility to vary the lipophilicity of the 
complex by variation of the alkyl group R, made complexes incorporating three 
phophinate pendant arms and a chromophore an interesting target. Complexes with 
two different alkyl groups (methyl, benzyl) were selected as goals for initial work. 
2.9.1 Complex synthesis 
Two different strategies were used in the synthesis of the two analogous ligands. 
Each route involved protection and deprotection steps to achieve the selective 
substitution of the cyclen ring nitrogens. 
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65 
u ftJUO 
B o C j O f I 
0(Bu 
46 
V 
M e C N 
( C H j O ) „ 
T H F 
1 3 % 
63 
O f B u 
66 
T F W C H j C l j 
9 0 % 
- N N 
69 68 67 
Scheme 2.24 - Synthesis of the methyl phosphinate ligand, L 
The synthesis of the protected methyl phosphinate ligand, 69, commenced with 
protection of three cyclen ring nitrogens by Boc groups. The remaining nitrogen was 
alkylated with the bromomethyl derivative of 1-azaxanthone, 63, in a subsequent 
reaction. The protecting Boc groups were removed by TFA in dry CH2CI2 and the 
monosubstituted cyclen derivative 67 was reacted with diethoxymethylphosphine 
and /»ora-formaldehyde, to yield the protected ligand 69. 
The synthesis of the benzyl phosphinate ligand, 74, began with a series of protecting 
and deprotecting reactions aimed at obtaining the mono-Boc protected cyclen 
derivative 70. The cyclen was first acylated at three ring nitrogens by ethyl 
trifluoroacetate, and the remaining position was protected by a Boc group. The 
derivative 70 was then obtained following mild base hydrolysis. The phosphinate 
pendant arms were introduced in an Arbusov reaction with diethoxybenzylphosphine, 
71, and paraformaldehyde in dry THF. This was followed by the removal of the Boc 
protection with TFA in DCM and alkylation of the free cyclen nitrogen to give the 
desired protected ligand 74. 
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H / \ H 
\ n C D C F j C O O E t 
H \ / H 
N a O H 
H / \ H 
\ / \ / 
J + 
y - o ( B i 
( C H ; 0 ) n ^ 
T H F 
2 4 % 
V 
r C 
65 70 71 72 
// f^^ °^  
M e C N 
T F A / C H j C I ; 
8 3 % 
WO" 
74 63 
N N 
73 
Scheme 2.25 - Synthesis of the benzyl phosphinate ligand, 
The synthesis was completed by acid hydrolysis of the phosphinate ethyl groups and 
complexation with an appropriate lanthanide (111) salt in aqueous methanol adjusting 
the pH to 6. The neutral complexes, [LnL^'] and [LnL^^], were purified by column 
chromatography on alumina. 
1) 6 M H C I reflux 
2) L n C l j , H j O / M e O H . p H 6 
Ln = T b . E u 
r r ^ J - 'Ln-
N' ' / 
( V -
70 R = Me 
75R = CH2Ph 
[LnL^'j R = Me 
[LnL"] R = CHjPh 
Scheme 2.26 - Synthesis of the phosphinate complexes, [LnL'^] and | L n L ' ' | 
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2.9.2 Complex properties 
The phosphinate complexes containing the azaxanthone chromophore had the 
favourable luminescence properties that were expected. The luminescence lifefitimes 
are summarised in Table 2.6. 
Ligand Tb Eu 
3.57 ms 1.16 ms 
3.63 ms 1.25 ms 
Table 2.6 - Luminescence lifetimes for the phosphinate complexes (H2O, 295 K) 
The luminescence lifetime in D2O was measured for the benzyl phosphinate complex 
[TbL^^] and was found to be 3.58 ms. This indicates that there are no water 
molecules directly bound to the metal centre, even though the ligand is only 
octadentate. This behaviour was observed with other complexes bearing the benzyl 
phosphinate pendant arms and is probably due to the steric hindrance of the metal 
centre by the benzyl groups and the overall lipophilic character of the complex.^^ The 
luminescence quantum yield for the benzyl phosphinate complex [TbL^^J was 44%. 
These results were not further developed, apart from quenching studies (Chapter 3), 
in this thesis but were taken as an encouragement to use phosphinate arms in further 
work with luminescent complexes. 
2.10 Conclusions 
Two new chromophores incorporating carboxylic acid functionality and their D03A 
complexes have been synthesised. Their photophysical properties were investigated. 
The tetraazatriphenylene chromophore, 12, gives rise to highly emissive complexes. 
The only drawback in the case of this chromophore is its tendency over time to lose 
one or even both of its carboxylic acids. The monocarboxylate complexes have, 
however, been shown to be highly emissive and stable with time in media used for 
commercial assays. The monoacid complexes also retain one possible conjugation 
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point. Complexes of the azathioxanthone chromophore exhibit only weak lanthanide 
emission. This is in part due to strong chromophore fluorescence in aqueous media. 
An analogous azaxanthone chromophore, containing a carboxylic acid ester, has 
been incorporated into cationic amide arm complexes, which have been shown to be 
highly emissive. Further work with these complexes is presented in Chapter 4. 
Further work was aimed at amending properties of the azaxanthone chromophore by 
making its N-oxide. The N-oxide complexes are not emissive in aqueous media and 
cannot be used for cellular imaging purposes. Phosphinate pendant arm complexes 
have been synthesised as well, and have been shown to have good photophysical 
properties. 
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3 Quenching studies 
A large number o f factors needs to be taken into consideration during the design o f 
luminescent lanthanide complexes for cellular imaging purposes.''^ Some of these, 
such as the prerequisites for sensitizing chromophores, have been discussed in 
previous chapters. Further understanding can be obtained f rom a mechanistic 
analysis o f the pathway leading to lanthanide emission, Scheme 3.1 
lanthanide 
hgand fluorescence luminescence 
sons—Ln 
hv' 
energy 
"em transfer "^m " v 
h v ' "^ISC l^ET 
sens—Ln 'sens—Ln • 'sens—Ln — ^ sens—Ln* 
I^BET aosorpfron 
kq[Q] k , [ 0 2 ] 
Scheme 3.1 - Photophysical kinetic scheme for sensitised lanthanide luminescence 
This scheme shows that there are three excited states in the overall excitation 
pathway. The first two are the singlet and triplet excited states o f the chromophore 
and the third one is the excited state o f the lanthanide ion. The chromophore excited 
states can undergo several other energy-, electron- or vibrational- relaxation 
processes, which can lead to a decreased quantum yield for lanthanide emission. 
Thus, the sensitizing chromophores need to be chosen with care. The deliberate 
controlled perturbation o f these excited states can also be used in the design o f 
sensitive probes.^' '* 
The lanthanide excited state can be quenched by a variety o f processes. Vibrational 
deactivation by energy matched X - H (X = O, C or N) oscillators is well known. The 
sensitivity o f Tb^* and Eu^'^excited states to vibrational quenching by OH and amine 
N H groups needs to be considered in ligand design. ^ ' ^ Energy transfer to 
chromophores with appropriate absorption spectra can also occur and has found 
application in many time resolved assays.^'^ 
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Furthermore, another quenching pathway, involving an electron/charge transfer 
process, can be anticipated. The terbium and europium ^DQ excited states lie high 
above their ground states at 244 and 206 kJ mol ' ' respectively. In addition, these 
excited states have lifetimes of the order o f milliseconds. This energy can be utilised 
as a driving force for an electron-transfer process.^ It has been observed that this 
process occurs in the presence of electron rich species, which can, in the limiting 
case, be oxidised with the concomitant reduction of the complex. The facility of such 
a process can be assessed using the Weller equation (1). '" 
AG^j. - nF (E -E ,)-E . - ^ y Jmor' (1) 
Here, Eox is the oxidation potential o f the electron donor (quencher), Ered is the 
reduction potential of the complex, Etn* is the energy o f the lanthanide excited state 
(2.52 and 2.13 eV for terbium and europium respectively) and e^/er is a Coulombic 
attraction factor correcting for the transient formation o f a charge separated species, 
which is usually small (< 0.2 eV)." 
The first implication, obvious from equation (1) is that terbium complexes should be 
quenched more readily by this mechanism than europium complexes of the 
corresponding ligands, due to the higher energy o f the terbium excited state 
(difference o f 38 kJ mol ' ' ) . This in turn implies, at least in the case o f terbium 
complexes, that the electron is accepted by the heterocyclic chromophore, rather than 
the metal.^ 
Thus, knowing the reduction potential o f the chromophores, and using equation (1), 
an estimate can be obtained as to which electron rich species should be expected to 
exhibit this kind o f quenching. For the tetraazatriphenylene complexes, with the 
chromophore reduction potential of -1.1 V , and halide anions it is only iodide (Eox = 
+ 0.54 V ) " that should effectively quench the lanthanide luminescence. The 
oxidation potentials o f + 1.07 V and + 1.36 V for bromide and chloride respectively 
should rule them out as possible quenchers.'*'^ 
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As these lanthanide complexes were developed for cellular imaging, other electron 
rich species needed to be investigated as possible quenchers of lanthanide emission. 
The two most obvious ones are urate (EQX = +0.59 V) and ascorbate (EQX = +0.30 
V). '^ These two compounds are present in most eukaryotic cells with concentrations 
ranging from 0.1 to 1 mM and probably act in synergy, as part of the cell's 
antioxidation mechanisms. 
In addition, initial observations of this type of quenching have shown that it is both 
the emission intensity and its lifetime that are reduced. This indicates that a 
dynamic/collisional quenching process is taking place.'*'^  
3.1 Investigation of dynamic quenching 
The Stem-Volmer equation (2) is commonly used to quantify the extent of quenching 
by a given quencher'"': 
^°/ = ^ +kMQh^+K,M (2) 
lo and I in equation (2) are luminescence intensities in the absence and presence of 
the quencher respectively,' kq is the rate constant for the bimolecular quenching 
process, TQ is the luminescence lifetime in the absence of quencher and [Q] is the 
quencher concentration. The product of kq and T ( K S V ) is the Stem-Volmer quenching 
constant, which has units M ' ' . The quenching susceptibility is usually quoted as the 
inverse value of the Stem-Volmer Ksv (M), which indicates the concentration at 
which the luminescence is quenched to 50% of its initial value. 
A similar equation relating luminescence lifetimes can be used for dynamic 
quenching, equation (3). 
^y(=\+KsM (3) 
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A linear relationship is thus obtained. A n example o f the experimental approach is 
given below (Fig 3.1) for the quenching o f the lanthanide excited state by iodide and 
ascorbate in the dianionic complex [LnL'^]^". 
• TbD03AdpqCOOH-IODIDE 
• TbD03AdpqCOOH-ASCORBATE 
EuDOSAdpqCGGH-IODIDE 
X EuD03AdpqCOOH-ASCORBATE 
Quencher concentration (mM) 
Figure 3.1 - A representative Stern-Volmer plot for quenching of [LnL^]^" by iodide and 
ascorbate* (298 K , p H 7.4,100 m M H E P E S , 10 m M NaCl ) 
A range of complexes, including those prepared as a part o f this thesis, were studied 
in terms o f their susceptibility to this type o f dynamic quenching, with the aim to 
enhance the understanding o f the underlying mechanisms. The need for such a study 
was evident, especially as initial experiments showed deviations f rom predictions 
based on the idealised relationships implicit in equations (1), (2) and (3).^ 
3.2 Dynamic quenching studies with a series of lanthanide 
complexes 
The usual experimental set up for quenching studies involved a solution o f a given 
complex at -10 buffered to p H 7.4 wi th 100 m M HEPES buffer and containing 
10 m M NaCl. The measurements were carried out at 298 K . 
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Scheme 3.2 - List of complexes used in the quenching study 
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3.2.1 Quenching with potassium iodide 
The data obtained with solutions containing varied concentrations of potassium 
iodide followed the relationship implicit in equation (3) and gave linear Stem-
Volmer plots. The results are summarised in Table 1. 
Entry Complex Terbium Europium 
1 [ L n L ' ] ^ " 0.92 27 
2 [ L n L ' ] 2.10 >1000 
3 [LnL^]^- 6.90 >1000 
4 1.64 85.5 
5 2.35 10.8 
6 [ L n L " " ! 2.25 >1000 
7 [LnL^^"] 3.21 >1000 
8 [ L n L ^ Y ' 2.50 >1000 
9 [ L n L ^ ' ] 36.6 120 
10 [ L n L " ] 26.2 139 
11 [ L n L " ] 53.5 125 
12 [Lnl?^]- 35.2 N.d. 
13 [ L n L ' Y ' 10.9 250 
14 [ L n L ' Y " 9.20 278 
15 [ L n L Y ^ 5.60 N.d. 
16 [ L n L ^ Y ' >1000 N.d. 
Table 3.1 - Inverse Stern-Volmer quenching constants K s v ' (mM) for quenching of the 
lanthanide luminescence by iodide (298 K , 10 ^ M complex, p H 7.4, 10 m M NaCI, 0.1 M H E P E S 
buffer) 
The expected higher sensitivity of terbium complexes to quenching is maintained in 
every case. The following order o f susceptibility to quenching was observed for 
charged complexes positive > neutral > negative. This trend can be explained by 
simple electrostatic attraction/repulsion ideas and is evident especially for entries 1-3 
and to a lesser extent, for entries 4, 6 and 8. 
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The susceptibility to quenching is also a function o f the reduction potential of the 
chromophore. This trend is observed for a set of complexes with different 
chromophores but identical pendant arms, such as entry 1 and 11. The azaxanthone 
complexes are quenched to a lesser extent than the tetraazatriphenylene ones, as their 
standard reduction potentials are -1.6 and -1.1 V . 
3.2.2 Quenching with Urate and Ascorbate 
A similar study was carried out using uric and ascorbic acid as the quenching agents. 
Entry Complex Urate Ascorbate 
Terbium Europium Terbium Europium 
17 [ L n L ^ ' 0.025 0.07 0.18 0.39 
18 [ L n L ' l 0.005 0.11 0.35 2.92 
19 0.01 0.16 0.75 4.13 
20 0.009 0.49 0.24 0.51 
21 0.018 0.028 0.47 0.47 
22 0.05 0.05 0.55 1.13 
23 [LnL^^"] 0.03 0.08 0.99 7.50 
24 0.012 0.084 0.38 2.55 
25 [ L n L ^ ' ] 0.02 N.d. 0.48 N.d. 
26 [LnL^^] 0.06 0.36 0.93 11.3 
27 [ L n L ^ ' l 0.012 0.28 0.57 8.90 
28 [ L n L ^ Y 0.01 N.d. 0.61 N.d. 
29 0.02 0.27 0.30 1.52 
30 [ L n L " ] ' " 0.04 0.60 0.37 1.50 
31 [ L n L Y ^ 0.018 N.d. 0.19 N.d. 
32 [ L n L ^ Y ' >1000 N.d. >1000 N.d. 
Table 3.2 - Inverse Stern-Volmer quenching constants Ksv' (mM) for quenching of the 
lanthanide luminescence by urate and ascorbate (298 K , 10 fxM complex, pH 7.4, 10 mM NaCI, 
0.1 M H E P E S buffer) 
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The higher susceptibility o f terbium complexes to quenching was also observed with 
these quenchers. Other results obtained from this study, did not adhere to the 
predictions based on equations 1-3. 
Most importantly, each complex showed a much higher sensitivity (up to an order o f 
magnitude) to quenching by urate compared to ascorbate. This behaviour does not 
match the expectation based on their oxidation potentials o f +0.59 and +0.30 V , 
respectively. The sensitivity to quenching by urate/ascorbate mirrored the ease of 
reduction o f the chromophore, for complexes based on the same ligand parent 
structure (e.g. D 0 3 A ) . No overall trend was evident, however, based on overall 
charge i.e. coulombic effects, as was the case for iodide. The steric shielding o f the 
metal centre seems to play a more important role. Comparing, for example, the 
azaxanthone D 0 3 A complex (Entry 27) to its benzyl phosphinate analogue (Entry 
26), it is evident that the more sterically hindered benzyl phospinate complex is less 
sensitive to quenching. 
The data presented in Table 3.2 were obtained with concentrations o f urate in the 
range from 5 to 50 | i M and ascorbate 50 to 500 n M . This concentration range had to 
be used as the Stem-Volmer plots o f XQ/T versus quencher concentration showed 
deviation from linearity predicted by equation 3, consistent with saturation behaviour. 
[Q]/mM 
Figure 3.2 - Nonlinear behaviour of T O / T plots for urate (squares) and ascorbate (open triangles) 
with complex | T b L " | ' * ( p H 7.4, 0.1 IVl H E P E S , 10 mM NaCI, 10 complex, 295 K ) ' 
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This effect is especially marked for terbium complexes in quenching experiments 
with urate. Non-linear behaviour and the tendency to reach a l imiting XQ/T value was 
also observed with high concentrations of ascorbate as well . This nonlinear 
behaviour was most evident with cationic complexes, such as [LnL*]"'"^, where 
deviations f rom linearity were observed at 50-200 |a,M urate concentration. Urate 
concentrations 3-4 times higher were required for such an effect with the 
corresponding neutral and anionic complexes. 
Thus, another parameter was needed to be defined in order to describe the quenching 
behaviour exhibited by urate and ascorbate. The TQ/T value, at a fixed quencher 
concentration was considered. Analysing these values for example for complexes 
[ L n L * ] ^ ^ [ L n L ' ] and [ L n L ^ ] ^ - w i t h 50[iM urate, TQ/T values are 5.1, 11.5 and 5.6 
respectively. It can be clearly seen that the charge effects that dominated iodide 
quenching are not important in this case. Indeed, the cationic complex is the least 
sensitive. This behaviour is further emphasised by examining the limiting TQ/T values, 
which are 8 for the cationic complex and >20 for the other two. 
3.2.3 Amide arm complexes of functionalised azaxanthone 
complexes 
rrbL'°]2 
coo- PI w 
[TbL=']^  
Figure 3.3 - Structures of complexes showing limited sensitivity to quenching by electron rich 
species 
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A surprising result was observed for the 'phenyl amide' arm azaxanthone complexes 
with carboxylate [TbL^"]^"^ and methylamide [TbL^']**^ groups in the chromophore 
structvire. The carboxylate complex was virtually unquenched. (Figure 3.4). 
! 85 
1 75 
1.65 
1 55 
g 145 
1.35 
1.25 
115 
1.05 
0.95 
*TbPh3AZAC00Me 
• TtPh3AZACOOH 
8 10 12 
Concentration of Kl (mM) 
Figure 3.4 - Stern-Votmer plot comparing quencliing by iodide of the methyl ester |TbL^]^^ and 
carboxylate acid ITbL^j^'^ complexes (pH 7.4, 0.1 M H E P E S , 10 m M N a C l , 10 p M complex, 295 
K ) 
Furthermore, the methylamide complex, [TbL^']^*, shows high resistance to being 
quenched as well, with a V x value of only 1.03 in the presence of 19.7 mM iodide. 
Similarly in the case of ascorbate and urate quenching nearly no sensitivity was 
observed for the carboxylate complex, [TbL'*"]^^. 
The methylamide was also resistant to quenching, with XQIX values of 2.09 and 1.06, 
for ascorbate (19.7 mM) and urate (0.2 mM) respectively. 
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3.95 
345 
I 2.95 
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1 95 
g 3,95 
. TbPh3AZACOOMe 
• TbPhSAZACOOH 
2 3 4 
Concentration of Ascotbate (mM) 
. TbPh3AZAC0OMe 
• TbPhSAZACOOH 
0.1 0.15 
Concentration of Urate (mM) 
Figure 3.5 - Stern-Volmer plots comparing quenching by ascorbate and urate of the methyl 
ester ITbL*]^"^ and carboxylic acid [TbL^"!^"^ complexes (pH 7.4, 0.1 M H E P E S , 10 m M NaCI, 10 
fxM complex, 295 K ) 
These results can be rationalised in terms of simple Coulombic repulsion for the 
carboxylate complex (TbL^"]^*, as the acid group is deprotonated under the 
conditions of the experiment giving the chromophore a local negative charge. This 
effect, however, was not so dramatic for the tetraazatriphenylene complexes [LnL' ' ]^ 
Furthermore, it cannot explain the relatively high insensitivity to quenching of the 
methylamide [LnL^']^"^ complex. Another possibility is a change of the reduction 
potential of the chromophore. But, the introduction of an electron withdrawing 
carbonyl group should increase the susceptibility of the chromophore to reduction 
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and thus increase the sensitivity to quenching, as was the case for the methyl ester. 
Thus, ftjrther investigation is needed for a greater understanding. 
3.2.4 Investigation of the Quenching Mechanism 
The observation o f non-linear behaviour in the quenching o f lanthanide emission by 
urate and ascorbate, as well as the unexpected sensitivity to quenching by urate, led 
to the need to explore further the underlying quenching mechanism. 
k-| V.2 1^  
A*+D - " (A*D) -> " (A«-D»^) ^ -^ (A»-+D*" - ) 
k.1 k .2 
1/T 0 
A+ D 
Scheme 3.4 - Kinetic scheme for collisional quenching proposed by Weiler and Rehm''* 
The Stem-Volmer model used to interpret the quenching data is based on the kinetic 
scheme proposed by Weller and Rehm (Sheme 3.4).'^ This model assumes the 
formation o f an encounter complex ( A * D ) , with overall kinetics being controlled by 
diffusion, followed by electron transfer from the donor to the acceptor. 
A n alternative scheme has been proposed, during the analysis o f quenching data for 
certain systems, especially pairs o f aromatic donors and acceptors. In this case, a 
relatively long lived exciplex is postulated as an intermediate in the mechanism 
(Scheme 3.5).'^-'^ 
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A + D 
h v 1/TO 
A+ D 
k i k 2 
^ ( A * D ) ^ = 
k . 
(A^ -D^ )^ 
k 3 
A+ D 
Scheme 3.5 - Kinetic scheme for quenching involving an associative step, forming a long lived 
exciplex 
In this case, provided that k . 2 » k 3 , an equilibrium constant Kex for the formation o f 
the exciplex can be defined: 
(4) 
The exciplex lifetime is then dependent on (k3)"'. The 'Stern-Volmer' quenching 
constants obtained in measurements where such a mechanism is in operation, have 
limited validity, and have a different meaning than defined earlier. A new, nonlinear, 
relationship for the dependence o f lanthanide luminescence on quencher 
concentration can then be defined: 
T i^ + KjQ]) (5) 
This relationship also includes the possibility o f a l imiting value o f TQ/T being equal 
to kaToat high quencher concentrations. The formation o f the long lived exciplex can 
be enhanced by weak forces such as charge transfer, hydrogen bonding or TI-TC 
interactions. In particular, charge transfer between the n systems is likely, especially 
in the case o f the electron rich urate anion and the electron poor chromophores. 
130 
CHAPTER 3 Quenching studies 
UN \ _ • • HN Y \ 
HOH2C HOHjC 
HO \ J • HO \ / 
Scheme 3.6 - Urate and ascorbate one electron oxidation' 
As an association step is involved in the mechanism according to Scheme 3.5 it 
should be expected that this process would occur to a lesser extent with increasing 
temperature. This is contrary to processes that conform to Scheme 3.4, which are 
purely collisional and should be activated with increasing temperature. 
Therefore, the temperature dependence o f emission lifetime o f [TbL"l^^ was 
measured for a fixed quencher concentration. The conditions were the same as for 
other quenching experiments (10 |xM complex, pH 7.4, 10 m M NaCI, 100 m M 
HEPES). The quencher concentration was half the value o f Ksv' ' for iodide and 
ascorbate and 50 ]xM for urate. The results are summarised in the Arrhenius plot 
(Figure 3.6), where ln(k) is plotted against 1/T. 
3 3.2 
m (K ' X10^) 
3.4 
Figure 3.6 - Arrhenius plot for quenching of jTbL 'V^ with iodide (circles), urate (crosses) and 
ascorbate (squares)' 
The different behaviour observed for urate and ascorbate, as compared to iodide, 
supports the suggestion that different processes might be involved. Further analysis 
o f this data shows a small positive activation enrgy E a = + 1.5 (±0.3) kJ mol"' for 
iodide and negative values o f - 6 and - 3.6 kJ mol"' were found for ascorbate and 
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urate, respectively. The activation entropies for urate and ascorbate could then be 
estimated using Eyring's transition state analysis, and a negative value for AS^ = -
260 (± 20) J m o f ' K ' ' was found, in accord with the proposed associative process. 
An experiment testing the effect of ionic strength was carried out to further test this 
hypothesis. It was again carried out with [TbL^]^* under the conditions o f previous 
experiments (10 complex, pH 7.4, 100 m M HEPES, 298 K and with 40 \iM urate 
or 10 m M iodide), and with NaCl concentration varied from 10 to 800 mM. The 
lifetime dropped fi-om 1.50 to 1.25 ms in a control experiment, without added 
quencher, in the concentration range of added NaCl. The lifetime change in the case 
of urate was rather small going from 0.6 to 0.8 ms at 0.8 M NaCl. A more dramatic 
increase in lifetime was observed for iodide, where the change was from 0.7 to 1.25 
ms, reaching this l imit at only 0.2 M NaCl concentration. This is in line with 
expectations based on the sensitivity of collisional encounters o f charged species to 
ionic strength. 
The data obtained for the temperature and ionic strength dependence of the 
luminescence lifetime support the idea that iodide quenching happens by purely 
collisional process. In contrast, an associative process, likely to involve an exciplex 
is more plausible for ascorbate and urate. This hypothesis has subsequently been 
supported by quenching experiments with selected catechols, which showed similar 
behaviour to urate, as expected f rom their structure.^ 
3.3 Urate sensing 
The high sensitivity o f lanthanide emission to quenching by urate, which can be an 
issue in the cellular imaging use o f these complexes, can however be usefial. The fact 
that the Ksv'' values for urate are an order of magnitude lower than for ascorbate and 
several orders o f magnitude lower than for iodide, indicate the possibility to use this 
quenching potency for determination of urate concentration, even in the presence o f 
these species.'* 
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Measuring urate concentration is an interesting goal as it is an important marker 
measured in clinical conditions. Uric acid is the final metabolic product for purines, 
such as nucleobases adenine and guanine. Their metabolites are converted to uric 
acid in the liver, with its equilibrium concentration in the body being controlled by 
its relative rate o f synthesis and renal excretion. 
Elevated uric acid levels (hyperuriceamia) are most commonly associated with gout, 
increased breakdown of cell nuclei and renal disease. Increased uric acid levels are 
observed often also for leukemia, lymphoma or myeloma, where uric acid levels 
need to be monitored to avoid kidney damage.'^ Gout patients suffer f rom pains and 
inflammations caused by uric acid precipitation in joints. Kidney stone formation is 
also more likely due to elevated uric acid concentrations (above 0.60 mg/ml in serum 
and between 1.5 and 4.5 mmol/ml in urine). Elevated uric acid levels can also be 
linked to inappropriate diet and intoxications such as overconsumption of alcohol. 
Defects leading to decreased uric acid levels (hypouriceamia) are less common and 
are usually linked to AIDS, diabetes, mellitus and some malignant diseases. Thus, 
the need for quick and accurate measurement o f uric acid concentration in biological 
liquids is obvious, so that appropriate treatment can be used.'^°' ^' 
3.3.1 Current assays for uric acid 
Uric acid assays used currently for in vitro analysis of uric acid concentrations in 
samples o f biological liquids are based on the action of the uricase enzyme. This 
enzyme transforms uric acid into a more water soluble product (allantoin) and 
produces hydrogen peroxide as a side product. ' Hydrogen peroxide is then the 
detected analyte. The detection can be done in several ways; oxidation o f a phenolic 
dye to a strongly coloured compound or by the action of peroxidise enzyme, leading 
to the production o f an intensively coloured chromogen or a strongly emissive 
fluorophore. These methods have, however, several drawbacks. Firstly, they suffer 
from ascorbate interference (leading to the need of co-administration of ascorbate 
oxidase) and bilirubin. A linear response for the clinically used kits is obtained for 
the concentration range from 0.12 to 6 mmol f ' in urine and 0.09 to 1.8 mmol f ' in 
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plasma and serum. Furthermore, the analysis requires at least 30 minutes of 
incubation and careful pH control.'^'' Careful storage to avoid contamination, damage 
or denaturation is also needed, both for the enzymes and the dyes involved. 
3.3.2 Ra t iomet r ic measu remen t us ing a Tb/Eu m i x t u r e 
The fact that a europium complex of a given ligand is quenched to a lesser extent 
than its terbium analogue allows the use of quenching of lanthanide emission to 
measure urate concentration. In a mixture where both europium and terbium 
complexes of a common ligand are present, the urate concentration can be related to 
the ratio of the terbium and europium emission intensity, at selected wavelengths (e.g. 
546/616 or 546/700). Thus, a ratiometric measurement of the desired variable is 
obtained. 
Such a ratiometric measurement is very desirable, as the measured signal is solely a 
function of one variable; uric acid concentration in this case. Since in this system the 
two ligands are the same, differing only in the metal ion, all interferences will 
happen to both ligands to the same extent and will be eliminated, as the intensity 
ratio is measured. Such interferences include sample to sample variation of protein 
content, light scattering by particulates or differing surface adhesion. Interferences 
more specific for the given system, such as static quenching of the chromophore 
singlet excited state (e.g. by halides)^^, will be also eliminated, as they will happen to 
the same extent for each component. 
3.3.3 P roo f o f concep t exper imen t s 
Initial experiments have been carried out with complexes [LnL^*]^". A 1:1 mixture of 
the corresponding terbium and europium complexes was prepared at pH 7.4 in 100 
mM HEPES buffer. The absorbance was 0.1 at both 313 and 348 nm (approximately 
corresponds to 5 |aM solution of each complex). 
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•02C 
Figure 3.7 - Structure of complex [LnL^']'' used in proof of concept experiments for urate 
concentration determination 
A 1 mM solution of uric acid was prepared (standardised with absorbance at 290 nm; 
e = 1.22*10'* M ' ' cm'') in 100 mM HEPES (pH 7.4). Triplicate measurements were 
carried out with uric acid concentrations ranging from 0 to 50 |xM, to obtain a 
calibration curve. Urine samples from healthy volunteers were prepared as well in 
100, 300 and 500 fold dilution and triplicate measurements were taken as well. 
Measurements were carried out using an Analytik Flash Scan plate reader, using 96 
well plates. Ten spectra were recorded and averaged and 546/616 and 546/700 ratios 
were calculated and plotted against uric acid concentrations to obtain the calibration 
curve, which was tentatively fitted with biexponential decay. A high precision of this 
measurement was demonstrated by less than a 1% variation in the ratios measured 
for any given uric acid concentration. This high accuracy is inherent to ratiometric 
measurements. 
Uric acid concentrations in the urine samples were easily calculated using the 
calibration curve. Parallel measurements were carried out using a commercial uric 
acid assay (Invitrogen, Amplex Red Uric Acid kit), which uses horseradish 
peroxidise, on these samples as well. The two methods gave uric acid concentrations, 
which were within 10% from each other. It should be noted that the enzyme kit 
precision is estimated to be no better than 10%. 
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Figure 3 .8- Plot ofvaritation of the Tb (546 nm) and Eu (616 nm) emission intensity ration as a 
function of added urate (pH 7.4,0.1 HEPES, 298 K)'* 
Thus, a ratiometric, nonezymatic assay for uric acid in urine and possibly other 
biological fluids, with accuracy at least comparable to current commercial assays, 
can be envisaged on the basis of these results. 
3.4 Protein Effect 
All of the complexes presented in the study contain a heterocyclic chromophore 
consisting of at least three ftised aromatic rings. Such a structure can exhibit 
reversible binding with proteins, as has been recently observed by modulation of 
emission and relaxivity (Gd^^) in protein titration measurements.^ ^ Serum albumins 
are one of the most abundant proteins in mammalian cells, and well known for 
binding aromatic guests. It was therefore considered fitting to study their effect on 
quenching susceptibility for selected luminescent complexes ( [TbLY^, [TbL^'*"]"**, 
[TbL^'*''l^^and [TbL']) . 
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Figure 3.9 - Complexes used in the protein binding study 
The addition of bovine serum albumin to each of the mentioned complexes led to a 
decrease in their emission intensities and lifetimes. 
The lifetimes were also measured in a solution containing 0.4 mM of serum albumin 
and 0.1 mM of uric acid. The luminescence lifetimes obtained were 0.57, 0.38, 0.28 
and 0.06 ms for [ThVf\ [TbL^'*"]^^, [TbL^""]^^ and [TbL'] respectively. This 
demonstrates that the D03A complex [TbL'] is sensitive to quenching by urate in 
the presence of protein to a much higher degree than the other complexes. These 
results offer an explanation to the difficulties experienced in fluorescence 
microscopy experiments using this complex. 
V' 
O HjO 
N, ': / ,N 
V;tb-
6^=\ 
NH 
[ T b L " ] ' * 
Figure 3.10 - Structure of methylamide complex [TbL^'j' 
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For azaxanthone complexes, such as [TbL'^']^"^, the luminescence lifetime was 
reduced only from 1.52 to 1.40 upon addition of protein, and the lack of sensitivity of 
the amide complexes to quenching by urate was mentioned earlier. 
3 .5 Conclusions 
A large number of complexes have been studied in terms of their susceptibility to 
quenching by electron rich species such as iodide, ascorbate and urate. Empirical 
rules relating structure and this quenching sensitivity could, thus, be established. 
Further work has demonstrated a fundamental difference in the quenching by iodide, 
which proceeds by a purely collisional mechanism, and ascorbate and urate, which 
are postulated to involve formation of a relatively long lived exciplex. 
It has been demonstrated that the difference in sensitivity to quenching displayed by 
analogous terbium and europium complexes can be used to measure concentrations 
of the quenching species (e.g. urate) even in biological samples (e.g. urine, plasma). 
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4 Conjugation Experiments and Cellular uptake 
studies 
Considerable progress has been made in the field of highly emissive and well defined 
lanthanide (III) complexes over the past decade. These complexes have found use in 
several assays and sensors, often employing time resolved methods. They can 
provide information in their spectral profile, luminescence lifetime or circular 
polarisation. In particular, their long luminescence lifetimes make them very 
attractive for applications in cellular imaging, where time gating can significantly 
reduce the signal to noise ratio. Thus, it comes as no surprise that lanthanide 
complexes capable of traversing the cellular membrane have been developed and 
observed in fluorescence microscopy experiments. A mechanistic understanding of 
the uptake and subsequent fate of these complexes in cells needs to be developed.''^' 
Differential localisation profiles within cellular compartments for a range of Eu and 
Tb complexes have been established. However, the key structural elements that 
determine the predominant localisation profile have not yet been established 
unequivocally. 
OEt 
H , 0 
ribosomes 
nucleolus 
O E I 
HN, 
OMe 
E l O 
lysosomes 
^ 3 . 
'9 
MeO 
nucleus 
Figure 4.1 - Different cellular localisation proflles for selected emissive lanthanide complexes'' 
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A more versatile approach in the development of complexes with defined localisation 
profiles, could involve an emissive complex, which can be conjugated to different 
localisation moieties (vectors). Thus, the localisation profile would be determined 
primarily by the nature of the attached vector. 
Figure 4.2 - General structure of emissive lanthanide complex based on cyclen, incorporating 
three pendant arms and a heterocyclic chomophore 
Considering cyclen based complexes, represented by the generalised structure in 
Figure 4.2, incorporating three pendant arms and a heterocyclic sensitiser, two 
general points of attachment can be envisaged. The linking group could either be 
incorporated into the heterocyclic chromophore structure or via one of the pendant 
arms. The position trans to the chromophore is the most likely one to be chosen for 
the linking arm, due to synthetic considerations. Such an approach has been 
employed previously (Figure 4,3), and is being further developed as a part of current 
work in Durham. 
[ T b L " ] ' * 
Figure 4.3 - Structure of a complex bearing a free amino group in the pendant arm as an 
attachment point for protein conjugation using isothiocyanate methodology^ 
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Incorporating the linking group into the chromophore structure, even i f complicating 
chromophore synthesis, will be advantageous in later synthetic steps, as the N-linked 
donor groups can be the same, which removes protection and deprotection steps 
needed for introduction of different pendant arms. Also, in the case where 
conjugation of a responsive system would be desired, linking through the 
chromophore could be beneficial. This is due to the fact that the pendant arms 
defining the coordination sphere of the metal need to be engineered and introduced 
solely with the aim to tune the properties of the complex for the given responsive 
function. This is more difficult i f one of them is to be used as a linking point. 
4.1 Conjugation using a linking group incorporated into 
the chromophore structure 
The synthesis of three chomophores containing a carboxylic acid/ester group, which 
can be utilised as a linking point in conjugation work, has been described in chapter 
2 (Figure 4.4). 
12 30 41 
Figure 4.4 - Structures of three chromophores bearing carboxylic ester groups which can be 
utilised for conjugation via amide bond formation 
Each of the chromophores has advantages and disadvantages. The 
tetraazatriphenylene, 12, gives rise to highly emissive complexes with excitation at 
348 nm, but its synthesis is moderately difficuh with rather low overall yields. The 
azaxanthone, 41, and azathioxanthone, 30, chrompohores are obtained more readily. 
Moreover, complexes bearing the azathioxanthone chromophore, 30, can be excited 
at 370 nm. The excitation wavelength for azaxanthone complexes is at 336 nm, but 
the peak tails well above the 340 nm needed for practicable use in fluorescence 
imaging. The high amount of chromophore fluorescence ((pn up to 50% in water). 
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low quantum yields of lanthanide luminescence and oxygen sensitivity for terbium 
complexes limit the uses of the azathioxanthone chromophore, 30. The azaxanthone 
chromophore gives complexes with quite good quantum yields ((pH20^'' = 20-40 %) 
and so was chosen as the chromophore of choice for the conjugation work. It should 
be noted that first attempts of conjugation experiments were carried out on 
complexes with the azathioxanthone chromophore. 
Several different types of pendant arms have been incorporated into the ligand used 
in the luminescent lanthanide complexes. The three major types of pendant arms 
used are the carboxylate arm, the amide pendant arm and the phosphinate pendant 
arm. 
^<J° >cr"^ " >Cf" 
Carboxylate arm Amide arm Phosphinate arm 
Figure 4.5 - Structures of the most commonly used chelating groups in emissive ianthanide 
complexes 
Some of the lanthanide complexes bearing only carboxylate pendant arms have not 
been observed in cells in fluorescence microscopy experiments. This is believed to 
be due to their high susceptibility to quenching by species such as urate or axorbate 
and their low protein binding affinity (Chapter 3). Complexes incorporating amide 
arms have been established as being observable in fluorescence microscopy. Their 
simple and versatile synthesis, allowing the variation of the group R, is also 
beneficial. Phosphinate pendant arms give rise to very emissive complexes, 
especially for lipophilic R groups, such as benzyl. Their more difficult synthesis and 
low water solubility are their drawbacks, even though preliminary experiments 
indicated that these complexes are observable in fluorescence microscopy 
experiments. The amide arm using the S'-l-phenylethyl amine was chosen for intial 
coupling studies, as complexes of this pendant arm have been well studied in cellular 
experiments and comparisons to complexes bearing different chromophores could be 
made. 
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AAA H P L C methods for monitoring and purification 
As has been noted before, lanthanide (III) ions are paramagnetic, which has 
implications for NMR measurement. Routine use of NMR in the same way as for 
organic compounds and complexes of other metals is more difficult, even though 
relatively sharp ' H NMR spectra can be obtained for complexes of certain 
lanthanides (e.g. Eu^ "^  or Yb^" )^. Also, reaction monitoring methods used in organic 
chemistry, such as thin layer chromatography, usually cannot be used due to the 
charged nature of the complexes. Reversed phase H P L C , however, is ideally suited 
to monitor the progress of reactions of the complexes that will be described in the 
following sections. Due to the highly polar nature and the milligram quantities used, 
reversed phase chromatography was also the method of choice for purification in 
many instances. The chromatographic gradients used in this work are described in 
Appendix 1 and a selection of representafive chromatograms is presented in 
Appendix 2. 
4.1.2 Development of conjugation methodology 
The synthesis of complexes incorporating azaxanthone or azathioxanthone 
chromophores with (methoxy)carbonyl substitution was described in chapter two 
([LnLY^ and [ L D L Y " ) -
Ph' 
X = S; [LnL ' ] ' * ; Ln = Eu 
X = O; [LnL°]'*; Ln = Eu, Gd, Tb 
Figure 4.6 - Generalised structure of amide arm complexes prepared as a starting point for 
conjugation experiments 
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Even though the methyl ester can, in theory, react with primary amines to form an 
amide bond, such a reaction usually needs rather forcing conditions and a large 
excess of amine, which can lead to metal decomplexation. A different route needs to 
be employed, providing a more active derivative of the carboxylic function towards 
nucleophilic attack. Hence, the methyl ester was converted to the carboxylic acid by 
mild base hydrolysis (KOH, pH 10, HsO/MeOH, 298 K). 
X = S; [LnL^]'*; Ln = Eu 
X = 0; [LnLY*; Ln = Eu, Gd, Tb 
1)K0H/pH 10 
H,O/Me0H 
2) HCI1M -Lnl'-
X = S; [ L n L " ] ' * ; Ln = Eu 
X = O; [LnL^Y*; Ln = Eu, Gd, Tb 
Scheme 4.1 - Mild base hydrolysis of chromophore ester group (Appendix 2, Chromatograms 
6.2.1 and 6.2.2) 
Amide bond formation is a well studied problem and a wide range of methods for 
carboxylic acid activation has been developed. Initial attempts to activate the 
carboxylic acid in the azathioxanthone complex [EuL^ ]^'"* ,^ were carried out with PL-
IIDQ resin, which activates the carboxylic acid by the formation of a mixed 
anhydride, in a manner similar to the use of chloroformates. 
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V - -N 
1^  E I J V - - - ^ 
PL-IIDQ resin n\) 
N. ,N 
HjNR 
MeCN 
R = ^Pr, CHjPh 
[ E u L " ] ' 
[ E U L " ' ] ' * R = /-Pr 
[ EuL""! '* R = CHjPh 
Scheme 4.2 - Attempt of amide bond formation using heterogeneous catalyst (PL-IIDQ resin) 
This attempt was, however, unsuccessful. Isobutyl chloroformate was used in the 
next attempt, carried out in single phase, to determine whether the mixed anhydride 
methodology is feasible. 
\ H 
75 
0 
Ethyl diisopropyl amine HN 
DMF 
[ E u L " ] ' [ E u L " " ] ' * 
Scheme 4.3 - Attempt of amide bond formation using mixed anhydride activation 
Initial positive results were however not reproducible and new methods using more 
modem activation strategies were employed subsequently. A single step EDC/HOBt 
catalysed amide forming reaction was tried out in the next attempt. 
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EDC 
HOBt 
NEt3 
DMF 
[ L n L ' = ] ' 
Scheme 4.4 - Amide bond formation using E D C and HOBt catalysis 
Reproducible results were obtained using this methodology. Excess EDC and HOBT 
had to be used to achieve modest conversions (50%) and significant side product 
formation was observed. Further methods were therefore tested to obtain a more 
practicable conjugation route. A two step sequence was chosen, involving the 
formation and isolation of the intermediate N-hydroxysuccinimidyl (NHS) active 
ester. 
EDC 
DM SO 
[ L n L " ] ^ 
Scheme 4.5 - Formation of the N-hydroxysuccinimdyl activated ester (Appendix 2, 
chromatogram 6.2.3) 
The active ester complex, [LnL"'^ ]"''^ , was isolated, purified and stored in the dark at 
low temperature (-18°C). 
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KOH/pH 10 
H J O / M B O H 
HjNCsH, , 
Tb(OTf)3 
UeCN 
I TbL" j3* 
Scheme 4.6 - Alternative reaction scheme with amide bond formation at the ligand stage 
An alternative approach, where the coupling was attempted on the ligand, was tried 
out as well. This route, gave results establishing its feasibility, but was not used as it 
is more suitable to have the conjugation step after complexation as this leads to a 
smaller number of reactions. Also, the possibility to store the active ester complexes 
[LnL"'^ ]^ '^  makes that route very pragmatic. 
4.1.3 Synthes is of simple amide derivatives 
Having identified the NHS active ester complex, [LnL"*^ ]^ "^ , as a key intermediate for 
the conjugation experiments, its versatility in reactions with different amines needed 
to be established. Three primary amines of differing alkyl chain length (methyl, 
hexyl and dodecyl), were chosen for initial 'proof of concept' experiments. The other 
motive for choosing these amines was the desire to investigate whether this structural 
change would result in different behaviour in cellular experiments. 
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The reaction of the active ester complex, [LnL^*]^ " ,^ with the amines in dry DMF is 
fast and proceeds cleanly. Complete conversion was observed by reverse phase 
HPLC for samples of the reaction mixture taken for analysis 30 minutes after 
reaction initiation. 
r 
' • • ' • j ^ - ' - ' - L n ? ; - - - . ^ 
r 
HjN-R 
[ LnL^'l^* R = CH3 
[ LnL'*]^* R = CeHia 
[ L n L " ] ^ * R = Ci2H25 
Scheme 4.7 - Reaction of the active ester complex with primary amines (Appendix 2, 
chromatograms 6.2.4-6.2.6) 
The amide complexes were purified by precipitation onto Et20, followed by 
preparative reverse phase HPLC. These experiments were carried out with Tb'^ "^  
complexes only, with the exception of the hexylamide example. 
The amide complexes remained strongly emissive and the luminescence lifetimes in 
H2O were in the expected range 1.5-1.7 ms. 
4.1.4 Conjugation to oligoarginine peptide sequences 
It is known that peptide sequences with a high content of positively charged residues 
such as arginines, aid the translocation of various compounds across the cellular 
membrane.^'^ Two simple peptides were therefore selected for conjugation to the 
active ester complex, [LnL^^]^^, (H-Arg7-0H and H-LysArg7-0H). The H-Lys-Arg7-
OH sequence was chosen as its primary amine group was expected to be more 
reactive in the conjugation reaction than the terminal a-amino group of arginine in 
the other peptide or, indeed, its own a-amino group. 
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The peptides were supplied as their hydrochloride salts and therefore a base needed 
to be used in the coupling reactions to deprotonate the ammonium groups. No 
reaction was observed in initial experiments using dry DMF as a solvent and 
diisopropyl-ethylamine or 4-dimethylamino pyridine, even with elevated reaction 
temperature (40°C). This problem occurred with each peptide. 
Formation of product was observed when carrying out the reaction in H2O buffered 
with 0.1 M HEPES to pH 7.4. The hydrolysis of the active ester was observed as a 
competing reaction and an excess of complex [LnL^^]'''^ had to be used. The 
conjugates were purified using HPLC separation. 
r 
H-ATBrOH / 
or 
H-Lys-ArOT^H 
0.1 M H E P E S 
pH7.4 
° " " - T b ? * - - . . . . ? 
[ L n L " ] ^ * R = Arg7-0H 
[LnL'Y* R = Lys-Arg7-0H 
Scheme 4.8 - Conjugation of oligopeptide sequences (Appendix 2, chromatograms 6.2.7 and 
6.2.8) 
The luminescence properties showed that the lifetime remained virtually unchanged 
in comparison to other derivatives, but a decrease in the overall luminescence 
quantum yield was apparent and will be discussed in section 4. 
4.1.5 Conjugate with a 'non-peptidic' oligoguanidinium vector 
As has been mentioned in the introduction (p. 34), the oligoguanidinium vector, 
synthetised by de-Mendoza and conjugated to fluorescein, resulted in mitochondrial 
localisation of the conjugate. The vector was obtained as a kind gift from the group 
of de-Mendoza as a part of a collaboration. The coupling reaction was carried out in 
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DMF. The purification was achieved by precipitation of the reaction mixture onto 
Et20 and by HPLC separation. 
H' H 
N N 
H' H 
4PFe-
80 
N N 
H* H 
H P 
N 
Scheme 4.9 - Synthesis of the oligoguanidinium conjugate (Appendix 2, chromatograms 6.2.9 
and 6.2.10) 
Reduced luminescence quantum yield, but unchanged luminescence lifetime was 
observed in this case as was the case for the oligoarginine peptide conjugates. 
4.1.6 Conjugation to PAMAM dendrimer 
In their earlier work, Lukes et. al. have observed enhanced relaxivities for Gd''^ 
complexes conjugated to a PAMAM dendrimer. The functionality of these 
conjugates can be enhanced by incorporating labels of different types, such as a 
fluorophore. Thus, a dual imaging (MRI/Optical) probe could be obtained. The 
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synthesis of a conjugate containing emissive lanthanide complex and Gd'^ '^  complex 
was planned as a joint project between Durham and the Prague goup. 
[TbL«] 36i3+ 
HjN GjPAMAM 
H,N GjPAMAM 
D M F * I B O H 
Y 
(Gd) 
(Tb,Gb,L"] 
[ T b L " l 
HjO/KOH 
pH9 
4 0 ° C 
N " 
O H 
S C N 
H 
^ N H 
H N G,PAMAM 
81 
[TbL«] 
Scheme 4.10 - Synthesis of the Tb/Gd dendrimer conjugate 
The coupling of the active ester complex [TbL^ ]^^ "*" with a G2-PAMAM dendrimer 
(16 terminal amino groups) was carried out in DMF/MeOH. The only control used 
for the number of complexes loaded per dendrimer was the stoichiometry of the two 
reactants, with the aim of gaining an average loading of 1-2 complexes per 
dendrimer. The purification of the conjugate was carried out by dialysis using 
benzoylated cellulose tubing (cut off 1200 g/mol, Appendix 2 chromatograms 6.2.11-
6.2.14). 
Further steps of the synthesis were carried out in Prague in the group of Professor 
Lukes. The remaining (14-15) amino groups of the conjugate [TbL'*^] were coupled 
with an excess of the isothiocyanate ligand 81. The reaction mixture was purified by 
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ultrafiltration on YM3 membrane with the cut of f at 3000 g/mol. The synthesis was 
accomplished by complexafion of the conjugated ligand moieties with GdCls and the 
reaction mixture was again ultrafiltered on the YM3 membrane to obtain the 
conjugate complex [TbxGdyL'*"*]. 
The emission spectrum of the final conjugate shows Tb emission overlaying 
significant organic fluorescence. The lifefime of the terbium emission in H2O is 1.77 
ms. This indicates that the Tb^^ cation remains in the well defined coordination 
sphere of the ligand , L^*. 
4 . 0 0 E + 0 5 
3 . 5 0 E + 0 5 
3 . 0 0 E + 0 5 
2 . 5 0 E + 0 5 
2 . 0 0 E + 0 5 
E 1. 
1 . 0 0 E + 0 5 
5 . 0 0 E + 0 4 
4 5 0 5 0 0 5 5 0 
Wave length (nm) 
600 6 5 0 
Figure 4.7 - Emission spectrum of |Tb,GdyL''^| 
The ICP-MS measurement, however, showed the Tb:Gd ratio to be 1:50 instead of 
the expected 1:15. This is most likely due to loss of Tb^^ during the conjugation and 
complexafion reacfions in the steps following conjugafion of complex [TbL^]^^. 
Even though this shows the need to optimise the synthetic route in any fiiture work, 
the remaining data prove that the synthesis of a dual imaging probe is possible using 
this strategy. 
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4.1.7 Conjugation of a quencher molecule 
Catechol molecules are effective quenchers of the lanthanide excited state, as has 
been mentioned in Chapter 3. The 3,4-methylenedioxy-benzylamine has been used in 
current project in Durham. The aim of this work is the synthesis of complexes 
containing covalently linked quenchers, such as complexes [LnL"*"*]"^ , as potential 
probes for reactive oxygen species. In this case, the quencher is integrated into the 
pendant arm. 
[LnL«)* 
Figure 4.8 - Complex containing a covalently linked quencher molecule 
A significantly decreased luminescence lifetime and emission quantum yield was 
observed for the terbium complex, consistent with intramolecular quenching of the 
Tb excited state by the electron-rich aromatic moiety." 
Thus, it was of interest to prepare the conjugate of complexes [LnL''']^ "*", 
incorporating a 3,4-methylenedioxy benzylamine moiety, to investigate the effect on 
lanthanide luminescence. 
The coupling reaction was carried out in dry DMF and the reaction mixture was 
purified by precipitation from diethyl ether followed by HPLC separation. 
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° " ' - L r i ? ; - - . . . . , ? 1^  Ln?"--^. _ / 
[ L n L " ] ' 
Scheme 4.11 - Conjugation of 3,4-methylenedioxybenzyi amine (Appendix 2, chromatogram 
6.2.15; chromatography Method D) 
The luminescence lifetime (1.38 ms) was decreased for the Tb^ "^  complex, compared 
to analogous amide derivatives described (ca. 1.6 ms), but not as significantly as 
expected. There was no significant change to the lifetime of the Eu^ "^  complex. Both 
complexes have, however, a significantly reduced overall quantum yield, in a similar 
way to the conjugates with the peptide and oligoguanidinium vector. 
4.1.8 Cholesterol conjugate 
Cholesterol is an important component of biological membranes and several 
fluorescently labelled derivatives have been used to study its partitioning in cellular 
media. Thus, attempting to synthesise a conjugate with, a suitably derivatised 
cholesterol moiety was identified as an interesting target. 
The only possibility for straightforward conjugation offered by the cholesterol 
molecule is its hydroxyl group. A direct conjugation to form a cholesteryl ester is 
possible, but a small spacer (4-aminobutanoic acid) was chosen, as the amino group 
is more reactive with the NHS ester of [LnL 36,3+ 
The synthesis was carried out in three steps starting with a coupling of cholesterol, 
83, and Boc protected 4-aminobutanoic acid, 84. EDC and HOBt were used as the 
156 
CHAPTER 4 Conjugation Experiments and Cellular uptake studies 
activating reagents in dry MeCN and CHCI3 . The product, 85, was crystallised from 
a CHCh/MeOH mixture. 
E D C 
HOBI 
MeCN/CHCb 
/ N 
° ' '•'•ja': 
TFA/CHjCl j 
[LnL«] ' 86 
Scheme 4.12 - Synthesis of a cholesterol conjugate (Appendix 2, chromatograms 6.2.16 and 
6.2.17) 
The structure of the cholesteryl ester 85 was established by partial assignment of its 
' H and '•'C N M R spectra, in comparison to that of cholesterol, 87, itself and using the 
literature assignments of cholesterol ' H and '•'C N M R spectra.'^ The spectra are 
displayed in Appendix 3 and a partial assignment is shown in Figure 4.9. The most 
diagnostic change of the shift of the proton in position 3 on the cholesterol structure, 
which moves from 3.53 ppm in cholesterol, 87, to 4.62 ppm in the cholesteryl ester 
85. This is the expected change of a ' H N M R shift for protons on an a-carbon of an 
aliphatic alcohol, being transformed into the corresponding carboxylic acid ester. 
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Further evidence for the formation of ester 85 is the 2:1 peak integral ratio of the 
signal at 3.15 ppm, corresponding to the protons on carbon 4 of the butanoate chain, 
and the signal at 5.36 ppm, corresponding to the double bond proton of the 
cholesterol structure. It is expected that the remaining part of the cholesterol structure 
will not be affected by this transformation; hence, no benefit was seen in completing 
the assignment of the ' H and '^C N M R spectra. 
1.52 (p; 
87 
1 . 5 2 (P 
0 . 1 5 6 , N 
Clear 2:1 ratio 
85 
Figure 4.9 - Partial assignment of ' H and '^C resonances for cholesterol, 87, and the cholesteryl 
ester, 85 
The Boc group was removed by TFA in CH2CI2 and the deprotected cholesterol 
derivative 86 was coupled with the active ester complex [TbL^^ ]"'"^ . The reaction was 
carried out in dry DMF using 4-dimethylaminopyridine as a nucleophilic catalyst for 
the coupling with cholesterol derivative 86, which was not neutralised in the work up, 
as a danger of lactam ring formation was anticipated. The product was purified by 
precipitation onto diethyl ether and H L P C separation. 
The luminescence properties did not change in any significant way, compared to 
other derivatives, and the emission lifetime, xyb, in HiO was 1.42 ms. 
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4.1.9 Coupling to Human Serum Albumin 
Conjugation of the terbium complex to Human Serum Albumin (HSA) was also 
carried out. The interest was both in proving the possibility to couple the active ester 
complexes directly to macromolecules such as proteins, as well as to create a 
covalently linked HSA conjugate, allowing a comparison of its properties to results 
obtained in experiments exploring the noncovalent interactions of luminescent 
lanthanide complexes with HSA. 
The reaction was carried out in water over 24 h and the reaction mixture was purified 
by dialysis on cellulose tubing with a cut off of 8000 g/mol. The isolated conjugate 
maintained a Tb^ "^  luminescence lifetime of 1.63 ms in water. 
4.1.10 Comparison of emission spectra of complexes 
containing different carboxylic acid derivatives in the 
chromophore structure 
The detailed structure of lanthanide emission spectra, especially for Eu^ "^ , is 
dependent on the primary coordination sphere of the metal and can be very 
informative.'"^ Differential changes in the intensities and structures of the bands can 
be used for ratiometric measurements. It was therefore of interest to compare the 
emission spectra of the methyl ester, [EuL*]^"", carboxylic acid, [EuL"'"]"'"", and the 
hexylamide, [EuL''^ ]"'"*^  complexes. Significant changes in the spectral form could be 
utilised in a design of a ratiometric determination of interconversion of these 
functional derivatives of carboxylic acid (e.g. to track enzymatic kinetics). 
As can be seen from Figure 4.10 there is an overall emission intensity decrease for 
the amide, [EuL^ ]^^ " ,^ and carboxylic acid, [EuL"""]^ "^ , complexes when compared to 
the methyl ester complex, [EuL ] . 
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Figure 4.10 - Europium emission spectra for different functional derivatives of the 
chromophore carboxylic acid functional group (H2O, 295 K) 
No significant change in the form of the spectra can be detected. Thus, these 
fixnctional group conversions cannot be detected by ratiometric changes in Eu"^ ^ 
emission. 
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Figure 4.11 - Comparison of emission spectra for [TbL*|^* and |TbL^"p* (H2O, 295 K) 
Another possibility for ratiometric measurement could be based on differential 
changes in the Tb and Eu spectra with respect to a given variable, as has been 
demonstrated in the experiments for uric acid concentration measurement. Inspection 
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of Figure 4.11 however shows that the change in the emission intensity is the same 
for the Tb^^ complexes as for the Eu"*^  ones. 3+ 
It had been noted during the synthetic work on these complexes that the emission 
intensity of the carboxylic acid complexes [LnL'*")^^ was pH dependent 
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Figure 4.12 - Emission spectra of |EuL^*|** at different pH (H20,295 K) 
This pH sensitivity is linked to the protonation equilibrium of the carboxylic acid 
group of the chromophore and as can be seen (Fig. 4.12) it does not result in a 
change in the form of the Eu^^ emission profile; only a decrease in emission intensity 
is observed, consistent with charge transfer quenching of the chromophore singlet 
excited state. 
4.1.11 Quantum yield differentiation 
As noted in the sections discussing the synthesis of the individual conjugates, the 
meassured lifetime variation was very small (1.38-1.75 ms for Tb^^). However, this 
was not true for the variation of quantum yields. These differ substantially and could 
be observed even by inspection of HPLC chromatograms obtained with fluorescence 
detection. To fiarther quantify these differences, the dependence of the total 
integrated emission against absorbance was measured for several Tb^^ complexes. 
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Figure 4.13 - Plot of integrated emission intensity against absorbance for selected Tb^^ 
complexes (295 K, H2O) 
The quantum yield differences can be inferred from the gradients of such plots. 
Figure 4.13. It can be seen that the relative difference of quantum yield of the methyl 
ester complex, [TbL*]^ and the oligoguanidinium complex [TbL'"']^* is an order of 
magnitude. The two-fold difference with the C12 amide complex [TbL^^]^ mirrors 
observations made by analysis of the emission spectra. 
Substituent: OMe NHC,2 HN(Arg)y Guanidinium 
<Pem 1.0 0.46 0.11 0.09 
Table 4.1 - Relative overall emission quantum yields, relative to [TbL*|^* ( (p ' / / ' 19%) 
The modest changes of the quantum yield between the ester and the amide are 
probably due to small changes of the energies of the singlet and triplet state of the 
chromophore, which can affect the rate of energy or electron transfer. The large 
decrease of the quantum yield for the two guanidinium containing complexes is more 
likely to be a result of static quenching of the singlet excited state, probably 
involving a charge transfer interaction with these groups. Similar obsevations were 
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made also for the complexes containing the 3,4-methylene dioxybenzylamine group, 
the PAMAM dendrimer conjugate and the protein conjugate. 
4.2 Cellular imaging studies and further relevant 
experiments 
Fluorescence microscopy experiments were undertaken to assess the characteristics 
of the synthesised complexes for cellular imaging purposes. These observations were 
accompanied by supporting experiments establishing, for example, cytotoxicity and 
the nature of the non-covalent binding to protein, for selected examples 
4.2.1 Cell uptake experiments with azaxanthone complexes in NIH 
3T3 and CHO cells 
The initial cellular uptake experiments were carried out with six Tb^ "^  complexes 
bearing phenylamide pendant arms and a differently substituted azaxanthone 
chromophore (Figure 4.14). 
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Figure 4.14 - Complexes used in initial cell uptake experiments to investigate the effect of 
differential substitution on the azaxanthone chromophore 
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The experiments were carried out with mouse skin fibroblasts (NIH 3T3) and 
Chinese hamster ovarian (CHO) cells. These were grown on microscope cover-slips 
in 6-24 well plates using DMEM and F-12 HAM media (penicillin streptomycin, 
foetal calf serum) for NIH 3T3 and CHO cells respectively. The cells were incubated 
with 100 i^M solutions of the complexes for 18-20 h at 37°C and under an 
atmosphere of 5% CO2. The cover-slips were washed with phosphate buffered saline 
(PBS) prior to mounting onto microscope slides and imaging on a Zeiss Axiovert 200 
inverted microscope, using the 40 x oil contact objective. The Zeiss G365 and BP 
546/12 filters were used in excitation and emission channels respectively. The 
images are presented in yellow, as opposed to the green corresponding to Tb 
emission, to improve the image contrast. 
Figure 4.15 - Fluorescence microscopy images of NIH 3T3 cells loaded with: A) (TbL"|*^ R = H, 
B) | T b L * l ^ R = C O O M e , C) |TbL'°l'^ R = C O O H and D) |TbL^*]^ R = CONCsHo 
The images in Figure 4.15 show localisation of the complexes in well defined spots 
in the cytosol clustered mostly in the perinuclear region for the parent azaxanthone 
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complex [TbL"]^"^, the methyl ester complex [TbL^]^ and the hexylamide complex 
[TbL^ ]^*'"^ . It is presumed that this pattern is consistent with late 
endosomal/lysosomal localisation. The images of cells loaded with the carboxylic 
acid complex [TbL^]'*^ showed very little fluorescence and were not significantly 
different from cells that had not been treated with any complex at all. A similar result 
was observed for the methyl amide complex [TbL^']^^. The dodecylamide complex 
[TbL^']^ was also loaded into cells but could not be imaged successfiilly, as this 
complex was very cytotoxic and tended to kill most of the cells being examined. 
1 5 1 
20lini_ 
Figure 4.16 - Fluorescence microscopy images of C H O cells loaded with: A) | T b L " j ^ R = H, B) 
[TbL*]^ R = COOMe, C) [TbL^"!^* R = C O O H and D) [TbL^'j^^ R = CONCuH^s 
Similar results were obtained in CHO cells. The images for the parent azaxanthone, 
[ T b L " ] ^ and especially the methyl ester, [TbL*]^ complexes were not as clear as 
in the case of NIH 3T3 cells, with significantly fewer well defined, strongly 
fluorescent spots in the cytosol. A similar situation was observed for the hexylamide 
complex [TbL^ ]^"* .^ The intemalisation of the carboxylic acid, [TbL^**]^ ,^ and methyl 
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amide, [TbL""]"'" ,^ complexes was virtually not observed, as in the case of the NIH 
3T3 cells. The dodecylamide complex, [TbL"'^ ]"'^ , however, proved to be much less 
cytotoxic to CHO cells than to the NIH 3T3 cells. Thus, fluorescence images could 
be recorded and revealed a punctate localisation with well defined spots in the 
cytosol, distinctly different to that observed for the other complexes. Localisation to 
highly membranous organelles, such as the Golgi apparatus or endoplasmic 
reticulum could be assumed, based on the long aliphatic chain of the dodecylamide 
complex [TbL'"]'''^; this needs to be proved by further co-localisation studies. 
4.2.2 Two photon fluorescence imaging of NIIH 3T3 and IHeLa cells 
Further cellular experiments were carried out in collaboration with Drs. Ga-Lai Law 
and Ka-Leung Wang in Hong Kong. The images were recorded with two photon 
excitation (X^ x - 720 nm). The cells were grown in culture dishes allowing the cells 
to attach overnight. The cell medium in each well was changed to fresh medium (no 
added complex) immediately prior to image acquisition. 
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Figure 4.17 - Complexes used in cellular imaging experiments using two photon excitation 
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The images were taken at different time intervals whilst, the cells were kept in a 
chamber at 37°C under 5% CO2 atmosphere. 
Complexes based on the triphenyl amide pendant arm ligand system with differently 
substituted azaxanthone chromophores were used in this study (20 ^M). The 
conjugates with the hepta-arginine, [TbL^*]^*, and the oligoguanidinium vector, 
[TbL'*"]^^ were used, as well as some of the complexes used in the previous study, 
(Figure 4.17). 
Figure 4.18 - Fluorescence microscopy image of NIH 3T3 cells stained with |TbL"p^, R = H, 
recorded 3 h after loading 
The NIH 3T3 cells loaded with the unsubstituted azaxanthone complex ( T b L " ] ^ 
were examined 3h after the addition of the complex to the growth medium. The 
complex was observed distributed throughout the cytosol, with some tendency to be 
localised in endosomes/lysosomes of the perinuclear region. 
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Figure 4.19 - Fluorescnce microscopy images of NIH 3T3 cells stained with |TbL*l^% R = 
COOMe, recorded 3li after loading 
Figure 4.20 - Fluorescence microscopy images of NIH 3T3 cells stained with |TbL*]^*, R = 
COOMe, recorded 5h after loading 
The methyl ester complex [TbL*]^ was observed to imemalize in the NIH 3T3 cells 
rapidly and was highly emissive. A degree of nuclear staining was observed in some 
instances, but staining of the cytosol was the most common feature observed. A more 
localized (compartmental) localization was apparent in images obtained 5h after 
loading. 
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Figure 4.21 - Fluorescence microscopy images of NIH 3T3 ceils stained with [TbL^]''*, R = 
C O O H , recorded 2 h (A) and 3h (B) after loading 
The carboxylic acid complex [TbL^]^^ was taken up much more slowly by the NIH 
3T3 cells compared to the other complexes. The complex luminescence was 
observable within a few minutes after loading for each of the other complexes, but it 
took 45 min for the acid complex to be observable. The images obtained using this 
complex, were also less bright in comparison to others. 
Figure 4.22 - Fluorescence image of NIH 3T3 cells stained with (TbL'*]^*, R = /-Bu, recorded 3h 
after loading 
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The complex containing an azaxanthone chromophore substituted with a r-Bu group, 
[TbL^']''*, was found to enter the NIH 3T3 cells rapidly and stain the cytoplasm. The 
staining appears to consist of distinct spots rather than a uniform distribution. The 
morphology changes in the cells observed during these experiments suggest that this 
complex is more cytotoxic than the others. 
Figure 4.23 - Fluorescence images of NIH 3T3 cells stained with [TbL^*!^*, R = Arg?, recorded 
(A) a few minutes after loading and (B) after overnight loading 
The hepatarginine conjugate complex [TbL"'*]^* was found to translocate rapidly 
across (of the order of 5-10 minutes) the cellular membrane early after loading. 
Bright images could be obtained after an overnight staining period, giving a profile 
strongly reminiscent of a lysosomal distribution. 
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Figure 4.24 - Fluorescence microscopy images of NIH 3T3 cells stained with [TbL'**]''^, R = 
guanidinium, recorded (A) 3h after loading and after (B) overnight loading 
Observation of NIH 3T3 cells loaded with the oligoguanidiniimi conjugate complex 
[TbL'*"]^^ showed fast crossing of the dye across the cellular membrane, resulting in 
rather weak images at early observation times. More intense staining was observed 
after overnight loading. The suspected mitochondrial localization, at the earlier time 
points, needs confirmation by a co-localization study with MitoTracker dyes. 
Figure 4.25 - Fluorescence images of HeLa cells stained with (A) [TbL*]**, R = COOMe, and (B) 
[TbL^']' \ R = Arg7, recorded Ih after loading 
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The methyl ester [TbL ]^"'"' and heptaarginine conjugate [TbL^*]^ "^ complexes were 
also loaded into HeLa cells. The ester complex again resulted in significantly 
brighter images. The localization seems mainly perinuclear, in each case. 
4.2.3 Protein binding 
As discussed in Chapter 3, protein binding of the complexes can have a significant 
impact on the results obtained in cellular imaging experiments using the lanthanide 
complexes. Protein binding can shield the lanthanide complexes from local 
quenching species, ensuring that the complex wil l actually be emissive in cellulo. 
Protein binding binding experiments were therefore undertaken with the parent 
azaxanthone [LnL"]"'"^, methyl ester [LnL*]"''^, carboxylic acid [LnL^"]^ "^ and /-butyl 
[LnL^ ]^^ "^ complexes. 
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Figure 4.26 - Structures of complexes used in the protein binding study 
The most common experiment investigating the binding of a lanthanide complex to a 
protein is a protein titration of the Gd^"*^  complex monitoring changes in the relaxivity 
value of the complex rip.'^' This measurement is based on the dependence of 
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relaxivity on the rotational correlation time of the complex in solution, which 
increases significantly upon binding to a protein. 
A solution of human serum albumin (HSA) was added to the solutions of the four 
studied complexes and changes in relaxivity were monitored. The starting relaxivity 
values of 2.5-3 mM"'s"' were in line with expectation for cationic complexes, where 
slow exchange of the bound water molecule is anticipated.'''' The limiting 
relaxivity values reached following addition of excess of HSA were 9 mM''s"' for 
complex [GdL"]^^, 8.5 mM 's"' for complex [GdL"]-*^, 8 mM"'s ' for complex 8,3+ 
[GdL^']^ and 11.5 s 'mM ' for [GdL^"]^^ 
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Figure 4.27 - Variation of relaxivity with added protein for complexes |GdL"|^* (purple circles), 
[GdL*]*^ (red squares), [GdL^"]^* (blue squares) and [GdL"|*^ (yellow triangles) (310 K, H2O, 
[complex I =0.25 mM) 
Fitting of the binding curves was attempted to estimate the equilibrium constant. This, 
however, was not possible as further analysis has shown that there are at least 3-4 
complexes bound to a protein molecule. These results are similar to the observations 
made with the phenylamide arm complex bearing a tetraazatriphenylene 
chromophore [GdL*]^*, and are consistent with 'non-specific' binding of the 
relatively lipophilic complex.^ 
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Figure 4.28 - Structure of tetrazatrjphenylene complex used in protein titration experiment 
An estimate of the relative binding affinity was derived by considering the protein 
concentration needed to achieve 50% of the observed relaxivity change. 
Substituent H COOMe COOH t-Bu 
HSA concentration (mM) 0.011 0.016 0.019 0.029 
Table 4.2 - HSA concentrations required to achieve 50 % of the total observed relaxivity change 
in the protein binding experiment 
Using this estimation of the protein affinity the complexes may be ranked in the 
following order of decreasing protein affinity: [GdL'Y^ > IGdLY^ ~ [GdL^Y^ > 
Protein binding can in principle be monitored also by its effect on the luminescence 
properties of Eu'''^  and Tb^ "^ . Changes in the emission spectral form of the Eu^^ 
complexes constitute one of the more useful tools for such an investigation. 
The emission spectra of the Eu"^ "^  analogues of the complexes used in the relaxivity 
measurements were recorded in pure H2O, and in the presence of a 10-fold excess of 
HSA. Unfortunately, only luminescence intensity reductions were recorded and no 
significant changes in spectral form could be discerned. Thus, protein association 
does not affect the local coordination environment of the lanthanide ion. 
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Figure 4.29 - Emission spectra of selected complexes in the absence and presence of added HSA 
(295 K , H2O, [complex] = 17 pM) 
4.2.4 Cytotoxicity studies 
It became apparent during the fluorescence microscopy experiments that there exist 
significant differences in the cytoxicity levels of the lanthanide complexes used. The 
complexes were usually added to the cell growth medium at 100 concentration 
and in most cases a preliminary assessment of cell viability by examinafion of cell 
morphology in brightfield microscopy did not suggest significant cytotoxicity. Some 
exceptions were, however, noted, such as the dodecylamide complex [TbL"*']^^ and 
the oligoguanidinium conjugate complex [TbL'*"]^ .^ Thus, a more systematic 
approach was adopted to establish the relative cytotoxicity of the complexes. The 
IC50 values were measured, indicating the concentration of a substance needed to 
induce cell death to 50% of the cells. 
The measurement of the IC50 values was done using an MTT assay by Ms. 
Elizabeth J. New (Durham). This procedure uses the conversion of MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) to a purple formazan 
product in the mitochondria of viable cells. The product formazan compound is 
insoluble in water and the spectrophotometrical measurement is done after 
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dissolution in DMSO. In a typical set up 5000 NIH 3T3 cells would be dosed into the 
wells of 96 well plates for a plate reader in 100 |a,l of DMEM growth medium. The 
cells would be then dosed with complex concentrafions ranging from 0-100 and 
incubated for 24 h. Triplicate measurements were carried out. The MTT would be 
added and a further 4h incubation would follow. The growth medium was then 
removed and replaced with DMSO (150 i^l). The absorbance at 540 nm was 
measured immediately after 20 s shaking period. The IC50 value corresponds to the 
concentration resulting in 50% absorbance, compared to control cells. 
Complex IC50 (ixM) 
[TbLY^ R = COOMe 95 (±17) 
[GdL^Y^ R = COOH 150(±3) 
[TbL^Y^ R = CONHCn 7.2 (±0.5) 
[TbL^Y^ R = CONGuan 13(±5) 
[GdL^"]'^ R = /-Bu 58 (±0.3) 
Table 4.3 - IC50 values (errors in parentheses) in NIH 3T3 cells for selected complexes, as 
measured by the MTT assay 
The measured IC50 values are in good agreement with observations made in 
microscopy measurements. Thus the methyl ester [TbL*]''"^ and carboxylic acid 
complexes [TbL^"]'''^ did not show significant cytotoxicity at the concentrations used, 
but the other complexes did. The cytotoxicity suggested by the microscopy 
experiments was most noticeable for the dodecylamide [TbL^ ]^"''^  and 
oligoguanidinium conjugate [TbL'*"]"''^  complexes; indeed the IC50 values (Table 4.3) 
are very low. The IC50 value for the oligoguanidinum conjugate complex, [TbL"*"]^ "^ , 
is also in good agreement with the literature value (8 ^iM) determined for a conjugate 
of this vector to fluorescein.^" 
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4.2.4.1 Distinguishing apoptosis and necrosis 
Mitochondrial localization was also observed in previous work'^ with a fluorescein 
conjugate of the oligoguanidinium vector used in complex [TbL'*"]^ "^ . Thus, 
apoptosis was hypothesized to be the mechanism by which [TbL'*"]"'* induced cell 
death. To prove this and how the dodecylamide complex, [TbL''^]''' ,^ exhibits its high 
cytotoxicity, an apoptosis/necrosis differentiation experiment was carried out. The 
experiment uses flow-cytometry and the Annexin V-FITC Apoptosis Detection Kit, 
supplied by SIGMA.^' 
To carry out the experiment, cells were grown to confluence in 6-well plates. 
Immediately prior to dosing, medium was removed and fresh medium (1 mL) was 
added. Cells were treated with complex for 4h and 24h at concentrations above the 
previously-determined IC50 values. An apoptotic control was prepared by incubating 
with 1 |ig/mL staurosporine for 3 hours. The control for necrosis was prepared by 
incubafing cells on ice for three hours with 70% ethanol. After incubation, cells were 
harvested by trypsinisation and centrifugation, and were re-suspended in 500 |j.L 
binding buffer (10 mM HEPES, pH 7.5 containingl40 mM NaCl and 2.5 mM CaCh). 
The suspension was incubated at room temperature in the dark for 10 minutes with 
annexin V-FITC (0.5 |ig/mL) and propidium iodide (5 jig/mL). The fluorescence of 
the cells was immediately determined by flow cytometry. Results were compared to 
an untreated control, and to established literature controls for necrosis and apoptosis. 
The experiment was carried out in both NIH 3T3 and CHO cell lines. The flow-
cytometry images correlate fluorescence of the Annexin-FITC conjugate, as the 
apoptosis marker, on the x-axis and the propidium iodide fluorescence, which 
indicates necrosis, on the y-axis. The plot area is divided into four sections R2, R3, R4 
and R5. Where viable cells are present in section R4, early apoptotic cells are in 
section R5, late apoptotic cells are in section R3 and necrotic cells are in section R2. 
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Figure 4.30 - A flow-cytometry plots of NIH 3T3 and C H O cells obtained 24 h after treating the 
cells with the oligoguanidinium conjugate complex, |TbL'"'|^* 
The oligoguanidinium conjugate complex [TbL'*"]^* exhibits apoptosis as the mode 
of acfion in each cell line as can be seen from the flow-cytometry diagrams (Figure 
4.30). 
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Figure 4.31 - A flow-cytometry plots of NIH 3T3 and C H O cells obtained 24 h after treating the 
cells with the dodecylamide complex, [TbL^'|^ 
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It can be seen from Fig. 4.31 that the dodecylamide complex [TbL^']^^ is not 
cytotoxic towards CHO cells and comparison to Figure 4.30 shows also a larger 
population of viable NIH 3T3 cells. The distribution of the cells is different in the 
case of NIH 3T3 cells, in comparison to the oligoguanidinium complex [TbL'*°]^*, 
but the dead cells fall into segment R3 indicating late apoptosis. The necrotic 
character of the cell death in the case of the dodecylamide complex [TbL^^]^ is 
better demonstrated with cells observed only 4h after dosing with the complex 
(Figure 4.32). 
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Figure 4.32 - A flow-cytometry plot of NIH 3T3 cells obtained 4 h after treating the cells with 
the dodecylamide complex, [TbL^'*)'^ 
The necrotic pathway is clearly shown in Figure 4.33 for the dodecylamide complex 
[TbL^^l^^. The late apoptotic character is observed as a result of longer exposure 
(Figure 4.31), when apoptotic processes can be inifiated in cells already undergoing 
primarily necrosis. 
These results are consistent with the expectations for the mode of action of these 
complexes. Furthermore, the differential sensitivity of NIH 3T3 and CHO cells 
treated with the dodecylamide complex [TbL"*']^ is in line with the observations 
made in microscopy experiments. 
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4.3 Conclusions and future work 
A conjugation method has been established for complexes containing azaxanthone 
chromophore with a carboxylic acid fimction. The preliminary work has been carried 
out on complexes containing amide pendant arms. Coupling reactions were 
successfully undertaken with several amine reactants, including Arg-rich peptide 
sequences, a PAMAM dendrimer and a protein (HSA). It has been demonstrated that 
the conversions to different derivatives, of the incorporated carboxylate function, do 
not significantly affect the luminescence properties of the complexes. Some of the 
conjugates did however seem to exhibit static quenching of the chromophore excited 
state by amine and guanidinium groups. 
It has also been demonstrated that changing the substituent on the chromophore can 
result in significant changes in the cellular localisation behaviour, with respect to cell 
penetration, distribution and relative cytotoxicity. 
Thus, it has been demonstrated that the approach of using a single luminescent 
lanthanide complex, conjugated to an appropriate vector can in principle result in a 
selective probe. The complexes already synthesised need to be more extensively 
studied to achieve a deeper understanding of their interactions with biological 
systems. Use of different pendant arms, chomophores and vectors needs to be 
investigated as well. An interesting option is the synthesis of conjugates where the 
vector would be able to recognise a tag on a specific protein molecule and label it. 
Another option is the creation of a targeted complex conjugate with the coordination 
sphere designed as a responsive one, which would lead to targeted probes. A further 
interesting option could be synthesis of 'lipid-like' molecules, labelled with 
luminescent lanthanide complexes based on D03A. Such an approach could be 
beneficial as only the complexes within the interior of a membrane, shielded from 
local quenching, should be highly luminescent. 
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5 Experimental 
All reactants were used as supplied from commercial sources unless stated otherwise. 
Reactions requiring exclusion of moisture were carried out under an argon 
atmosphere. Water and H2O refer to high purity water with conductivity of 
0.04 |iScm'', obtained from the "PuriteSTILL Plus" purification system. 
Thin-layer chromatography was carried out on neutral alumina plates (Merck Art 
5550) or silica plates (Merck 5554) and visualised under UV (254 r\m). Preparative 
column chromatography was carried out using neutral alumina (Merck Aluminium 
Oxice 90, activity I I - I I I , 70-230 mesh), pre-soaked in ethyl acetate, or silica (Merck 
Silica Gel 60, 230 ± 400 mesh). 
' H and '^ C NMR spectra were recorded on a Varian Mercury 200 ( ' H at 199.975 
MHz, '^ C at 50.289 MHz), Varian Unity 300 ( ' H at 299.908 MHz, '^ C at 75.412 
MHz), Varian VXR 400 ( ' H at 399.968, '^C at 100.572 MHz), or a Bruker AMX 500 
spectrometer. Chemical shifts are reported relative to TMS and were referenced using 
the residual protio solvent resonances. Chemical shifts are reported in ppm and 
coupling constants in Hz. Splitting patterns are described as singlet (s), doublet (d), 
triplet (t), quartet (q), or multiplet (m). 
Mass spectra with electrospray ionisation (ES) were recorded on a VG Platform II 
(Fisons instruments), operating in positive or negative ion mode, with methanol as the 
carrier solvent. Accurate masses were recorded on a Thermo Finnigan LTQ 
instrument. 
Melting points were measured using a Reichart-Kofler block and are uncorrected. 
Measurements of pH were performed using a Jen way 3320 pH meter and Aldrich 
Chemical Company micro-pH combination electrode, calibrated using pH 4, pH 7 and 
pH 10 buffer solutions. 
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UVA^is absorbance spectra were recorded on a Perkin Elmer Lambda 900 
UVA^is/NIR spectrometer. Emission Spectra and Lifetimes were measured on a 
Perkin Elmer LS55 luminescence spectrometer and Instruments SA Fluorolog 3-11 
spectrometer and DataMax v2.1 for Windows. 
Phosphorescence emission spectra were recorded at 77 K using an Oxford 
Instruments optical cryostat and LS 55B spectrometer, with EPA (diethyl ether, 
isopentane and ethanol, 5:5:2) as solvent. 
The HPLC analysis and separation was carried out on a Perkin Elmer system 
comprising of Perkin Elmer Series 200 Pump, Perkin Elmer Series 200 Autosampler, 
Perkin Elmer Series 200 Diode array detector and Perkin Elmer Series 200 
Fluorescence detector. GILSON-FC203B fraction collector was used in separation 
procedures. The stationary phase used was the Phenomenex Synergi 4|a Fusion-RP 80, 
and the colurrins used came in two different sizes; 150x4.6 mm (flow rate Iml/min) 
and 250x10 mm (flow rate 5 ml/min). The gradients used are described in Appendix 1. 
Lifteime values were measured following excitation of the sample by a short pulse of 
light, monitoring the integrated intensity of light (546 nm for terbium, 613 run for 
europium) emitted during a fixed gate time, tg, a delay time, ta, later. A gate time of 
0.1 ms was used. The data obtained follow the exponential decay: 
I = Aoe^ -^ ) 
where I = intensity at time t after the flash 
Ao = a pre-exponential factor 
k = rate constant for the decay of the excited state 
A linear form of the relationship was obtained: 
In I = In Ao - At 
The data were fitted with this equation in Microsoft Excel. The excited state lifetime, 
T, is the inverse of the rate constant, k 
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C/l 
C 
Time 
Measured parameters for lifetime measurements 
The quantum yield for a given process is defined as the total number of photons 
emitted by that process divided by the total number of photons absorbed. The 
techniques and equipment necessary for an absolute determination of quantum yields 
are not commonly available. Therefore the usual method is to determine a relative 
quantum yield where the compound of unknown quantum yield is compared to a 
compound of known quantum yield. The unknown quantum yield can be calculated 
using the following equation. 
0) =<D. 
' A Er h Vl 
Where r and x refer to reference and unknown respectively 
A = absorbance at Xex 
E = corrected integrated emission intensity 
I = corrected intensity of excitation light 
r| = refractive index of solution 
The reference complexes used, unless stated otherwise, were TbPhadpqC and 
EuPh3dpqC. For each of the standard and unknown samples solutions of absorbance 
between 0.02 and 0.1 were prepared. The absorbance and total integrated emission 
intensity was determined for each sample. A plot of integrated emission against 
absorbance gives a straight line with slope E / A . The quantum yield of an unknown 
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sample can thus be determined from the following equation, assuming identical 
excitation conditions and refractive indices. 
O = 0 'J^'P'^ 
slope ^  
Errors in quantum yield measurements can arise due to the inner filter effect or errors 
in the amount of absorbed light. This effect can be minimised by only using samples 
with absorbances below 0.2. Errors in the amount of light absorbed by each sample 
can be minimised by choosing the excitation wavelength in the flat part of the 
absorption curve and by using a small bandpass for excitation. 
Epifluorescence images were taken on a Zeiss Axiovert 200M epifluorescence 
microscope with a digital camera. CPL spectra were measured at the University of 
Glasgow, with the assistance of Dr. R. D. Peacock. Inductively coupled plasma mass 
spectrometry determinations of europium, gadolinium and terbium concentrations 
were made by Dr. C. Ottley in the Department of Earth Sciences at Durham 
University. Relaxivity measurements were made at 37 °C and 60 MHz on a Bruker 
Minispec mq60 instrument. 
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5.1 Ligand and Complex synthesis 
2-Methyl-1,10-phenanthroline^ (6) 
A solution of 1,10-phenanthroline (10 g, 55 mmol) in dry THF (100 ml) was added to 
a stirred solution of methyl lithium (1.6 mol dm"^  in EtzO, 34.5 ml, 55 mmol) in dry 
THF (150 ml) at 0°C under argon. The mixture was stirred overnight at room 
temperature under argon to give a dark green solution. The reaction was quenched by 
careful addition of water (100 ml) at 0°C. THF was removed under reduced pressure 
using a rotary evaporator and the product extracted into diethyl ether (3 x 150 ml) 
Activated manganese dioxide (53 g, 0.61 mol) was added and the solution was stirred 
for 1.5 h. Magnesium sulphate was added and the solution stirred for a further 2h. 
Filtration through a Celite plug yielded a clear yellow solution. The solvent was 
evaporated to dryness to yield the crude product, which was purified by 
recrystallisation from ethyl acetate/hexane to give the product as a pale yellow solid 
(3.60 g, 19 mmol, 35 % ) , mp 75-76°C (lit ' . 78°C). ' H N M R (300 MHz, CDCI3): 6 
2.93 (3H, s, CH3), 7.48 (1 H, d, J = 8.1, H3), 7.57 (1 H, dd, J = 8.1, 4.2, H8) , 7.69 
(1 H, d, J = 8.7, H6), 7.71 (1 H, d, J = 8.7, H5), 8.09 (1 H, d, J = 8.1, H4), 8.19 (1 H, 
dd, J = 8.1, 1.8, H7), 9.18 (1 H, dd, J = 4.2, 1.8, H9). '^C N M R (75 MHz, CDCI3): 5 
22.9 (CH3), 122.8 (C8), 123.7 (C3), 125.5 (C6), 126.5 (C5), 126.7 (qAr), 128.8 (qAr), 
136.1 (C7), 136.2 (C4), 145.7 (qAr), 146.0 (qAr), 150.3 (C9), 159.5 (C2). m/z (ES^) 
195 (MH^), 217 (MNa^), 411 (MzNa^). 
2-Methyl-1,10-phenanthroline-5,6-dione^ (7) 
A mixture of 2-methyl-1,10-phenanthroline (2.00 g, 10.3 mmol) and potassium 
bromide (12.25 g, 102.9 mmol) was placed in an ice bath. Cold sulphuric acid (43 ml) 
was added carefully to the flask in a dropwise fashion, which turned the solution to a 
dark reddish colour. Concentrated nitric acid was then added in a similar way and the 
solution was boiled under reflux overnight. The mixture was cooled, poured into 
water (500 ml) and neutralised by addition of potassium hydroxide pellets. The 
product was extracted into dichloromethane (4 x 300 ml), which was dried over 
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K2CO3 and removed under reduced pressure to yield a yellow solid. Purification was 
achieved by chromatography on silica (gradient elution: CH2CI2 to 1% CH3OH-
CH2CI2, Rf = 0.34 (5% MeOH-CH2Cl2) to yield the product as a yellow solid (1.55 g, 
67%), m.p. 98-100°C (lit ' . 98-100°C). ' H NMR (300 MHz, CDCI3): 5 2.84 (3 H, s, 
CH3), 7.43 (1 H, d, J = 8.1, H3), 7.56 (1 H, dd, J = 7.8, 4.8, H8), 8.38 (1 H, d, J = 8.1, 
H4), 8.48 (1 H, dd, J - 8.1, 2.1, H7), 9.13 (IH, dd, J - 4.8, 1.8, H9). '^C (75 MHz, 
CDCI3): 5 26.2 (CH3), 125.6 (C8), 125.9 (C3), 126.2(q Ar), 128.3 (q Ar), 137.5 (C7), 
137.7 (C4), 152.7 (q Ar), 153.2 (q Ar), 156.6 C9, 167.4 (C2), 178.7 (C5), 192.2 (C6). 
m/z (ES"") 246 (MNa^). 
Diethyl-2,3-diaminobutane-1,4-dicarboxylate dihydrochloride^ (11) 
A suspension of 2,3-diamino-l,4-butanedioic acid (2.5 g, 16.9 mmol) in dry ethanol 
was saturated with HCl. The reaction mixture was boiled under reflux for 48 h. The 
product was obtained as white solid by removing part of the solvent under reduced 
pressure and filtration of the obtained precipitate. The product was obtained as a white 
solid (2.37 g, 8.6 mmol, 51%), m.p. 181-183°C ( l i t l 178°C). ' H NMR (300 MHz, de-
DMSO): 1.21 (6H, t, J = 7.2, OCH2CH3), 4.22 (4H, q, J = 7.2, OCH2), 4.843 (2H, s, 
CH), 9.24 (6H, bs, NH3^). '^ C NMR (75 MHz, DMSO): 6 19.1 (CH3), 57.7 (CH), 
68.5 (CH2), 170.3 (CO). 
Diethyl 7-methyldipyrido[3,2-a:2',3'-c]quinoxaHne-2,3-dicarboxylate (12) 
o 
A solution of 2-methyl-l,10-phenanthroline-5,6-dione (1.5 g, 6.7 mmol) and the 
dihydrochloride of diethyl-2,3-diamino-butane-l,4-dicarboxylate (1.9 g, 6.9 mmol) in 
dry EtOH (150 ml) was boiled under reflux overnight. The reaction mixture was 
allowed to cool to 20°C and activated Mn02 (13 g, 150 mmol) was added. The 
reaction mixture was stirred at room temperature for 5 h. Solvent was removed under 
reduced pressure. The residue was dissolved in an aqueous solution of EDTA (pH 7) 
and CH2CI2. Layers were separated and the aqueous solution was extracted with 
CH2CI2 (3 X 100 ml). The combined organic extracts were dried over Na2S04 and 
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solvent was removed under reduced pressure to give the crude product. Purification 
was achieved by chromatography on alumina (CH2CI2). The product was obtained as 
a light yellow solid (900 mg, 2.3 mmol, 34%), m.p. > 225°C (decomp). ' H N M R (300 
MHz, CDCI3) : 5 1.50 (6H, t, J = 7.2, OCH2CH3) , 3.02 (3H, s, CH3) , 4.59 (4H, q, J = 
7.2, OCH2) , 7.71 ( IH , d, J = 8.4, H6), 7.83 ( IH , dd, J = 8.1, 4.5, H I 1), 9.38 ( IH , dd, J 
= 4.5, 1.5,H10),9.42(lH,d, J = 8.4, H5), 9.57 ( IH , dd, J = 8.1, 1.5, H12). '^CNMR 
(75 MHz, CDCI3) : 5 14.2 (OCH2CH3) , 26.1 (CH3), 63.1 (OCH2) , 124.1 (q Ar), 124.3 
(C6), 124.6 ( C l l ) , 134.5 (CI2), 134.6 (C5), 139.9 (q Ar), 140.6 (q Ar), 143.6 (q Ar), 
144.4 (q Ar), 147.9 (q Ar), 148.2 (q Ar), 153.5 (CIO), 163.6 (C7), 165.0 (CO), 165.1 
(CO), m/z (ES^) 391 (MH^), 413 (MNa^). HRMS (ES^) 391.1399 (C2iH,9N404 
requires: 391.1401) (MH^). 
Diethyl-7-carboxaldehyde-dipyrido[3,2-f:2',3'-h]quinoxaline-2,3-
dicarboxylate (13) 
Selenium dioxide (480 mg, 4.33 mmol) was added to a solution of diethyl 7-
methyldipyrido[3,2-a:2',3'-c]quinoxaline-2,3-dicarboxylate (810 mg, 2.07 mmol) in 
dioxane (170 ml). The mixture was boiled under reflux for 4 h and was allowed to 
cool down afterwards. The reaction mixture was filtered through a Celite plug. The 
solvent was removed under reduced pressure to give the crude product, which was 
used without ftirther purification. ' H NMR (200 NMR, C D C I 3 ) : 51.52 (6H, t, J = 7.2, 
OCH2CH3) , 4.60 (4H, q, J = 7.2, 6 C H 2 ) , 7.92 ( IH , dd, J = 8.4, 4.6, HI 1), 8.46 ( IH, d, 
J = 8.2, H5), 9.43 ( I H , dd, J = 4.6, 1.8, HIO), 9.61 ( I H , dd, J = 8.4, 1.8, H12), 9.74 
( IH , dd, J = 8.4, 0.8, H6), 10.60 ( I H , d, J = 0.8, COH). '^C NMR (75 MHz, CDCI3): 5 
14.2 (CH3), 63.3 (CH2), 121.7 (C5), 125.0 ( C l l ) , 126.8 (q Ar), 129.2 (q Ar), 134.7 
(C12), 136.0 (C6), 139.5 (q Ar), 141.2 (q Ar), 144.5 (q Ar), 145.3 (q Ar), 147.8 (q Ar), 
148.4 (q Ar), 153.9 (CIO), 154.8 (C7), 164.6 (CO ester), 164.7 (CO ester), 193.7 (CO 
aldehyde), m/z (ES^) 459 (MNa^ + MeOH). HRMS (ES^) 437.1454 (C22H21N4O6 
requires: 437.1456) (MH^+MeOH). 
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Diethyl 7-(hydroxymethyl)dipyrido[3,2-f:2',3'-h]quinoxaline-2,3-
dicarboxylate (14) 
Sodium cyanoborohydride (130 mg, 2.07) was added to a solution of diethyl 7-
carboxaldehyde-dipyrido[3,2-f:2',3'-h]quinoxaline-2,3-dicarboxylate (840 mg, 2.07 
mmol) in CHCh-EtOH 7 : 1 (105 ml). The reaction mixture was boiled under reflux 
for 4h. The reaction mixture was poured into concentrated Na2C03 (150 ml). The 
organic phase was separated and the aqueous layer was extracted with C H C I 3 (4 x 120 
ml). The organic layer was dried over K2CO3, filtered an the solvent removed under 
reduced pressure to give the crude product, which was purified by recrystallisation 
from CHCh/hexane to yield a pale yellow-green solid (400 mg, 0.98 mmol, 48%), 
m.p. > 195°C (decomp). ' H NMR (300 MHz, C D C I 3 ) : 5 1.51 (6 H, t, J = 7.2, 
OCH2CH3), 4.59 (4H, q, J = 7.2, OCH2), 5.24 (2H, s, C H 2 O H ) , 7.83 ( IH, dd, J = 8.1, 
4.5, HI 1), 7.94 ( IH , d, J = 8.4, H6), 9.30 ( IH, dd, J=4.5, 1.8, HIO), 9.53 ( IH , d, J = 
8.4, H5), 9.60 ( I H , dd, J = 8.1, 1.8, H12). '^ C NMR (75 MHz, CDCI3) : 5 14.4 (CH3), 
63.1 (OCH2), 66.0 ( C H 2 O H ) , 121.9 (C6), 124.5 ( C l l ) , 125.3 (qAr), 126.5 (qAr), 
134.6 (C12), 135.1 (C5), 140.0 (q Ar), 140.4 (q Ar), 144.0 (q Ar), 144.4 (q Ar), 147.5 
(q Ar), 148.0 (q Ar), 153.4 (CIO), 164.7 (C7), 164.9 (CO), 165.0 (CO), m/z (ES^) 
429 (MNa^). HRMS (ES^) 407.1350 (C2iH ,9N405 requires: 407.1350) (MH^). 
Diethyl 7-(chloromethyl)dipyrido[3,2-f:2',3'-h]quinoxaline-3,2-
dicarboxylate (15) 
Phosphorus trichloride (473 mg, 3.44 mmol) was added to a solution diethyl 7-
(hydroxymethyl)dipyrido[3,2-f:2',3'-h]quinoxaline-2,3-dicarboxylate (350 mg, 0.86 
mmol) in C H C I 3 (150 ml). The reaction mixture was heated under reflux for 6 h and 
allowed to cool down to room temperature afterwards. The reaction was quenched by 
addition of concentrated aqueous Na2C03 solution (150 ml). The layers were 
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separated and the water was extracted with CH2CI2 (3 x 150ml) and CHCI3 (1 x 150 
ml). The organic layer was dried by K2CO3. The solvent was removed under reduced 
pressure to give the crude product. Purification was achieved by chromatography on 
alumina (gradient elution: CH2Cl2to 2% CH3OH-CH2CI2) The product was obtained 
as a yellow glass (95 mg, 0.22 mmol, 26 % ) . ' H NMR (300 MHz, CDCI3): 6 1.45 (6H, 
t, J = 7.2, OCH2CH3), 4.53 (4H, q, J = 7.2, OCH2), 5.07 (2H, s, CH2CI), 7.78 ( IH, dd, 
J - 8.1, 4.5, HI 1), 8.05 ( IH, d, J = 8.4, H6), 9.31 ( IH , dd, J = 4.5, 1.8, HIO), 9.50 ( IH, 
dd, J = 8.1, 1.8, H12), 9.53 ( IH, d, J = 8.7, H5). '^ C NMR (75 MHz, CDCI3): 5 14.4 
(CH3), 47.3 (CH2CI), 63.2 (OCH2), 123.8 ( C l l ) , 124.6 (C6), 125.6 (q Ar), 126.6 (q 
Ar), 134.5 (C12), 135.7 (C5), 140.1 (q Ar), 140.4 (q Ar), 144.3 (q Ar), 144.4 (q Ar), 
147.6 (q AT), 148.1 (q Ar), 153.8 (CIO), 161.0 (C7), 165.0 (CO), 165.1 (CO), m/z 
(ES^) 447 (MNa*). HRMS (ES^) 425.1012 (C2iH,8ClN404 requires: 425.1011) (MH^). 
1,4,7-Tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane^ 
(33) 
0 
0 
o N N 
N NH 
A solution of /-butyl bromoacetate (10.3 g, 52.8 mmol) in acetonitrile (82 ml) was 
added dropwise to a stirred mixture of 1,4,7,10-tetraazacyclododecane (3 g, 17.4 
mmol), NaHCOs (4.42 g, 52.6 mmol) and 4 A molecular sieves in acetonitrile (15 ml). 
The reaction mixture was stirred overnight at room temperature, filtered and the 
solvent was removed under reduced pressure. The residue was purified by 
chromatography on silica (CH2CI2 followed by CH2CI2, THF 7:3 to Ammonia, MeOH, 
THF, DCM 1:1:12:6). The product was obtained as white solid (2.45 g, 4.76 mmol, 
27%), m.p. 189-192°C (lit". 166-168°C). ' H NMR (300 MHz, CDCI3): 5 1.45 (27 H, 
CH3), 2.90 (12H, br m, CH2ring), 3.85 (4H, br m, CH2ring), 3.28 (2H, s, CH2), 3.37 
(4H, s, CH2). m/z (ES^) 515.6 (MH^). 
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1-(Diethyl-7'-methyldipyrido[3,2-f:2\3'-h]quinoxaline-2,3-dicar^^ 
4,7,10-tris-tert-butoxycarbonylmethyl-1,4,7,10-tetraazacyclododecane 
(34) 
Potassium carbonate (11 mg, 0.079 mmol) and a catalytic amount of K I were added to 
a solution of l,4,7-tris-/er?-butoxycarbonylmethyl-l,4,7,10-tetratacyclododecane (40 
mg, 0.077 mmol) and diethyl-7-(chloromethyl)dipyrido[3,2-f:2',3'-h]quinoxaline-2,3-
dicarboxylate (35 mg, 0.083 mmol) in acetonitrile (5 ml). The mixture was heated 
under reflux overnight, under argon. The solution was filtered and the salts were 
washed with CH2CI2. The solvent was removed under reduced pressure to give the 
crude product. Purification was achieved by chromatography on alumina (gradient 
elution: CH2CI2 to 2% CH3OH-CH2CI2). The product was obtained as a yellow glass 
(40 mg, 0.44 mmol, 56%). ' H NMR (200 MHz, CDCI3): 5 1.08 (18 H, s, CH3), 1.43 
(9 H, s, CH3), 1.50 (3H, t, J = 7.2, CH3), 1.51 (3H , t, J = 7.2, CH3), 2.25-3.58 (24 H, 
br m, CH2 ring, NCH2), 4.58 (2H, q, J = 7.2, OCH2), 4.59 (2H, q, J = 7.2, OCH2), 
7.84 ( IH , d, J - 8.4, H6), 7.86 ( IH , dd, J = 8.2, 4.4, HI 1), 8.98 ( IH , dd, J = 4.4, 1.8, 
H 10), 9.53 ( IH, d,J= 8.4, H5), 9.59 ( IH , dd, J = 8.2, 1.8, H12). '^ C NMR (75 MHz, 
CDCI3): 5 14.4 (OCH2CH3), 28.0 (CH3), 28.3 (CH3), 56.4-60.8 (CH2 ring), 63.3 
(OCH2), 81.9-82.8 (CH2CO,CH2), 124.5 (C6), 124.7 (CI 1), 125.2 (q Ar), 126.7 (q Ar), 
134.9 (C12), 135.2 (C5), 139.9 (q Ar), 140.2 (q Ar), 144.2 (q Ar), 144.7 (q Ar), 147.3 
(q Ar), 147.7 (q Ar), 153.3 (CIO), 163.2 (C7), 164.8 (COOEt), 164.9 (COOEt), 173.0 
(CO), m/z (ES^) 926 (MNa^). HRMS (ES*) 903.4963 (C47H67N80,o requires 
903.4975) (MH*). 
192 
CHAPTER 5 Experimental 
[TbL^h TbD03Adpq(COOH)2 
0^ / o 
A solution of l-(diethyl-7'-methyldipyrido[3,2-f:2',3'-h]quinoxaline-2,3-
dicarboxylate)-4,7,10-tris(/er^-butoxycarbonylmethyl)-1,4,7,1 Otetraazacyclododecane 
(20 mg, 0.022 mmol) in 6 M HCl ( 1 0 ml) was heated under reflux overnight. The 
solvent was removed under reduced pressure to give the hydrochloride salt of the 
ligand. The product was checked by ' H N M R to ensure complete ester hydrolysis, and 
was used for complexation immediately. ' H NMR (300 MHz, CD3OD): 5 2.90-4.00 
(24 H, br m, CH2), 8.62 ( 2 H , m, C6, CI 1), 9.57 ( 2 H , m, C5, C 1 2 ) , 10.34 (H, (i,J= 8 .1 , 
HIO). 
The ligand was dissolved in a mixture of methanol and water ( 1 : 1 , 6 ml) and the pH 
was raised to 5.5 by addifion of an aqueous solution of KOH ( 1 M). TbCl3.6H20 ( 1 0 
mg, 0.027 mmol) was added and the mixture heated at 90°C for 48 h. The pH was 
readjusted to 5.5 after 2 4 h. The solvents were removed under reduced pressure and 
the residue was dissolved water and the pH was adjusted to 7.0 and ion exchange 
(Dowex SOWH"^ ) was performed using a weakly acidic resin. The solution was freeze-
dried to yield a white solid, which was purified by reverse phase HPLC (Method H, 
Appendix). >.abs(H20) 347 nm; TTb(H20) 2.26 ms. HRMS (ES") 833.1339 
(C3iH3oN80io'^ ^Tb requires: 833 .1344) (M-H"). 
[EuL^], EuD03Adpq(COOH)2 
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The europium complex was prepared in an analogous manner to the Tb example. The 
product was obtained as a white solid (10 mg, 12 f^mol, 22 %). X,abs(H20) 347 nm; 
XEU(H20) 1.07 ms. H R M S (ES") 825.1285 (C3IH3ON80IO'^'EU requires: 825.1289) ( M -
H-) . 
Thiobenzoic aci(f (21) 
Concentrated hydrochloric acid (14.2 ml) was added to an ice cooled mixture of 4-
aminobenzoic acid (10.0 g, 72.9 mmol) and ice (32.0 g). A solution of sodium nitrite 
(5.03 g, 72.9 mmol) in water (32 ml) was added slowly keeping the temperature 
below 5°C. A solution of potassium ethyl xanthate (11.7 g, 7.30) in water (15 ml) was 
added to a stirred solution of Na2C03 (9.50 g, 89.6 mmol) in water (63 ml). The 
resulting solution was heated up to 70°C. The suspension from the diazotisation 
reaction was added slowly to the xanthate. The resuhing mixture was kept under 
argon and was stirred at 70°C for 1 h. A solution of sodium hydroxide (11.7 g, 0.29 
mol) in water (32 ml) was added, and reaction mixture was heated to reflux for 2 h 
and then allowed to cool down to room temperature. The reaction mixture was 
acidified to pH 2 with concentrated HCl. The precipitate formed was filtered off, 
washed with 1 M HCl and dried under reduced pressure to give the product as a white 
soUd (10.5 g, 68.2 mmol, 94%), which was analysed by ' H NMR and used without 
further purification, m.p. 219-222°C (lit ' . 219-220°C). ' H NMR (200 MHz, CDCI3): 
3.65 ( IH, s, SH), 7.32 (2H, d, J = 8.4, H3, H5), 7.96 (2H, d, J = 8.2, H2, H6). '^ C 
NMR (75 MHz, CDCI3): 5 126.3 (CI), 128.3 (C3, C5), 130.7 (C2, C6), 140.0 (C4), 
171.5 (CO), m/z (ES-) 153 (M-H^). HRMS (ES") 153.0015 (C7H5O2S requires: 
153.0016) (M-H-). 
Methyl-4-thiobenzoate^ (25) 
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A solution of 4-thiobenzoic acid (5 g, 32.4 mmol) in dry MeOH (150 ml) was 
saturated with HCl. The reaction mixture was heated under reflux, under argon for 48 
h. The solvent was removed under reduced pressure to give the product as a 
colourless solid (5.45 g, 32.4 mmol, 100%) which was used without further 
purification. ' H NMR (300 MHz, CDCI3) : 6 3.60 ( IH, s, SH), 3.88 (3H, s, CH3), 7.27 
(2H, d,J= 7.8, H3, H5), 7.88 (2H, d, J= 7.8, H2, H6). '^ C NMR (50 MHz, CDCI3): 6 
52.3 (CH3), 127.4 (CI), 128.4 (C3, C5), 130.7 (C2, C6), 138.5 (C4), 166.8 (CO). 
2-(4'-Methoxycarbonylphenylthio)-6-methyl-nicotinic acid (27) 
s 
To a stirred solution of methyl-4-thiobenzoate (5 g, 29.7 mmol) and 2-chloro-6-
methyl-nicotinic acid (4.25 g, 24.8 mmol) in D M F (28 ml) was added copper (I) 
bromide (220 mg, 1.53 mmol) and the resulting mixture was heated at 120°C for 10 
minutes. K2CO3 (5.21 g, 37.7 mmol) was added, followed by D M F (20 ml). The 
reaction mixture was heated to 150°C overnight. The reaction mixture was allowed to 
cool down and diluted by water (150 ml). The resulting solution was washed with 
ether (4 x 150ml). The pH of the solution was adjusted to 4 by addition of acetic acid. 
The precipitated product was collected by filtration and dried under reduced pressure 
to yield the title compound as a pale yellow solid (4.8, 64 % ) , m.p. 190-192 °C; 
(Found: C, 59.23; H, 4.25; N , 4.47. C15H13NO4S requires: C, 59.39; H, 4.32; N, 
4.62%); 5 H ( D M S 0 , 500 MHz) 2.23 (3H, s, CH3), 3.86 (3H, s, OCH3) , 7.11 ( IH, d, J 
7.8, H^), 7.61 (2 H, d, J8.1, tf', H^), 7.95 (2H, d, J 8.1, tf'), 8.13 ( I H , d, J7.8, 
H ' ) ; 6C ( D M S O , 125 MHz) 24.7 (CH3), 52.9 (OCH3), 120.3 (C^) , 121.4 (C^), 129.9 
(C'), 129.9 (C^', C^') , 135.5 (C^', C^'), 138.4 ( C ' ' ) , 140.1 (C), 159.4 ( C \ 162.1 (C^), 
166.6 ( C O O C H 3 ) , 167.7 ( C O O H ) ; m/z (ESMSO 302 ([M-H]", 100%). 
7-Methoxycarbonyl-2-methylazathioxanthone (30) 
- O 0 
A mixture of 2-(4'-methoxycarbonylphenylthio)-6-methyl-nicotinic acid (4 g, 13.2 
mmol) and polyphosphoric acid (120 ml) was heated to 120°C and vigorously stirred 
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for 24 h. The reaction was allowed to cool down to room temperature and was diluted 
by dry methanol (300 ml). The reaction mixture was heated under reflux for a ftarther 
16 h. The majority of methanol was removed under reduced pressure to give a sticky 
syrup, which was diluted by water to give 1 1 of solution. The pH of the solution was 
adjusted to 7 by the addition of NaOH pellets and was extracted with CHCI3 (3 x 300 
ml). The solvent was removed under reduced pressure to yield the title compound as a 
greenish solid (3.25 g, 86 % ) , sublimes 190-194 °C. (Found: C, 62.38; H, 3.71; N, 
4.81. C,5H,|NO3S:0.25 H2O requires: C, 62.36; H, 3.98; N, 4.85%); 6H(CDC13) 2.69 
(3H, s, CH3), 3.99 (3H, S, OCH3), 7.32 ( IH, d, J 8.0, H^), 7.70 ( I H , d, J 8.5, H \ 8.25 
( IH , dd, J8.5, 2.0, U\ 8.58 ( I H , d, J 8.0, H") , 8.88 ( IH, d, J 2.0, H^); 6c (CDCI3, 125 
MHZ) 25.2 (CH3), 52.7 (OCH3), 122.7 (C^), 124.4 (C" ' ) , 127.0 ( C \ 128.8 (C^ ' ) , 
129.0 ( C ' ) , 131.7 (C^) , 132.8 ( C \ 138.1 ( C \ 142.6 (C^ ' ) , 157.8 ( C ' ' ) , 164.3 (C^), 
166.2 (COOCH3), 180.1 (C-^); m/z (ESMS^) 286 ([M+H]^ 30%), 308 ([M+Naf, 
100%), 593 ([2M+Na]^ 15%). 
3-Bromomethyl- 7-methoxycarbonylazathioxanthone (31) 
y^-Bromosuccinimide (NBS) (175 mg, 0.98 mmol) and dibenzoyl peroxide (10 mg, 
0.04 mmol) were added to a solution 7-methoxycarbonyl-2-methylazathioxanthone 
(500 mg, 1.75 mmol) in CCI4 (30 ml). The reaction mixture was heated under reflux 
for 2 h after which NBS (175 mg, 0.98 mmol) and dibenzoyl peroxide (10 mg, 0.04 
mmol) were added again. The reaction mixture was heated under reflux for a further 
34 h. Further additions of dibenzoyl peroxide were made at 4 h (10 mg, 0.04 mmol), 
6.5 h (10 mg, 0.04 mmol), 9.5 h (20 mg, 0.08 mmol), 24 h (10 mg, 0.04 mmol) and 
29.5 h (10 mg, mmol) after the reaction start. Further additions of NBS (90 mg, 0.51 
mmol) were made at 24 h and 29.5 h after the reaction start. The reaction mixture was 
allowed to cool down, filtered and the solvent was removed under reduced pressure to 
give the crude product. The residue was purified by chromatography on silica 
(gradient elution: CH2Cl2-Toluene 1:1 to 2% CH30H-49% CH2Cl2-49% toluene) to 
yield the title compound as a light yellow solid (90 mg, 25%), Rf 0.42 (Silica, 2% 
MeOH : 49% toluene : 49% CH2CI2), sublimes 186-190 °C. (Found: C, 49.19; H, 2.70; 
N, 3.84. CisHioBrNOjS, requires: C, 49.47; H, 2.77; N , 3.85%); 5H (CDCI3, 500 MHz) 
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4.00 (3H, s, CH3), 4.61 (2H, s, CH2), 7.61 ( I H , d, J 8.5, H^), 7.71 ( IH, d, J 8.5, H^), 
8.28 ( IH, dd, J 8.5, 1.5, U\ 8.82 ( IH , d, /8 .5 , H''), 9.20 ( IH , d, J 1.5, H^); 5c (CDCI3, 
125 MHz) 32.4 (CH2), 52.8 (CH3), 122.3 (C^), 125.8 (C'), 127.1 (C^), 128.9 (C^'), 
129.2 {C\ 131.8 (C^), 133.2 (C*), 139.3 (C'), 142.3 (C^'), 157.8 (C''), 161.5 (C'), 
166.1 (COOCH3), 179.8 (C^); m/z (ESMS*) 364 ([M+H]*, 20%), 386 ([M+Na]^ 
100%), 749 ([2M+Na]^ 55%). 
1-(7-Methoxycarbonylazathioxanthone)-4,7,10-tris-tert-
butoxycarbonylmethyl-1,4J, 10-tetraazacyclododecane (35) 
A solution of 4-aza-3-bromomethyl-8-methoxycarbonylthioxanthone (90 mg, 0.25 
mmol), 1,4,7-tris-/e/-/-butoxycarbonylmethyl-1,4,7,10-tetraazacyclododecane (130 mg, 
0.25 mmol) and CS2CO3 (84 mg, 0.26 mmol) in acetonitrile (5 ml) was heated under 
reflux for 20 h. The solvent was removed under reduced pressure, the residue was 
dissolved in CH2CI2 (20 ml) and the solvent was removed under reduced pressure 
again. The residue was dissolved in CH2CI2 (20 ml), the suspension was filtered to 
remove the salts and the solvent was removed under reduced pressure. The 
purification was achieved by chromatography on alumina (gradient elution: CH2CI2 to 
5% CH3OH-CH2CI2) to give the desired product as a pale yellow glass (60 mg, 0.075 
mmol, 30 %) Rf 0.48 (Alumina, 5% MeOH:CH2Cl2). 6H (CDCI3, 500 MHz) 1.32 (18 
H, s, CH3), 1.59 (9H, s, CH3), 2.05-3.90 (24H, br m, CH2 ring, CH2CO, CH2), 3.99 
(3H, s, OCH3), 7.44 ( I H , d, J8.5, H^), 7.52 ( IH , d, J8.5, H^), 8.26 ( I H , dd, J8.5, 1.5, 
H^), 8.81 ( IH, d, J8.5, H") , 9.21 ( IH , d, J 1.5, H^); 6c (CDCI3, 125 MHz) 21.6 (CH2), 
28.3 (CH3), 52.9 (OCH3), 49.5-58.2 (CH2 ring, CH2CO), 82.4 (C"'"""), 123.0 (C^), 
125.4 (C'), 126.3 ( C \ 128.8 (C^'), 129.1 (C^), 131.8 (C^), 133.2 (C*), 138.9 (C), 
142.3 (C^), 158.4 (C' ), 164.5 (C^), 166.0 (COOMe), 173.2 (COOrBu), 179.9 (C^); 
m/z (ESMS*) 798 ( [M+H]^ 20%), 820 ([M+Na]*, 100%). Found: (ES*) 820.3952 
(C4iH59N509SNa requires 820.3926, [M+Na]*). 
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[TbL% TbD03AthxC00Me 
The solution of l-(4-aza-8-methoxycarbonylthioxanthone)-4,7,10-tris-/e/'r-
butoxycarbonylmethyl-l,4,7,10-tetraazacyclododecane (42 mg, 0.053 mmol) in TFA 
(2 ml) and CH2CI2 (0.1 ml) was stirred at room temperature for 18 h. The solvents 
were removed under reduced pressure. The residue was repeatedly (3 x) dissolved in 
CH2CI2 and the solvent removed under reduced pressure. The residue was analysed by 
NMR and the reaction mixture was stirred on for a further 12 h to ensure completion. 
Solvents were removed under reduced pressure and the same procedure was used to 
remove any excess of TFA. The residue was dissolved in water (5 ml) and MeOH (5 
ml) and TbCl3.6H20 (18 mg, 0.049 mmol) was added. The pH of the solution was 
adjusted to 5.5 by the addition of aqueous KOH solution (1 M). The reaction mixture 
was stirred at 65°C overnight. The pH dropped to 2.8 and was adjusted back to 5.5 
and the mixture was stirred at 65°C for further 2 h. Methanol was removed under 
reduced pressure and the remaining solution was diluted with water (10 ml). The 
reaction mixture was filtered. Water was removed by freeze drying and the residue 
was purified by HPLC (Method G, Appendix) to yield the title compound (9 mg, 
0.011 mmol, 22 % ) . Us(MeOH) 372 nm; 8(MeOH) 5360 M"' cm'', xxb (H2O) 0.53 ms, 
XTb(D20) 0.62 ms. HRMS (ES') 784.1078 (CsgHsiNjOg^^S'^ ^Tb requires: 784.1091) 
(M-H-) 
[EuL% EuD03AthxC00Me 
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The europium complex was prepared in an analogous manner to the Tb example. The 
product was obtained as a white solid. (10 mg, 17%). Xabs(MeOH) 372 nm; e(MeOH) 
5360 M " ' cm"', TEUCHZO) 0.51 ms, TEU(D20) 1.62ms; q^" = 1.31. Found: (ES") 
778.1060 (C29H31EUN5O9S requires: 778.1061) (M-H"). 
2-Phenoxy-6-methyl'nicotinic acid (62) 
0 
2-Chloro-6-methyl-nicotinic acid (3 g, 17.5 mmol) and-phenol (7.8 g, 83.2 mmol) 
were added to a solution of NaOMe, freshly made from sodium (0.84 g, 36.5 mmol) 
and dry MeOH (20 ml). The reaction was stirred under an argon atmosphere for 15 
minutes and the solvent was removed under reduced pressure. The residue, a yellow 
oil, was heated to 180°C for 12 h. The reaction mixture was allowed to cool down and 
dissolved in water. The aqueous solution was washed with Et20. The pH of the 
solution was decreased to 4 by the addition of acetic acid and the precipitated product 
was collected by filtration. The product was dried under a high vacuum (0.5 g, 2.18 
mmol, 12%), mp 108-110 °C. ' H N M R (300 MHz, CDCI3): 6 2.40 (3H, s, CH3), 7.03 
( IH, d, J7.8, H^), 7.18 (2 H, d, J7.6, H^'), 7.29 ( IH, t, J7.6, H'*'), 7.44 (2H, t, J7.6, 
H^'), 8.41 ( IH , d, J 7.8, H" ) . '^C N M R (75 MHz, CDCI3): 5 24.4 (CH3), 110.0 (C^), 
119.4 (C^), 121.8 (C^'), 125.8 (C*'), 129.6 (C^'), 143.6 (C), 152.0 (C''), 160.2 ( C ^ 
163.2 (C^), 164.7 (COOH). m/z (ES") 228.0 (M-H). HRMS (ES^) 230.0805 
(C,3H,2N03 requires: 230.0812) (MH^). 
2-Methyl-1-azaxanthone (55) 
0 
The mixture of 2-phenyloxy-6-methyl-nicotinic acid (1.2 g, 5.23 mmol) and 
polyphosphoric acid (50 g) was stirred at 120°C for 22 hours. The reaction mixture 
was dissolved in water (250 ml) and the pH of the resulting solution was increased to 
12 using KOH pellets. The aqueous solution was extracted with CHCI3 (3 x 200 ml). 
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The combined organic extracts were dried over Na2S04 and the solvent was removed 
under reduced pressure to give the product as an off white solid (1.02 g, 4.83 mmol, 
92.4 % ) , m.p. 110-112 °C. ' H N M R (300 MHz, CDCI3): 5 2.71 (3H, s, CH3), 7.30 ( IH, 
d, J7.8, 7.43 (1 H, ddd, J8, 7, 0.9, H ' ) , 7.61 ( IH , dd, J8, 0.9, H^), 7.77 ( IH, ddd, 
J 8, 7, 1.5, H^), 8.32 ( I H , dd, J 8, 1.5, H^), 8.60 ( IH , d, J7.8, H''). '^C NMR (75 MHz, 
CDCI3): 5 25.2 (CH3), 114.3 (C'), 118.6 (C^), 121.3 (C^), 121.8 (C^'), 124.7 (C\ 
126.7 (C^), 135.5 (C^), 137.4 (C"), 155.8 (C^'), 160.0 (C'"), 165.2 (C^), 177.7 (C^). m/z 
(ES"") 233.7 (M+Na^). HRMS (ES^) 212.0707 (CBHIQNOZ requires: 212.0706) 
(MH^). 
2-Bromomethyl-1-azaxanthone (63) 
0 
N-Bromosuccinimide (450 mg, 2.53 mmol) and dibenzoylperoxide (20 mg, 82.6 \imo\) 
were added to a solution of 2-methylazaxanthone (1.02 g, 4.83 mmol) in CCI4 (50 ml). 
The reaction mixture was refluxed for 18 hours. Further additions of N-
bromosuccinimide (2 x 450 mg) and dibenzoylperoxide (20 mg and 30 mg) were 
made after 2.5 and 5.5 hours from the start of the reaction. The reaction mixture was 
filtered and the solvent was removed under reduced pressure. The residue was 
purified by chromatography on silica (CH2Cl2/toluene 1:1 to 1% MeOH) to give the 
product as an off-white solid (380 mg, 1.31 mmol, 27%), mp 169-171°C. ' H NMR 
(300 MHz, CDCI3): 6 4.61 (3H, s, CHjBr), 7.45 ( IH , ddd, J 8, 7.2, 1.0, U\ 7.58 (1 H, 
d, J8 , H ^ 7.62 ( IH , d, J8 , H\ 7.80 ( IH, ddd, J 8, 7.2, 1.6, H^), 8.31 ( IH, dd, J8, 
1.6, H^), 8.72 ( IH, d, J 8, H'*). '^C NMR (75 MHz, CDCI3): 5 32.3 (CHzBr), 116.1 
(C'), 118.6 ( C ^ 120.9 (C^), 121.7 (C^'), 125.0 ( C \ 126.8 (C^), 135.9 (C^), 138.8 
(C'), 155.8 (C^'), 158.8 ( C ' ) , 162.1 (C^), 177.2 (C^). m/z (ES^) 290.1 (MH^). HRMS 
(ES^) 289.9809 (C^HgErNOz requires: 289.9811) (MH^). 
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1-(2-A2axanthonylmethyl)4,7,10-tris(tert-butoxycarbonylmethyl)-1,4,7,10-
tetraazacyclododecane (64) 
A solution of 2-bromomethylazaxanthone (200 mg, 0.69 mmol), l,4,7-tris(^er/-
butoxycarbonylmethyl)-l,4,7,-tetraazacyclododecane (319 mg, 0.62 mmol) and 
CS2CO3 (210 mg, 0.65 mmol) in acetonitrile (15 ml) was heated to reflux under argon 
atmosphere for 16 h. The solvent was removed in vacuo. The residue was dissolved in 
DCM, filtered and the solvent was removed in vacuo. The residue was purified by 
column chromatography on alumina (CH2CI2 to 2% MeOH) to give the product as a 
yellow glass (300 mg, 0.41 mmol, 66%). ' H N M R (300 MHz, CDCI3): 5 1.46 (27 H, s, 
r-Bu), 3.15 (16 H, br m, ring), 3.45 (2H, s, CH2 arm), 3.59 (4H, s, CH2 arm), 4.59 (2H, 
s, CH2), 7.45 ( IH , t, J 8, H^), 7.53 ( IH, d, J 8, rf), 7.60 ( I H , d, J 8, H^), 7.77 (1 H, t, 
J 8, 8.31 ( IH , d, J 8, H^), 8.67 (1 H, d, J 8, H " ) . '^C (125 MHz, CDCI3) : 5 28.7 
(CH3), 48.0 (ring C), 50.2 (ring C), 54.8 (ring C), 55.6 (ring C), 58.5 (CHz-AzaH), 
79.8 ('Bu), 115.4 (C^'), 118.7 (C'), 121.9 ( C \ 124.9 ( C \ 126.9 (C^), 135.8 (C*), 
137.4 (C''), 155.9 (C^'), 156.5 (C^'), 159.9 (C''), 161.1 (C^), 165.3 (COOffiu), 177.7 
(C^), m/z (ES^) 746.4 (M+Na^), 724.4 (MH^). HRMS (ES^) 724.4279 (C39H58N5O8 
requires: 724.4280) (MH''). 
[TbU% TbD03AAzaHN0x 
The solution of l-(2-azaxanthonylmethyl)-4,7,10-t^is(/er^butoxycarbonylmethyl)-
1,4,7,10-tetraazacyclododecane (50 mg, 0.069 mmol) in TFA (2 ml) and DCM (1 ml) 
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was stirred under an argon atmosphere at room temperature overnight. The solvent 
was removed under reduced pressure and the removal of /-butyl esters was verified by 
' H NMR. The residue was dissolved in TFA (0.5 ml) and H2O2 (0.15 ml). The 
reaction mixture was heated to reflux under argon atmosphere. Further three additions 
of TFA (0.5 ml) and H2O2 (0.15 ml) were made. Reaction carried on for 8h. The 
solvents were removed under reduced pressure. TbCl3.6H20 (50 mg) was added to the 
solution of the residue in H2O (2 ml) and MeOH (1.5 ml). The pH was adjusted to 6 
and the reaction mixture was heated to 60°C stirring under argon atmosphere. The pH 
dropped and was raised back to 6 during the course of the reaction. A precipitate 
formed during the reaction, which was removed by centrifugation. The solvent was 
removed under reduced pressure to give the product as a yellowish solid. Xabs(H20) 
348 nm; Xabs(MeCN) 344 nm; TTb(MeCN) 1.08 ms. 
[EuL^^], EuD03AAzaHN0x 
6' 
The europium complex was prepared in an analogous manner to the Tb example. The 
product was obtained as a yellowish solid. ^abs(H20) 348 nm; X,abs(MeCN) 344 nm; 
TEu(MeCN) 0.78 ms. 
1,4J-Tris(trifluoroethanoyl)-1,4J,10-tetraazacyclododecane^ 
.N NH 
0 = 
CF, 
Ethyl trifluoroacetate (16.5 g, 13.8 ml, 0.12 mol) was added dropwise to a solution of 
cyclen (5g, 0.029 mol) and triethylamine (4.04 ml) in dry MeOH (25 ml) cooled to 
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0°C. The reaction mixture was stirred at room temperature under argon for 4 h. The 
solvent was removed under reduced pressure. The residue was purified by column 
chromatography on silica (CH2CI2 to 5% MeOH) to give the product as a white solid 
(11.7 g, 0.025 mol, 86%), mp 77-80 °C. ' H NMR (300 MHz, C D C I 3 ) : 6 2.96 (4 H, m, 
N C H 2 ) , 3.55 (8 H, m, N C H 2 ) , 3.91 (4 H, m, CH2). '^ C NMR (75 MHz, CDCI3): 8 
43.26-52.91 (NCH2), 116.21 (q, C F 3 , JCF= 210), 157.12-157.96 (m, CO). '^F NMR 
(188 MHz, C D C I 3 ) : 5 -69.36 (m, C F 3 ) . m/z (ES^) 483.3 (MH^). 
1,4J-Tris(trifluoroacetyl)-10-tert-butoxycarbonyl-1,4,7,10-
tetraazacyclododecane 
-N N 
0 = = ^ v _ _ / y-o, 
CFJ 0 
D\tert-huty\ dicarbonate (1 .42 g, 6.51 mmol) was added to a solution of 1,4,7-
tris(trifluoroacetyl)-l,4,7,10-tetraazacyclododecane (2 g, 4 .34 mmol) and 
triethylamine (0.3 ml) in dry MeOH (20 ml). The reaction mixture was stirred under 
argon at room temperature for 2 4 h after which further ditertbuty\ dicarbonate (1 g) 
was added. Further additions of diterthutyl carbonate (1 g) were made after 48 and 72 
hours. The reaction was carried out over the period of 100 h. The solvent was 
removed under reduced pressure. The residue was purified by column 
chromatography on silica (CH2CI2 to 7% ethyl acetate) to give the product as a white 
solid ( 5 4 0 mg, 0.96 mmol, 11%) , mp 119-122 °C. ' H NMR (300 MHz, CDCI3): 6 
1.47 (9 H, s, C(CH3)3), 3.20-3.95 ( 1 6 H, bm, NCH2). '^ C NMR (75 MHz, CDCI3): 5 
27.98 (CH3), 48.54-50.70 (NCH2) , 81.04 (C), 116.03 (q, C F 3 , JCF = 210) , 156.67-
158.70 (m, CO). '^ F NMR (188 MHz, CDCI3) : 5 -69.70 (m, CF3) . m/z (ES^) 583.3 
(MH^). 
1-Tertbutyloxycarbonyl-1,4,7,10-tetraazacyclododecane (71) 
- N H N H 
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An aqueous solution of KOH (2 M, 6 ml) was added to a solution of 1,4,7-
/r/5(trifluoroacetyl)-10-rer/butoxycarbonyl-1,4,7,10-tetraazacyclododecane (3.0 g, 
5.35 mmol) in a mixture of MeOH (30 ml) and water (12 ml). The reaction mixture 
was stirred at room temperature under argon for 8 h. The solvent was removed under 
reduced pressure. The residue was dissolved in CH2CI2 (20 ml) and washed with 
concentrated aqueous Na2C03 and NaCl solutions respectively. The organic phase 
was dried over K2CO3 and solvent was removed to yield the product as a glassy solid 
(1.0 g, 69%). ' H NMR (300 MHz, CDCI3): 5 1.39 (9 H, s, € (^3)3 ) , 2.64 (4 H, t, J = 
4.5, NCH2), 2.74 (8 H, q, J = 5.4, NCH2), 3.35 (4 H, t, J - 5.4 Hz, NCH2). m/z (ES^) 
273.3 (MH^). 
Benzyl diethoxyphosphine (72) 
A solution of chlorodiethoxyphosphine (5 g, 31.9 mmol) in dry Et20 (50 ml) was 
added dropwise to a solution of benzylmagnesium chloride in Et20 (1 M, 32 ml) 
cooled to -15°C. The reaction mixture was warmed up and heated to reflux overnight. 
The reaction mixture was filtered and solvent was removed by distillation. The 
residue was purified by vacuum distillation (0.15 mbar, 52-56°C) to yield the product 
as a colourless liquid (2.5 g, 37 % ) . ' H NMR (300 MHz, C D C I 3 ) : 5 1.22 (6 H, t, J = 
7.2, CH3), 2.98 (2 H, d, J = 3.9, CH2), 3.89 (4 H, m, OCH2), 7.24 (5 H, m, phenyl). 
'^P NMR (120 MHz): 5 171.0. 
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1,4.7-Tris(ethoxybenzylphosphinatomethyl)-10-tertbutoxycarbonyl-
1,4,7,10-tetraazacyclododecane (73) 
Benzyl diethoxyphosphine (1.4 g, 6.6 mmol) was added to a mixture of 1-
/errbutyloxycarbonyl-1,4,7,10-tetraazacyclododecane (0.4 g, 1.47 mmol) and 
paraformaldehyde (0.3 g) in dry THF (23 ml). The reaction mixture was heated to 
reflux for 8 h. The reaction mixture was filtered and the solvent was removed under 
reduced pressure. The residue was purified by column chromatography on alumina 
(CH2CI2 to 6% MeOH) to yield the product as an oil (0.3 g, 24%). ' H NMR (300 
MHz, CDCI3) : 5 1.18 (9 H, m, CH3), 1.39 (9H, s, C(CH3)3), 2.60-3.80 (28 H, m, 
NCH2,PCH2), 3.95 (6 H, m, OCH2) , 7.30 (15 H, m, Phenyl). ^'P NMR (120 MHz): 5 
50.31. m/z (ES^) 883.4 (M+Na^). 
1,4,7-Tris(ethoxybenzylphosphinatomethyl)-1,4,7,10-
tetraazacyclododecane (74) 
Ph 
3 . -
/ 
A solution of l,4,7-rrzXethoxybenzylphosphinatomethyl)-10-/e/'rbutyloxycarbonyl-
1,4,7,10-tetraazacyclododecane (450 mg, 0.523 mmol) in CH2CI2 (10 ml) and TFA 
(20 ml) was stirred at room temperature under an argon atmosphere overnight. The 
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solvent was removed under reduced pressure. The residue was dissolved in CH2CI2 
(10 ml) and treated with saturated aqueous K2CO3 solution (10 ml). The product was 
extracted into CH2CI2 and the combined organic extracts were dried over K2CO3. 
Solvent was removed under reduced pressure to give the product as a pale brown oil 
(330 mg, 0.434 mmol, 83%). ' H NMR (300 MHz, CDCI3) : 5 1.18 (9 H, m, CH3), 
2.60-3.40 (28 H, m, NCH2, PCH2), 3.90 (6 H, m, OCH2) , 7.25 (15 H, m, Phenyl). '^P 
NMR (120 MHz): 5 51.45. m/z (ES^) 761.3 (MH^). 
1-(2-Methylazaxanthone)-4J,10-tris(ethoxybenzylphosphinatomethyl)-
1,4,7,10-tetraazacyclododecane (75) 
A solution of l,4,7-/m(ethoxybenzylphosphinatomethyl)-1,4,7,10-
tetraazacyclododecane (180 mg, 0.237 mmol), 2-bromomethyl-l-azaxanthone (76 mg, 
0.262 mmol) and CS2CO3 (77 mg, 0.236 mmol) in acetonitrile (20 ml) was heated to 
reflux under an argon atmosphere for 6 h. The reaction mixture was filtered and the 
solvent was removed under reduced pressure. The residue was purified by 
chromatography on alumina (CH2CI2 to 2% MeOH) to give the product as a brown 
glass (120 mg, 0.124 mmol, 52%). ' H NMR (300 MHz, C D C I 3 ) : 5 1.13 (9H, s, CH3), 
2.4-3.4 (28H, br. m, macrocycle, PCH2, PhCH2), 3.70-4.15 (8H, br. m, O C H 2 , CH2), 
7.26 (15 H, m, Ph), 7.41 ( IH, m, H \ 7.55 (2 H, m, , H^), 7.70 ( IH , m, H ^ 8.28 
( IH, m, H^), 8.68 ( IH , m, H^). '^P NMR (120 MHz): 5 49.87. m/z (ES^) 970.4 
(MH^), 992.5 (M+Na^). 
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[TbL"], TbPaBnjAzaH 
A solution of l-(2-methylazaxanthone)-4,7,10-/r/j(ethoxybenzylphosphinatomethyl)-
1,4,7,10-tetraazacyclododecane (35 mg, 36.1 |amol) in 6 M HCl (7 ml) was heated to 
reflux for 24 hours. The progress of the ester hydrolysis was monitored by ' H and ^ 'P 
NMR. The solvent was removed under reduced pressure. The residue was dissolved in 
water (3 ml) and MeOH (3 ml) and TbCl3.6H20 (15 mg, 40.2 ^mol) was added. The 
pH of the reaction mixture was increased to 5.5 by the addition aqueous KOH 
solution (1 M). The reaction mixture was heated to 60°C overnight; The solvents were 
removed under reduced pressure and the residue was purified by column 
chromatography on alumina (CH2CI2 to 10% MeOH) to give the product as a light 
yellow solid (10 mg, 9.6 i^mol, 27%). W H 2 O ) 335 nm; TTb(H20) 3.63 ms, XTb(D20) 
3.58 ms, (l)Tb (H2O) 44%; m/z (ES^) 1043 (MH^), 1065 (M+Na^). 
[EuL^^l EuPjBnjAzaH 
o \ / 
3P 
/ ^ N . ; .N 
The europium complex was prepared in an analogous manner to the Tb example. The 
product was obtained as lightly brown solid (9 mg, 8.7 |amol, 21 % ) . A.abs(H20) 335 
nm; 'c^ Eu(H20) 1.25 ms. 
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1,4,7-Tris(tert-butoxycarbonyl)-1,4,7,10-tetraazacyclododecane^ (66) 
O 0 
-N HN 
A solution of di-fe/V-butoxycarbonate (6.1 g, 27.9 mmol) in CH2CI2 (140 ml) was 
added dropwise to a stirred solution of l,4,7,10-tetraa2acyclododecane (2 g, 11.6 
mmol). The reaction mixture was stirred at room temperature under argon atmosphere 
for 3 hours. The solvent was removed imder reduced pressure and the residue was 
purified by chromatography on silica (CH2CI2 to 7% MeOH) to give the product as a 
white solid (2.95 g, 6.24 mmol, 67%), m.p. 76-78°C (lit^ 72-73°C). ' H NMR (300 
MHz, CDCI3): 5 1.42 (18H, s, CH3), 1.44 (9H, s, CH3), 2.81 (4H, br m, CH2), 3.26-
3.35 (8H, br m, CH2), 3.60 (4H, m, CH2). '^C NMR (75 MHz, CDCI3): 5 28.9 (CH3), 
29.0 (CH3), 46.1 (CH2), 49.9 (CH2), 51.2 (CH2), 79.4 (C), 79.6 (C), 155.8 (C=0), 
156.0 (C=0). m/z (ES^): 495 (MNa^), 967 (MzNa^). 
10-(2-Azaxanthonylmethyl)-1,4,7-tris(teributoxycarbony\)-1,4,7,10-
tetraazacyclododecane (67) 
A solution of 2-bromo-metyl-azaxanthone (50 mg, 0.172 mmol), 1,4,7-
tris(rer?butoxycarbonyl)-1,4,7,10-tetraazacyclododecane (81 mg, 0.171 mmol), 
K2CO3 (95 mg, 0.687 mmol) and a catalytic amount of KI in acetonitrile (5 ml) was 
heated to reflux overnight. The reaction mixture was filtered and salts were washed 
with CH2CI2. The solvents were removed under reduced pressure. The residue was 
purified by chromatography on alumina (CH2CI2 to 2% MeOH) to give the product as 
pale yellow solid (115 mg, 0.169 mmol, 99%), m.p. 170-171 °C. ' H NMR (300 MHz, 
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C D C I 3 ) : 6 1.39 (9H, s, CH3) , 1.46 (18H, s, CH3), 2.81 (4H, br m, ring CH2) , 3.20-3.70 
(12H, br m, ring CH2) , 3.96 (2H, s, CH2), 7.45 ( IH , ddd, J8, 7.2, 1.0, H^), 7.50 (1 H, 
d, J8, tf), 7.59 ( I H , dd, J 8, 1.0, H^), 7.75 ( IH, ddd, J 8, 7.2, 1.6, H*), 8.28 ( I H , dd, J 
8, 1.6, H^), 8.59 ( I H , d, J 8, H"). '^C NMR (125 MHz, C D C I 3 ) : 6 28.7 (CH3) , 48.0 
(ring C), 50.2 (ring C), 54.8 (ring C), 55.6 (ring C), 58.5 (CH2-AzaH), 79.8 ('Bu), 
115.4 (C' ), 118.7 ( C \ 121.9 ( C ^ 124.9 (C'), 126.9 (C^), 135.8 (C*), 137.4 (C'), 
155.9 (C^'), 156.5 (C'), 159.9 (C''), 161.1 (C^), 165.3 (COOrBu), 177.7 (C^). m/z 
(ESMS^) 682 (M + H, 50%), 704 (M + Na, 100%). HRMS (ES^) 682.3811 
(C36H52N5O8 requires: 682.3810) (MH^). 
1'Azaxanthonylmethyl-1,4,7,10-tetraazacyclododecane (68) 
NH HN 
A solution of l-(2-azaxanthonylmethyl)-4,7,10-/m(re/'/butoxycarbonyl)-1,4,7,10-
tetraazacyclododecane (115 mg, 0.169 mmol) in TFA (3 ml) and CH2CI2 (3 ml) was 
stirred at room temperature under an argon atmosphere overnight. The solvents were 
removed under reduced pressure. The residue was dissolved in CH2CI2 (20 ml) and 
the solvent was removed. This procedure was repeated three times. The residue was 
dissolved in aqueous KOH solution (1 M) and the product was extracted into CH2CI2 
(20 ml). The combined organic extracts were dried over K2CO3 and the solvent was 
removed to yield the product as a pale red glass (58 mg, 0.152 mmol, 90%), mp 137-
139 °C. ' H NMR (300 MHz, CDCI3) : 5 2.56 (4H, m, ring CH2), 2.69 (8H, s, ring CH2), 
2.80 (4H, m, ring CH2) , 3.87 (2H, s, CH2), 7.38 ( I H , ddd, J 8, 7.2, 1.0, H^), 7.56 (1 H, 
dd, J 8, 1.0, H^), 7.62 (1H, d, J 8, H^), 7.74 (1H, ddd, J 8, 7.2, 1.6, H*), 8.27 (1H, dd, J 
8, 1.6, H^), 8.65 ( I H , d, J 8, H"). '^C NMR (125 MHz, CDCI3) : 8 45.3 (cyclen C), 
46.5 (cyclen C), 47.3 (cyclen C), 52.2 (cyclen C), 61.2 (CHz-AzaH), 115.4 (C^'), 
118.6 (C^), 120.5 (C^), 121.8 (C^'), 124.7 ( C \ 126.8 (C^), 135.6 (C^), 138.0 (C), 
155.8 (C^'), 159.8 (C' ), 166.5 (C^), 177.5 (C^). m/z (ESMS^) 382 (M + H, 100%). 
HRMS (ES^) 382.2237 (C21H28N5O2 requires: 382.2238) 
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1-(2-Azaxanthonylmethyl)-4J,10-tns(ethoxymethylphosphinatomethyl)-
1,4,7,10-tetraazacyclododecane (70) 
Diethoxymethyl phosphine (130 mg, 0.955 mmol) was added to a mixture of l-(2-
azaxanthonylmethyl)-1,4,7,10-tetraazacyclododecane (90 mg, 0.236 mmol) and 
parafomaldehyde (60 mg) in THF (5 ml). The reaction mixture was heated to reflux 
under argon atmosphere overnight. The reaction mixture was filtered and solvent was 
removed under reduced pressure. The residue was purified by chromatography on 
silica (CH2CI2 to 2% MeOH) to yield the product as a brown glass (90 mg, 0.121 
mmol, 13 %). 'H NMR (300 MHz, C D C I 3 ) : 5 1.26 (9H, m, CH2CH3) , 1.53 (9H, m, 
CH3), 2.5-3.3 (22 H, br m, ring CH2, PCH2), 4.03 (8H, m, O C H 2 , CH2) , 7.41 ( IH, ddd, 
J 8, 7.2, 1.0, H ^ 7.58 (1 H, d, J 8, H^), 7.74 (2H, m, J 8 , H^,H*) , 8.29 ( IH, dd, 7 8, 
1.6, H ° ) , 8.64 ( I H , d, J8, H ' ) . ^'P NMR (120 MHz): 6 53.58. 
[TbL''], TbPjMejAzaH 
o A / 
A solution of l-(2-azaxanthonylmethyl)-4,7,10-
rr/'5(ethoxymethylphosphinatomethyl)-1,4,7,10-tetraazacyclododecane (45 mg, 60.7 
fimol) in 6 M HCl (2 ml) was heated to reflux for 24 hours. The progress of the ester 
hydrolysis was monitored by ' H and ^'P NMR. The solvent was removed under 
reduced pressure and the residue was dissolved in water (2 ml) and MeOH (2 ml) and 
TbCl3.6H20 (30 mg, 80.3 j^mol) was added. The pH of the reaction mixture was 
increased to 5.5 by the addition of aqueous KOH solution (1 M). The reaction mixture 
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was heated to 60°C overnight. The solvents were removed and the residue was 
purified by column chromatography on alumina (69 % CH2CI2, 30 % MeOH and 1 % 
ammonia solution). X^bs(H20) 335 nm; TTb(H20) 3.57 ms. 
[EuL^^l EuPsMesAzaH 
0 \ / 
The europium complex was prepared in an analogous manner to the Tb example. 
W H 2 O ) 335 nm; TEU(H20) 1.16 ms. 
2-(4'-Methoxycarbonyl)phenoxy-6-methyl-nicotinic acid (40) 
Methyl-4-hydroxy benzoate (10 g, 65.7 mmol) was added to a freshly made solution 
of sodium methoxide prepared from sodium metal (681 mg, 29.6 mmol) dissolved in 
dry MeOH (20 ml). The solvent was removed and 2-chloro-6-methyl-nicotinic acid 
(2.26 g, 13.2 mmol) was added to the residue. The reaction mixture was heated to 
150°C overnight. The reaction mixture was cooled down, dissolved in water and the 
resulting solution was washed with Et20 (3 x 20 ml). The pH of the aqueous solution 
was adjusted to 4 by the addition of acetic acid and the precipitate that formed was 
collected by filtration. The collected precipitate was dried under vacuum and purified 
by crystallisation from CHCh/hexane mixture to give the product as a white solid (2.3 
g, 8.01 mmol, 61 % ) , mp 139-141°C. ' H NMR (300 MHz, CDCI3) : 5 2.41 (3H, s, 
CH3), 3.91 (3H, s, OCH3), 7.02 ( I H , d, J8, H^), 7.18 (2 H, d, J9 , rf ), 8.07 (2H, d, J 
9, H^'), 8.32 ( IH, d, J8, H^). '^C NMR (75 MHz, CDCI3): 6 24.4 (CH3), 52.3 (OCH3), 
111.3 ( C \ 119.3 (C^), 121.0 (C^'), 126.6 (C^'), 131.4 (C^'), 143.4 (C), 157.6 (C''), 
160.6 (C^), 163.2 (C^), 166.7 (COOCH3), 168.2 (COOH). m/z (ES') 286.0 (M-H). 
HRMS (ES*) 288.0869 (C13H12NO3 requires: 288.0866) (MH^). 
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2-Methyl- 7-methoxycarbonyl-1-azaxanthone (41) 
A mixture of 2-(4'-methoxycarbonyl)phenoxy-6-methyl-nicotinic acid (2.3 g, 8.01 
mmol) and polyphosphoric acid was heated to 120°C overnight. The reaction mixture 
was allowed to cool down and was dissolved in MeOH (150 ml). The pH of the 
resulting solution was increased to 7 by addition of concentrated aqueous NaOH 
solution. The aqueous solution was extracted with CHCI3 (3 x 200 ml). The combined 
organic extracts were dried over K2CO3 and the solvent was removed under reduced 
pressure to yield the product as a off-white solid (0.8 g, 2.97 mmol, 37 % ) , m.p. 194-
196 °C. ' H NMR (300 MHz, CDCI3): 5 2.73 (3H, s, CH3), 3.98 (3H, s, OCH3), 7.24 
( IH, d, J9, H^), 7.65 (1 H, d, J9, H^), 8.41 ( IH , d,J9, U\ 8.61 ( IH, d, J9 , H") , 9.00 
( IH, s, H^). '^C NMR (75 MHz, CDCI3): 5 25.2 (CH3), 52.6 (OCH3), 114.4 (C'), 
118.9 (C^), 121.4 (C^'), 121.8 (C^), 126.8 (C^), 129.2 (C^), 136.0 (C^), 137.6 (C'), 
158.3 (C^'), 160.0 (C''), 165.72 (COOCH3), 165.75 (C'), 176.9 (CO), m/z (ES^) 
269.7 (MH^). HRMS (ES^) found: 270.0760 (C,3H,2N03 requires: 270.0761) (MH^). 
2-Bromomethyl-7-methoxycarbonyl-1-azaxanthone (42) 
0 o 
A solution of 2-methyl-7-methoxycarbonyl-l-azaxanthone (0.8 g, 2.97 mmol), N-
bromosuccinimide (0.25 g, 1.40 mmol) and dibenzoylperoxide (5 mg, 20.6 |imol) in 
CCI4 (10 ml) was heated to reflux. Further additions of NBS (0.25g,) were made after 
4.5, 8.5 and 48 h. Dibenzoylperoxide (5 mg) was added after 2, 4.5 and 7 h; (10 mg) 
after 8.5, 24, 27.5, 32 and 48 h. The reaction was carried out for a total of 55 h. The 
reaction mixture was filtered and the solvent was removed under reduced pressure. 
The residue was purified by chromatography on silica (CH2Cl2/toluene 1:1 to 1 % 
MeOH) to give the product as a light yellow sohd (140 mg, 0.402 mmol, 13.5 % ) , . 
Found: C, 51.64; H, 2.96; N , 3.96%; (Ci5H,oN04Br requires: C, 51.75; H, 2.90; N, 
4.02%). ' H NMR (300 MHz, CDCI3): 5 3.98 (3H, s, OCH3), 4.62 (2H, s, CH2Br), 
7.62 ( IH , d, J 8, H^), 7.68 (1 H, d, J 8.5, H^), 8.44 ( I H , dd, J 8.5, 2, H^), 8.74 ( I H , d. 
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J 8, H " ) , 9.00 ( I H , d, J 2, H^). '^C NMR (75 MHz, CDCI3): 8 32.3 (CHsBr), 52.8 
(OCH3), 116.2 (C'') , 119.2 ( C ^ 121.5 (C^'), 121.6 (C^), 127.3 (C') , 129.4 (C^), 136.6 
(C^), 139.0 (C\ 158.4 (C^'), 159.8 (C''), 162.7 (C') , 165.8 (COOCH3), 176.7 ( C ^ 
m/z(ES^) 348.1 (MH^). 
10-(7-Methoxycarbonyl-2-azaxanthonylmethyl)-1,4,7-
tris(tertbutoxycarbonyl)-1,4,7,10-tetraazacyclododecane (48) 
0 o 
- O 
A solution of 2-bromomethyl-7-methoxycarbonyl-l-azaxanthone (140 mg, 0.402 
mmol), l,4,7-/A-/Xrer/butoxycarbonyl)-1,4,7,10-tetraazacyclododecane ( 190 mg, 0.402 
mmol), K2CO3 (220 mg, 1.59 mmol) and a catalytic amount of K I in acetonitrile ( 1 5 
ml) was heated to reflux ovemight. The reaction mixture was filtered and salts were 
washed with CH2CI2 (3 x 20 ml). The solvents were removed under reduced pressure 
and the residue was purified by chromatography on alumina (CH2CI2 to 2 % MeOH) 
to give the product as a pale yellow sohd ( 200 mg, 0.270 mmol, 67%). ' H NMR (300 
MHz, CDCI3): 5 1.40 ( 9 H , s, CH3), 1.47 ( 1 8 H , s, CH3), 2 .81 ( 4 H , br s, ring CH2), 
3.20-3.70 ( 1 2 H , br m, ring CH2), 3.97 ( 3 H , s, CH3), 4.00 ( 2 H , s, CH2), 7.57 ( I H , d, J 
8, H^), 7.65 (1 H, d, J 8.5, H^), 8.41 ( I H , dd, J 8.5, 2, H ' ) , 8.61 ( I H , d, J 8, H ' ) , 8.98 
( I H , d, J 2 , H^). '^C NMR (75 MHz, CDCI3): 8 28.7 (CH3), 46.5-50.8 (C ring), 52.7 
(OCH3) 58.5-59 (CH2AZA), 79.9 (C^-tBu), 115.4 (C^ ), 119.1 ( C \ 121.6 (C^ ), 122.0 
( C ^ 127.0 (C' ) , 129.4 (C^), 136.2 (C^), 137.7 (C), 158.4 (C^), 159.8 (C''), 160.1 
(C^), 165.9 (COOCH3, COOrBu), 177.1 (C^). m/z (ES^) (MH^) 740.2 (MH^), 762.2 
(MNa^). HRMS (ES^) 740.3860 (C38H54N50,o requires: 740.3865) (MH^). 
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1-(7-Methoxycarbonyl-azaxanthonylmethyl)-1,4,7,10-
tetraazacyclododecane (50) 
NH HN 
A solution of l-(2-methyl-7-methoxycarbonyl-l-azaxanthonyl)-4,7,10-
/m(/'errbutoxycarbonyl)-l,4,7,10-tetraazacyclododecane (200 mg, 0.270 mmol) in 
T F A (7 ml) and CH2CI2 (5 ml) was stirred at room temperature under an argon 
atmosphere overnight. The solvents were removed under reduced pressure and the 
residue was dissolved in CH2CI2 (50 ml) and the solvent was removed. This procedure 
was repeated three times. The residue was dissolved in aqueous K O H solution (1 M) 
and the product was extracted into CH2CI2 (3 x 20ml). The combined organic extracts 
were dried over K2CO3 and the solvent was removed to yield the product as a red 
glass (100 mg, 0.228 mmol, 85 %). ' H N M R (300 MHz, C D C I 3 ) : 6 2.59 (4H, m, ring 
CH2), 2.71 (8H, s, ring CH2), 2.82 (4H, m, ring CH2), 3.89 (2H, s, CH2) , 3.95 (3H, s, 
OCH3) , 7.62 ( I H , d, J 8.5, H \ 7.69 (1 H, d, J 8, H^), 8.38 ( I H , dd, J 8.5, 2, H^), 8.67 
( I H , d, J 8, H") , 8.95 ( I H , d, J 2 , H^). '^C N M R (75 MHz, C D C I 3 ) : 6 45.4, 46.5, 47.4, 
52.3 (C ring), 52.8 (OCH3) , 61.2 ( C H 2 A Z A ) , 115.5 ( C ' ) , 119.1 (C^), 121.6 (C^'), 
122.0 (C^), 127.0 (C^), 129.4 (C^), 136.2 (C*), 137.7 ( C ) , 158.4 (C^'), 159.8 (C' ), 
160.0 (C^), 165.9 (COOCH3), 177.1 (C^). m/z (ES^) 440.3 (MH^). HRMS (ES^) 
440.2288 (C23H30O4N5 requires: 440.2292) (MH^). 
(S)-N-Chloroethanoyl-l-phenylethylamine'" (51) 
o 
A solution of chloroacetyl chloride (12.5 ml, 17.7 g, 157 mmol) in dry diethyl ether 
(50 ml) was added dropwise to the stirred solution of (iS)-l-phenylethylamine (10.6 ml, 
9.96 g, 82.2 mmol) and triethyl amine (12.6 ml, 9.15 g, 90.4 mmol) in dry diethyl 
ether (200 ml) kept at -5°C under argon atmosphere. The reaction mixture was 
allowed to warm up to room temperature and was stirred for a further 4h. The reaction 
mixture was washed with 0.1 M HCl solution and dried over K2CO3. The solvent was 
partially removed under reduced pressure yielding crystals of the product. Further 
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portions of product were obtained by cooling the mother liquors in the refrigerator 
overnight. The product was obtained as white needles (6.5 g, 32.9 mmol, 40 %), mp 
101-103°C (lit'*'. 95-96°C). ' H N M R (300 MHz, CDCI3) ^1.54 (d, 3H, J7 .0 Hz, CHj) , 
4.04 (d, I H , J 16.5 Hz, CH2CI), 4.10 (d, I H , J 16.5 Hz, CH2CI), 5.14 (m, I H , CH), 
6.78 (br, I H , CONH), 7.40-7.20 (m, 5H, Ph). '^C N M R (75.4 MHz, CDCI3) 52\.6 
(CH3), 42.6 (CH2CI), 49.2 (CH), 126.1 (Ph(o)), 127.6 (Ph(p)), 128.7 (Ph(n,)), 142.4 
(Ph(q)), 165.1 (C=0). m/z (ESMS^) 198 ([M+H]^ 10%), 220 ([M+Na]^ 100%). 
1-(2-Methyl-7-methoxycarbonyl-1-azaxanthone)-4,7,10-tris[(S)-1-(1-
phenyl)ethylcarbamoylmethyl]-1,4,7,10'tetraazacyclododecane (53) 
A solution of l-(2-methyl-7-methoxycarbonyl-l-azaxanthone)-1,4,7,10-
tetraaacyclododecane (190 mg, 0.43 mmol), (5)-N-chloroacetyl-l-phenylethylamine 
(285 mg, 1.44 mmol), K 2 C 0 3 ( 1 7 8 mg,) and K I in acetonitrile (10 ml) was heated to 
reflux overnight. The reaction mixture was filtered and the salts collected were 
washed with CH2CI2. The solvents were removed under reduced pressure and the 
residue was purified by chromatography on alumina (CH2CI2 to 2 % MeOH) to yield 
the product as a pale brown glass (300 mg, 0.32 mmol, 74%). ' H NMR (300 MHz, 
CDCI3): 5 1.43 (9 H, m, CH3), 2.3-3.5 (22H, m, ring and arm CH2), 3.79 (2H, s, CH2), 
3.95 (3H, s, OCH3), 4.7-4.95 (3H, m, CH), 7.0-7.4 (15, m, Ph), 7.58 ( IH, d, J8 .5 , H^), 
7.65 (1 H, d, J 8, H^), 8.36 ( I H , dd, J 8.5, 2, H*), 8.46 ( I H , d, J 8, H''), 8.93 ( IH, d, J 
2, H^). m/z (ES^) 923.4 (MH^), 945.4 (MNa^). HRMS (ES^) 923.4818 (C53H63O7N8 
requires: 923.4814) (MH^). 
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[TbL^JCh, TbPhaAZACOOMe 
--,Tb':-
A solution of l-(2-methyl-7-methoxycarbonyl-l-azaxanthone)-4,7,10-rr/.s[(S)-l-(l-
phenyl)ethylcarbamoylmethyl]-l,4,7,10-tetraazacyclododecane (100 mg, 0.108 mmol) 
and Tb(0Tf)3 (64 mg, 0.106 mmol) in acetonitrile (6 ml) was stirred at 60 °C 
overnight. The solvent was removed under reduced pressure and the residue 
redisolved in the minimum volume of acetonitrile. The solution was dropped onto 
Et20 (15 ml) and the precipitate was collected by centrifugation. This procedure was 
repeated three times. The residue was dissolved in MeOH/H20 mixture and the 
triflate counter-ions were exchanged for chloride using a strongly basic anion 
exchange resin. The solvent was removed to yield the product as an off white solid 
(70 mg). m/z (MALDI-TOF^) 1079.4 (M-2H^). H P L C : tR 8.01 min (Method A, 
Appendix), xib (H2O) 1.53 ms. 
[EuL^JCh, EuPhjAZACOOMe 
The europium complex was prepared in an analogous manner to the Tb example. The 
product was obtained as an off-white solid (190 mg). m/z (MALDI-TOF"") 1073.3 (M-
2H^). HPLC: tR 8.01 min (Method A, Appendix), TEU (H2O) 0.58 ms. 
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[GdL'jCh, GdPhjAZACOOMe 
The gadolinium complex was prepared in an analogous manner to the Tb example. 
The product was obtained as an off-white solid (90 mg). m/z (MALDI-TOF^) 1078.5 
(M-2H''). HRMS (MALDI-TOF") 1078.3825 (C53H6oGdN807 requires 1078.3833) 
(M-2H^), H P L C : tR 8.01 min (Method A, Appendix). 
[TbL^^JCh, TbPh3AZAC00H 
Ph 
" " - - ; , T b ' - . . 
A solution of TbPhaAZACOOMe (85 mg) in the mixture of H2O (4 ml) and MeOH (4 
ml) was stirred at room temperature for 24 h, maintaining the pH at 10 by the addition 
of aqueous K O H solution (IM). The reaction progress was monitored by HPLC 
(Method A, Appendix). The pH was adjusted to 7 with HCl solution (1 M). The 
solution was syringe filtered and the solvent was removed. The residue was purified 
by reverse phase H P L C (Method B, Appendix). The solvent was removed to yield the 
product as a white powder (30 mg). m/z (MALDI-TOF^) 1065.4 (M-2H*). HPLC: tR 
7.68 min (Method A, Appendix), xxb (H2O) 1.62 ms. 
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[EuL^°]Ch, EuPhsAZACOOH 
Experimental 
• E u -
The europium complex was prepared in an analogous manner to the Tb example, but 
it was used in fiirther experiments without H P L C purification. The product was 
obtained as an off-white powder (100 mg). m/z (MALDI-TOF^) 1059.3 (M-2H^). 
H P L C : tR 7.68 min (Method A, Appendix). T E U ( H 2 0 ) 0.51 ms. 
[GdL^°]Ch, GdPhaAZACOOH 
Ph 
NH 
V« K 
The gadolinium complex was prepared in an analogous manner to the Eu analogue. 
The solvent was removed under reduced pressure to yield the product as an off white 
powder (45 mg). m/z (MALDI-TOF^) 1064.1 (M-2H^).HPLC: tR7.68 min (Method A, 
Appendix). 
218 
CHAPTER 5 Experimental 
[TbL^^JCh, TbPhsAZACONHS 
E D C (120 mg, 0.404 mmol) and N-hydroxy succinimde (80 mg, 0.695 mmol) were 
added to the stirred solution of TbPhaAZACOOH (150 mg, worked up reaction 
mixture without H P L C purification) in dry DMSO (10 ml). The reaction mixture was 
stirred overnight at room temperature. The reaction progress was monitored by HPLC 
(Method A, Appendix). The product was precipitated by dropping the DMSO solution 
onto dry diethyl ether (30 ml). The residue was triturated with acetonitrile and was 
redissolved in H2O. The solvent was removed by freeze-drying to yield the product as 
a white solid (100 mg). m/z (ES^) 639.5 (M+NHS-H^^), 1277.1 (M+NHS-2H*). 
HRMS (ES^): found 639.210 (M+NHS-H^^); C6oH67N,oOi2'^^Tb requires 639.209, 
found 1277.415 (M+NHS-2H^); CeoHeeNioO.s'^^Tb requires 1277.411. H P L C : IR 8.06 
min (Method A, Appendix). 
[EuL^^JCh, EuPhjAZACONHS 
The europium complex was prepared in an analogous manner as the Tb analogue. The 
solvent was removed by freeze drying to obtain the product as a white solid (130 mg). 
H P L C : tR 8.06 min (Method A, Appendix), TEU (H2O) 0.53 ms. 
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[TbU 'JCh, TbPhjAZA CONC 
Methylamine (5 pd, 33% wt in absolute ethanol, 0.040 mmol) was added to a stirred 
solution of TbPh3AZAC0NHS (20 mg) in dry DMF (2 ml). The reaction mixture was 
stirred at room temperature under an argon atmosphere overnight and the reaction 
progress was monitored by H P L C . The reaction mixture was dropped onto diethyl 
ether (2 ml) and the product was collected by centrifiigation. The residue was 
redissolved in H2O and the solvent was removed by freeze-drying to yield the product 
as a white solid (10 mg). m/z (MALDI-TOF^) 1078.4 (M-2H^). H P L C : tR 7.52 min 
(Method A, Appendix). Tjb (H2O) 1.52 ms. 
[TbL^^JCh, TbPh3AZACONC6 
The hexyl amide complex was prepared in an analogous manner to the methyl amide 
analogue. The crude product was purified by H P L C (Method A, Appendix). The 
solvent was removed by fi-eezedrying to obtain the product as a white solid (8 mg). 
m/z (MALDI-TOF^) 1148.4 (M-2H^). HRMS (MALDI-TOF^) 1148.4770 
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(CsgHviNgOfiTb requires: 1148.4775) (M-2H^). HPLC: IR 8.68 min (Method A, 
Appendix). tTb (H2O) 1.55 ms. 
[EuL^^JCh, EuPh3AZACONC6 
The europium complex was prepared in an analogous manner to the terbium analogue, 
but was not purified by H P L C . The product was obtained as a white solid (9 mg). 
H P L C : tR 8.68 min (Method A, Appendix). 
[TbL^^JCh, TbPh3AZACONC12 
The dodecyl amide complex was prepared in an analogous marmer to the hexylamide 
analogue. The product was obtained as a white solid (7 mg). m/z (MALDI-TOF^) 
1232.5 (M-2H^). HRMS (ES^) 1232.5725 (C64H83N906Tb requires: 1232.5714) (M-
2H^); 1278.5800 (CgsHssNgOgTb requires: 1278.5769) (M+HC00H-2H^); 639.7926 
(CfisHgeNgOgTb requires: 639.7921) (M+HCOOH-H^^). H P L C : tR 10.30 min (Method 
A, Appendix). Xxb (H2O) 1.71 ms. 
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[TbC^JCh, TbPh3AZAC0NQN 
3,4-Methylenedioxybenzylamine (6 |il, 7 mg, 0.048 mmol) was added to the stirred 
solution of TbPh3AZAC0NHS (20 mg) in dry DMF (1 ml). The reaction mixture was 
stirred at room temperature under an argon atmosphere overnight and the reaction 
progress was monitored by H P L C (Method A, Appendix). The reaction mixture was 
dropped onto diethyl ether (10 ml) and the product was collected by centrifugation. 
The residue was redisolved and purified by H P L C (Method E ) . The solvent was 
removed by freeze drying to give the product as white powder (5 mg). m/z (MALDI-
TOF*) 1198.5 (M-2H^).HPLC: tR 8.21 min (Method A, Appendix). iTb (H2O) 1.38 ms. 
[EuL^^JCh, EuPhsAZACONQN 
The europium complex was prepared in an analogous manner to the Tb analogue. The 
product was obtained as a white solid (5 mg). m/z (MALDI-TOF^) 1192.3 (M-2H'"). 
H P L C retention time: 8.21 min (Method A, Appendix), TEU (H2O) 0.52 ms. 
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Boc Gama amino Cholest (85) 
E D C (50 mg), H O B T (35 mg) and DMAP (16 mg) were added to a solution of 
cholesterol (50 mg) and 4-N-^erNbutylcarboxyaminobutanoic acid (55 mg) in dry 
acetonitrile (5 ml). The reaction mixture was stirred at room temperature under argon 
overnight. The solvent was removed under reduced pressure and the product was 
obtained by crystallization from MeOH/DCM. m/z (ESMS^) 594.4 (MNa^). The 
NMR data is discussed in section 4.1.8 and displayed in Appendix 3. 
Gama amino Cholest (86) 
A solution of the /-butyl carboxy protected cholesterol derivative (30 mg) in TFA 
(2ml) and D C M (2ml) was stirred at room temperature under argon atmosphere 
overnight. The solvent was removed under reduced pressure. The crude product was 
used immediately in the next step of the reaction sequence. ' H NMR spectrum is 
displayed in Appendix 3. 
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[TbL^'^JCh. TbPh3AZACONCholest 
Cholest-3-yl-4-aminobutanoate (10 mg) was added to the stirred solution of 
TbPhjAZACONHS (5 mg) and DMAP (2 mg) in dry D M F (1 ml). The reaction 
mixture was stirred at room temperature under argon atmosphere overnight and the 
reaction progress was monitored by H P L C (Method A, Appendix). The reaction 
mixture was dropped onto diethyl ether and the product was collected by 
centrifligation. The residue was purified by H P L C (Method F , Appendix). The solvent 
was removed by freeze drying to yield the product as a white powder (1 mg) m/z 
(MALDI-TOF^) 1518.8 (M-2H^). HPLC: tR 12.69 min (Method A, Appendix), ixb 
(H2O) 1.42 ms. 
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[TbL'^JCh, TbPhjAZACOSpanish 
Ph 
The tetraguanidinium vector 80 (10 mg, 6.4 |j,mol) was added to a stirred solution of 
TbPh3AZAC0NHS (10 mg) in dry DMF (1 ml). The reaction mixture was stirred at 
room temperature under an argon atmosphere overnight and the reaction progress was 
monitored by H P L C (Method A, Appendix). The reaction mixture was dropped onto 
diethyl ether (10 ml) and the product was collected by centrifugation. The residue was 
purified by H P L C (Method C , Appendix). The product was obtained as a white 
powder (3 mg). m/z (MALDI-TOF^) 2134.7 (M-2H^). H P L C : tR 8.29 min (Method A, 
Appendix). iTb (H2O) 1.63 ms. 
[TbL^^J, TbPh3AZACON(Arg)70H 
HN (Arg)70H 
TbPh3AZAC0NHS (3 mg) was added to a stirred solution of Arg? (1 mg) in aqueous 
H E P E S buffer (0.1 ml, 0.1 M, pH 7.4). The reacfion mixture was sUrred at room 
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temperature for 24 h. The reaction progress was monitored by H P L C (Method A, 
Appendix) and further two additions of TbPhsAZACONHS (3 mg) were made. The 
solvent was removed under reduced pressure and the residue was purified by H P L C 
(Method A, Appendix), to give the product as a white solid (1 mg). m/z (MALDI-
TOF"") 2160.0 (M-2H^). H P L C : tR6.09 min (Method A, Appendix), xn (H2O) 1.53 ms. 
[TbL^^], TbPh3AZACONLys(Arg)70H 
Lys(Arg)70H 
TbPh3AZAC0NHS (5 mg) was added to the stirred solution of LysArg? (1 mg) in 
aqueous HEPES buffer (0.1 ml, 0.1 M, pH 7.4). The reaction mixture was stirred at 
room temperature for 24 h. The reaction progress was monitored by H P L C (Method A, 
Appendix) and further two additions of TbPhsAZACONHS (5 mg) were made. The 
solvent was removed under reduced pressure and the residue was purified by H P L C 
(Method A, Appendix), to give the product as a white solid (1 mg). m/z (MALDI-
TOF^) 2286.2 (M-2H^) H P L C : tR 6.09 min (Method A, Appendix), xxb (H2O) 1.53 ms. 
/•TbL^V, TbPhjAZACONGzPAMAM 
TbPh3AZAC0NHS (20 mg) was added to the stirred solution of G2PAMAM 
dendrimer (250 ^1, 20% w /w in MeOH, 43 mg, 0.013 mmol) in DMF (2 ml) and 
MeOH (2 ml). The reaction mixture was stirred at room temperature for 24 h. The 
reaction progress was monitored by H P L C (Method A, Appendix). The solvent was 
removed under reduced pressure and the residue was purified by diailysis (Dialysis 
Tubing: Sigma Aldrich D2272-FT, Benzoylated cellulose, cut off 1200 g/mol) to give 
the product as a white solid (30 mg). TH2O (1-45 ms). 
226 
CHAPTER 5 Experimental 
TbPhsAZACONHSA 
TbPhsAZACONHS (6 .7 mg) was added to the stirred solution of human serum 
albumin (20 mg) in H2O (3 ml). The reaction mixture was stirred at room temperature 
for 24 h. The solvent was removedunder reuced pressure and the residue was purified 
by dialysis (Dialysis Tubing: BDH D102, biodesing dialysis tubing, cellulose, cut off 
8000 g/mol) to give the product as a white solid (15 mg). xmo (1 -63 ms). 
10-(7-IVIetlioxycarbonyl-2-azatliioxanthonylmethiyl)-1,4J-
tris(tertbutoxycarbonyl)-1,4,7,10-tetraazacyclododecane (47) 
A solution of 2-bromo-7-methoxycarbonyl-l-azathioxanthone ( 2 3 0 mg, 0 .661 mmol), 
l,4,7-/m(/errbutoxycarbonyl)-l,4,7,10-tetraazacyclododecane ( 3 0 0 mg, 0 .635 mmol), 
K2CO3 ( 3 2 0 mg, 2 . 3 2 mmol) and a catalytic amount of K I in acetonitrile ( 2 3 ml) was 
heated to reflux overnight. The reaction mixture was filtered and salts were washed 
with CH2CI2. The solvents were removed under reduced pressure. The residue was 
purified by chromatography on alumina (CH2CI2 to 2 % MeOH) to give the product as 
a light-yellow solid ( 3 4 0 mg, 0 .450 mmol, 71%) . ' H NMR ( 3 0 0 MHz, C D C I 3 ) : 5 1.38 
( 9 H , s, CH3), 1.46 ( 1 8 H , s, CH3) , 2 .75 ( 4 H , br s, ring CH2), 3 . 2 0 - 3 . 7 0 ( 1 2 H , br m, ring 
CH2), 3 .97 ( 5 H , s, O C H 3 , CH2) , 7.48 ( I H , d, J 8, H^), 7 .68 (1 H, d, J 8 .5, H^), 8.25 
( I H , dd, J 8 .5, 2 , H^), 8 .72 ( I H , d, J 8, H"*), 9 .19 ( I H , d, J 2, H^). m/z (ES^) 756.3 
(MH^), 778 .4 (M+Na^), 1533.0 (2M+Na^). HRMS (ES^) 7 5 6 . 3 6 4 9 (C38H54N5O9S 
requires: 7 5 6 . 3 6 3 7 ) (MH^); 7 7 8 . 3 4 6 4 (C38H53N509SNa requires: 7 7 8 . 3 4 5 6 ) (M+Na^). 
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1-(7-Methoxycarbonyl-azathioxanthonylmethyl)'1,4,7,10-
tetraazacyclododecane (49) 
A solution of l-(2-methyl-7-methoxycarbonyl-l-azathioxanthone)-4,7,10-
rr/j'(/errbutoxycarbonyl)-l,4,7,10-tetraazacyclododecane (300 mg, 0.397 mmol) in 
T F A (10 ml) and CH2CI2 (7 ml) was stirred at room temperature under an argon 
atmosphere overnight. The solvents were removed under reduced pressure and the 
residue was dissolved in CH2CI2 (10 ml) and the solvent was removed. This procedure 
was repeated three times. The residue was dissolved in aqueous K O H solution (1 M) 
and the product was extracted into CH2CI2 (3 x 25ml). The combined organic extracts 
were dried over K2CO3 and the solvent was removed to yield the product as a red 
glass (120 mg, 0.263 mmol, 66%). ' H N M R (300 MHz, C D C I 3 ) : 6 2.59 (4H, m, ring 
CH2), 2.69 (8H, s, ring CH2), 2.82 (4H, m, ring CH2), 3.87 (2H, s, CH2) , 3.97 (3H, s, 
OCH3) , 7.62 ( I H , d, y 8, H^), 7.68 (1 H, d, J8 .5 , H^), 8.24 ( I H , dd, J 8 . 5 , 2, H^), 8.78 
( IH, d, J 8, H"), 9.19 ( I H , d, J 2, H^). m/z (ES^) 456.3 (MH^). HRMS (ES^) 
456.2062 (C23H30N5O3S requires: 456.2064) (MH^). 
1-(2-Methyl-7-methoxycarbonyl-1-azathioxanthone)-4J,10-tris[(S)-1-(1-
phenyl)ethylcarbamoylmethyl]-1,4,7,10-tetraazacyclododecane (52) 
A solution of l-(2-methyl-7-methoxycarbonyl-l-azathioxanthone)-1,4,7,10-
tetraazacyclododecane (80 mg, 0.176 mmol), 7V-chloroacetyl-l-phenylethylamine 
(106 mg, 0.538 mmol), K2CO3 (125 mg, 0.904 mmol) and K I in acetonitrile was 
heated to reflux overnight. The reaction mixture was filtered and the salts collected 
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were washed with CH2CI2. The combined organic washings were evaporated and the 
residue was purified by chromatography on alumina (CH2CI2 to 2 % MeOH) to yield 
the product as a brown glass ( 4 0 mg, 4 3 ^mol, 2 4 % ) . ' H NMR ( 3 0 0 MHz, CDCI3): 5 
1.48 ( 9 H , m, CH3), 2 . 40 -3 .95 ( 2 4 H , br m, ring CH2, CH2), 3 . 9 9 ( 3 H , s, OCH3), 4 .95 
( 3 H , br m, CH), 7 .62 ( 1H, d, J 8, E \ 7.71 (1 H, d, J 8 .5 , H^), 8 .27 ( I H , dd, J 8.5, 2, 
H*), 8 .73 ( I H , d, J 8, H''), 9 .18 ( I H , d, J 2, H^). m/z (ES^) 939 .5 ( M H ^ ) , 961 .4 
(MNa^). HRMS (ES^) 9 3 9 . 4 5 9 5 (C53H63N8O6S requires: 9 3 9 . 4 5 8 6 ) (MH^), 9 6 1 . 4 4 1 2 
(C53H62N806SNa requires: 9 6 1 . 4 4 0 5 ) (M+Na^). 
[EuCjCh, EuPhsTHAZACOOMe 
A solution of l-(2-methyl-7-methoxycarbonyl-l-azathioxanthone)-4,7,10-tris[(S)-l-
(l-phenyl)ethylcarbamoylmethyl]-l,4,7,10-tetraazacyclododecane ( 3 0 mg, 31.9 i^ mol) 
and Eu(0Tf)3 ( 2 0 mg, 28 .3 ^imol) in acetonitrile (2 ml) was heated to reflux overnight. 
The solvent was removed and the residue dissolved in the minimum amount of 
acetonitrile and was added dropwise to Et20 (30 ml). The precipitate formed was 
separated by centrifugation and the procedure was repeated. The product was dried 
under vacuum. The counter anion was exchanged for chloride using an anion 
exchange resin and the solvent was removed to give the product as a light yellow 
solid ( 2 5 mg, 20 .8 fxmol, 7 3 . 4 % ) . m/z (MALDI-TOF^) 1089.3 (M-2H^). W H 2 O ) 
3 7 0 nm; TEU(H20) 0 .53 ms. 
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[EuL^JCh, EuPhsTHAZACOOH 
A solution of EuPhaTHAZACOOMe (10 mg) in 0.02 M KOH solution (2 ml) was 
stirred at room temperature for 3 h. The reaction progress was monitored by HPLC. 
The pH of the reaction mixture was adjusted to 6 by addition of 1 M HCl solution. 
The precipitate was removed by syringe filtration. The reaction mixture was freeze 
dried to give the product as a white solid. 
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6 Appendixes 
Q.1 Appendix 1: HPLC Conditions 
6.1.1 Method A (Basic analytical gradient) 
Solvent A: H20/O.l% HCOOH (TFA or no added acid) 
Solvent B: ACN/0.1% HCOOH (TFA or no added acid) 
Flow: 1 ml/min 
Time (min) Solvent A (%) Solvent B (%) Curvature 
0 100 0 0 
15 0 100 1 
20 0 100 0 
25 100 0 -3 
27 100 0 0 
6.1.2 Method B 
Solvent A: HjO/OAVo HCOOH 
Solvent B: ACN/0.1% HCOOH 
Flow: 5 ml/min 
Time (min) Solvent A (%) Solvent B (%) Curvature 
0 100 0 0 
11 50 100 1 
13 0 100 -3 
16 0 100 0 
16 100 0 -3 
22 100 0 0 
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6.1.3 Method C 
Solvent A: H2O/0.1% HCOOH 
Solvent B: ACN/0.1% HCOOH 
Flow: 1 ml/min 
Time (min) Solvent A (%) Solvent B (%) Curvature 
0 100 0 0 
6 60 40 1 
11 60 40 0 
13 0 100 -3 
15 0 100 0 
18 100 0 -3 
20 100 0 0 
6.1.4 Method D 
Solvent A: H2O/0.1% HCOOH 
Solvent B: ACN/0.1% HCOOH 
Flow: 1 ml/min 
Time (min) Solvent A (%) Solvent B (%) Curvature 
0 80 20 0 
2 80 20 0 
4 40 60 1 
6 40 60 0 
7 0 100 -3 
9 0 100 0 
10 80 20 -3 
12 80 20 0 
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6.1.5 Method E 
Solvent A: H2O/0.1% HCOOH 
Solvent B: ACN/0.1% HCOOH 
Flow: 5 ml/min 
Time (min) Solvent A (%) Solvent B (%) Curvature 
0 80 20 0 
3 80 20 0 
6 40 60 1 
9 40 60 0 
10.5 0 100 -3 
13.5 0 100 0 
15 80 20 -3 
18 80 20 0 
6.1.6 Method F 
Solvent A: H2O/0.1% HCOOH 
Solvent B: ACN/0.1% HCOOH 
Flow: 1 ml/min 
Time (min) Solvent A (%) Solvent B (%) Curvature 
0 55 45 0 
1.5 55 45 0 
3 5 95 1 
6 5 95 0 
7.5 0 100 -3 
9 0 100 0 
10.5 55 45 -3 
12 55 45 0 
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6.1.7 Method G 
Solvent A: H2O 
Solvents: ACN 
Flow: 5 ml/min 
Time (min) Solvent A (%) Solvent B (%) Curvature 
0 100 0 0 
3 80 20 1 
4 40 60 1 
9 20 80 1 
10.5 0 100 1 
12 0 100 0 
13.5 100 0 -3 
15 100 0 0 
6.1.8 Method H 
Solvent A: HzO/O.P/oTFA 
Solvent B: ACN/0.1% TFA 
Flow: 5 ml/min 
Time (min) Solvent A (%) Solvent B (%) Curvature 
0 95 5 0 
4.5 75 25 1 
6.5 75 25 0 
7.5 0 100 1 
9 0 100 0 
10 95 5 -3 
12 95 5 0 
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6.2 Appendix 2: Selected chromatograms 
6.2.1 Chromatogram of methyl ester complex [LnL^^* 
0 1 2 3 4 5 6 7 
6.2.2 Chromatogram of carboxylic acid complex 
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6.2.3 Chromatogram of NHS ester comples formation 
- A 
6.2.4 Chromatogram of methyl amide complex 
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6.2.5 Chromatogram of the hexyl amide complex 
n / 
6.2.6 Chromatogram of the dodecyl amide complex 
0 1 2 3 A 5 5 7 8 9 10 11 12 13 Id 15 16 17 16 19 20 21 22 23 24 25 26 
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6.2.7 Chromatogram of the coupling reaction mixture for 
oligoarginine peptides 
-50 0 ( H 
TTi-nrTi : i ! i i i . | : i , i , ) J i i U ! ( i i i . i i | i i i i | i i i | i i | i • !M , i , . |,., ,| i,, h i. ( ' | i . i ' l .HI |. • u |i TI .| i i i ; J.KIII|EIII |i ri i | i n N i, M | r .• r|i u ij i. i i i i | i iripii i | i n i M i.i .• j] ii ,j | j i i i i',. 
0 1 2 3 4 5 6 7 B 8 10 11 12 13 14 15 16 17 IB IS 20 21 22 23 24 25 26 
6.2.8 Chromatogram for the purified conjugate with the 
oligoarginine peptide 
1 2 3 4 S 21 22 23 24 2S 26 
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6.2.9 Chromatogram of the oligoguanidinium vector conjugation 
reaction mixture 
20 21 22 23 24 25 26 
6.2.10 Chromatogram of the purified oligoguanidinium 
conjugate 
TiT|i;ii|nii|riii;Tiii|Tii'|'ii[|i'ii[i:ii|nti[Ttt/i 
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6.2.11 Chromatogram of reaction mixture of coupling to 
PAMAM dendrimer 
) 10 00-1 
ICOLD-
30 00: 
10 0O-! 
0 / 
6.2.12 Chromatogram of reaction mixture of coupling to 
PAMAM dendrimer (fluorescence detection) 
0 1 2 3 a 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 
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6.2.13 Chromatogram of purified conjugate with PAMAM 
dendrimer 
6.2.14 Chromatogram of purified conjugate with PAMAM 
dendrimer (fluorescence detection) 
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6.2.15 Chromatogram of purified quencher conjugate 
(Chromatography method D) 
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6.2.16 Chromatogram of cholesterol derivative conjugation 
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6.2.17 Chromatogram of purified cholesterol conjugate 
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6.3 NMR data for cholesterol and its derivatives 
Al l spectra were recorded in CDCI3 at 295 K unless stated otherwise 
6.3.1 NMR spectrum of Cholesterol 
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6.3.3 NMR spectrum of deprotected cholesteryl ester 86 (de 
DMSO) 
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6.3.4 Expansion of NMR spectrum for the Boc protected 
cholestery ester 85 
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6.3.5 ^^ C NMR spectrum of Cholesterol 
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6.3.6 " C NMR spectrum of Boc protected cholesteryl ester 85 
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6.3.7 Aliphatic region of the " C spectrum of Cholesterol 
I 
6.3.8 Aliphatic region of the " C spectrum of the Boc protected 
cholesteryl ester 85 
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6.3.9 COSY spectrum of Cholesterol 
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6.3.10 COSY spectrum of the Boc protected cholesteryl ester 
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6.3.11 HSQC spectrum of Cholesterol 
6.3.12 HSQC spectrum of the Boc protected cholesteryl ester 
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6.3.13 hiMBC spectrum of Cholesterol 
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6.3.14 HMBC spectrum of the Boc protected cholesteryl ester 
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6.3 NMR data for cholesterol and its derivatives 
All spectra were recorded in CDCI3 at 295 K unless stated otherwise 
6.3.1 NMR spectrum of Cholesterol 
6.3.2 NMR spectrum of Boc protected cholesteryl ester 85 
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6.3.3 NMR spectrum of deprotected cholesteryl ester 86 (de-
DMSO) 
6.3.4 Expansion of NMR spectrum for the Boc protected 
cholestery ester 85 
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6.3.5 ^^ C NMR spectrum of Cholesterol 
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6.3.7 Aliphatic region of the ^^ C spectrum of Cholesterol 
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6.3.8 Aliphatic region of the ^^ C spectrum of the Boc protected 
cholesteryl ester 85 
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6.3.9 COSY spectrum of Cholesterol 
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6.3.10 COSY spectrum of the Boc protected cholesteryl ester 
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6.3.11 HSQC spectrum of Cholesterol 
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6.3.13 HMBC spectrum of Cholesterol 
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6.3.14 HMBC spectrum of the Boc protected cholesteryl ester 
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